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Abstract
Neutrophils have been implicated in the pathogenesis of many human
diseases, including the adult respiratory distress syndrome (ARDS),
pulmonary fibrosis and ischaemia-reperfusion injury. Priming of
neutrophils by pre-exposure to bacterial products and inflammatory
mediators represents a potent means of augmenting both the bactericidal
capacity and injurious potential of these cells; in particular, the generation of
reactive oxygen species such as the superoxide anion (O2") may be enhanced
by up to twenty-fold. Greater understanding of the signalling mechanisms
underlying neutrophil priming could lead to novel therapeutic strategies
aimed at preventing neutrophil-mediated tissue injury in these conditions.
Exposure of neutrophils to the priming agents lipopolysaccharide (LPS),
tumour necrosis factor-a (TNFa) and platelet-activating factor (PAF) was
shown to modulate adhesion molecule expression and function (in particular
inducing upregulation of (3? integrins and shedding of L-selectin) in an
agonist-specific fashion, with a time-course which correlated with that
required to establish the primed state.
Neutrophil chemoattractant receptors are coupled to intracellular signalling
pathways by heterotrimeric G-proteins, principally Gi«2. I have shown that
TNFa, LPS and PAF increase the level of G;a2 expression detectable in
neutrophil membranes, the time-course for this effect mirroring that for
priming. However, the degree of G-protein upregulation is considerably less
than the enhancement of the respiratory burst, suggesting that downstream
signalling events play a more critical mechanistic role in priming. Two
major signalling pathways implicated in the activation of the neutrophil
respiratory burst were studied; the cleavage of the membrane phospholipid
phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2) by phospholipase C to
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yield inositol 1,4,5-trisphosphate (Ins(l,4,5)P3), and its phosphorylation by
phosphatidylinositol 3-hydroxykinase (PI3K) to phosphatidylinositol 3,4,5-
trisphosphate (PtdIns(3,4,5)P3). Accumulation of neutrophil Ins(l,4,5)P3 (the
signal for intracellular calcium release) in response to the secretagogue N-
formyl-methionyl-leucyl-phenylalanine (fMLP) was identical in unprimed
and primed neutrophils, suggesting that modulation of phospholipase C
activity is not involved in signalling neutrophil priming. A small but
significant enhancement of fMLP-stimulated PtdIns(3,4,5)P3 accumulation
(about 25%) was seen at 10 s in TNFa-primed versus unprimed cells, but 60 s
following fMLP stimulation this enhancement was 620%. This suggests that
enhanced and sustained PtdIns(3,4,5)P3 generation may be important in
signalling mechanisms leading to the primed respiratory burst.
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Abbreviations
ACLB Albumin-coated latex beads
ARDS Adult respiratory distress syndrome
ATP Adenosine triphosphate
BAC Bovine adrenal cortex
BAL Bronchoalveolar lavage
BCA Binchinoic acid
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[Ca2+]i Intracellular free calcium concentration
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FAK Focal adhesion kinase
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SOD Superoxide dismutase
TNFa Tumour necrosis factor-a
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Chapter 1: Introduction
1.1 The Neutrophil - General
Following its discovery by Ehrlich in 1879 the neutrophil has been
recognised as the most numerous of the circulating phagocytes, constituting
in most species approximately half the circulating white cell population; its
fundamental importance in host defence is emphasised by the fact that,
phylogenetically, it emerged long before the lymphocyte. Studies using
radiolabeled neutrophils suggest that they have a short circulating half-life
(about 6.6 hrs) in the blood (Mauer et al., 1960). Neutrophils are recruited
rapidly and in large numbers to sites of infection or inflammation, where
they respond to the injurious agent(s) by phagocytosis of microorganisms,
by the release of preformed toxic enzymes and proteins from an array of
granules, and by the de novo production of a range of potentially damaging
but ephemeral reactive oxygen intermediates (ROI). That these functions are
essential to host defence is illustrated by the marked propensity to develop
infection seen in certain deficiency syndromes, discussed below (section 1.5).
Paradoxically, it is believed that the inappropriate or excessive release of
these compounds may also contribute to inflammatory tissue injury in a
variety of disease states (section 1.6).
The neutrophil has previously been regarded as an unsubtle, immutable
vehicle, existing in either a fully quiescent or a fully activated state, recruited
in bulk to inflammatory foci to deliver its toxic products and to die. More
recent research has revealed that the neutrophil, although an end-stage cell,
is complex and variable in its functional responses. In particular, neutrophil
functions can be regulated by environmental factors, and their secretory/
injurious potential greatly amplified by a variety of priming agents; these
include bacterial products (such as lipopolysaccharide (LPS) and the
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formylated peptides), cytokines (such as tumour necrosis factor-a (TNFa),
interleukin-8 (IL-8), granulocyte macrophage-colony stimulating factor (GM-
CSF) and interferon-y (IFNy)), and lipid mediators (e.g. platelet activating
factor (PAF) and leukotriene B4 (LTB4)). These mediators, generated in the
vicinity of inflammatory sites, both stimulate an influx of neutrophils by
chemotaxis and modulate their effector functions, ideally eliminating the
injurious stimulus without damage to host tissue. However, as neutrophil
priming may also increase neutrophil-mediated tissue injury, the dissection
of priming mechanisms may lead to a fuller understanding of the
pathogenesis of host tissue damage, and ultimately to the development of
novel therapeutic strategies to reduce such injury.
Very low concentrations (10~10-10~9 M) of chemotactic agents such as the
complement component C5a, the formylated peptide N-formyl-methionyl-
leucyl-phenylalanine (fMLP) and the chemokine IL-8, induce neutrophil
shape-change with polarisation and chemotaxis. Directed migration leads to
the exposure of the neutrophil to progressively higher concentrations of
inflammatory mediators, resulting in priming and ultimately full activation.
Activated chemotactic receptors couple to GTP-binding proteins (G-
proteins), stimulating a variety of cellular signal transduction processes (see
Figure 1.1). Activation of phosphatidylinositol-specific phospholipase C
(PIC) results in the cleavage of the membrane phospholipid
phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2) to yield diacylglycerol
(DAG) and inositol 1,4,5-trisphosphate (Ins(l,4,5)P3). Ins(l,4,5)P3 diffuses
into the cytosol and induces the release of Ca2+ from intracellular stores
(Streb et al., 1983) with consequent influx of Ca2+ through the plasma
membrane, and a transient increase in cytosolic calcium concentration
([Ca2+]j). The lipid DAG remains membrane-associated; DAG is also













Figure 1.1 Signalling Pathways in Activated Neutrophils
PtdIns(4,5)P2 acts as a substrate for both PI3K and for PIC, yielding
PtdIns(3,4,5)P3 (physiological role(s) uncertain) and both Ins(l,4,5)P3 (the
messenger for intracellular Ca2+ release) and the PKC activator DAG (also
derived from PA, cleaved from phosphatidylcholine (PC) by PLD),
respectively. PAF and arachidonate are derived from PC by the action of
phospholipase A2.
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phospholipase D, and activates members of the protein kinase C family
(Nishizuka, 1984) which phosphorylate components of the oxygen radical-
generating system. G-protein coupled receptors also activate phospholipase
A2 (PLA2), leading to the generation of arachidonate, lyso-PAF and hence
PAF (Chilton et al., 1984). Arachidonate can activate the NADPH oxidase in
cell-free systems. The activation of various enzymes is regulated by
phosphorylation of critical tyrosine residues (see section 1.8.7). Finally, the
recently described phosphatidylinositol 3-hydroxykinase (PI3K) can
phosphorylate Ptdlns(4/5)P2 to generate the putative second messenger
phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3). Priming agents
could therefore be acting at the level of the receptors, G-proteins, signalling
pathways, tyrosine phosphorylation or effector mechanisms (NADPH
oxidase) to produce the enhanced responsiveness characteristic of the
inflammatory neutrophil.
1.2 Neutrophil Granules
Much of the destructive potential of the neutrophil relates to the proteases
and microbicidal factors localised within a variety of granules; additionally,
several adhesion molecules and chemotactic factor receptors stored in the
granule membranes can be mobilised to the plasma membrane upon
exocytosis. Differences in granule composition distinguish neutrophils from
other granulocytes. The traditional classification of neutrophil granules as
peroxidase-positive (azurophil, or primary) or peroxidase-negative (specific
or secondary) has proved too simple to account for the observed differential
exocytosis of granule protein and incorporation of granule membrane into




Secretory vesicle membranes contain the adhesion receptor CDllb/CD18
(Mac-1), essential for integrin-mediated neutrophil adhesion (Sengelov et al.,
1993a, Calafat et al., 1993) in addition to the fMLP-receptor (Jesaitis et al.,
1982), alkaline phosphatase, and cytochrome bssg (the membrane component
of the NADPH oxidase, Calafat et al., 1993); decay accelerating factor may
also be present (Berger et al., 1987). Secretory vesicles are the most readily
and rapidly mobilised of the neutrophil granules (Sengelov et al., 1993b),
providing prompt upregulation of cell surface CDllb/CD18 (promoting
adhesive events) and fMLP receptors (supplying the capacity to augment
cellular chemoattractant responsiveness).
1.2.2 Specific (Secondary) Granules
These spherical or rod-shaped granules are defined by their content of
lactoferrin; they are also an important store of cytochrome bsss (Borregaard
et al., 1983, Borregard and Tauber, 1984), FcRIII (receptors for the Fc portion
of antibodies, Tosi et al., 1992), adhesion molecules (Bainton et al., 1987) and
fMLP receptors (Fletcher and Gallin, 1983).
1.2.3 Gelatinase (Tertiary) Granules
These granules are smaller than the specific granules and constitute
approximately 25% of all peroxidase-negative granules. They are principally
composed of the protease gelatinase, which may be involved in digesting the
vascular basement membrane to allow neutrophil extravasation (Weiss and
Peppin, 1986)
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1.2.4 Azurophilic (Peroxidase-Positive) Granules
Azurophil granules store the majority of the proteolytic and bactericidal
proteins (myeloperoxidase, cathepsins, elastase, (3-glucuronidase, lysozyme,
defensins etc.) with no receptors or adhesion molecules demonstrated in
their membranes. Azurophil granules are mobilised slowly, and generally
only in a limited fashion.
1.3 The NADPH Oxidase and the Respiratory Burst
During phagocytosis, neutrophils (and other phagocytes) exhibit an intense
burst of oxygen consumption (Baldridge and Gerard, 1933) known as the
respiratory burst, which is essential for the killing of ingested
microorganisms. The net reaction of the burst is the transfer of electrons
from NADPH (generated by the hexose monophosphate shunt) to oxygen,
producing superoxide anions (CV). The enzyme system which catalyses this
reaction is known collectively as the NADPH oxidase; defects within this
system lead to the condition of chronic granulomatous disease (CGD),
characterised by increased susceptibility to bacterial infection. Study of the
neutrophils of patients suffering from this condition has yielded much
information concerning the individual components of the NADPH oxidase
and their functions (reviewed by Thrasher et al., 1994).
1.3.1 Cytochrome b558
Cytochrome bsss is located within the plasma membrane and in the
membranes of peroxidase-negative granules. It consists of an a- and a (3-
subunit, designated p2lPhox and p9lPhox respectively according to their
molecular weights (phox - phagocyte oxidase). Absence of the cytochrome is
the commonest molecular lesion underlying CGD (Casimir et al., 1992); both
subunits are required for mutual stability. In the majority of cases, CGD is
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X-linked, the gene coding for p9lPhox being located on the X chromosome. A
small number of patients lacking cytochrome bsss do so as a consequence of
an autosomal recessive inheritance of a defective p2lPhox. The binding site
for NADPH has been shown to reside in the p9lPhox component of the
oxidase (Rotrosen et al., 1992); indeed, the entire electron transport chain
from NADPH to oxygen is contained within the cytochrome bssg, although
cytoplasmic factors are essential for its activation/regulation (section 1.3.2).
1.3.2. Cytosolic components of the NADPH Oxidase: p47Phox, p67Phox and
p40Phox
One third of patients with CGD display an autosomal recessive pattern of
inheritance, the majority having a normal flavocytochrome and lacking one
of two cytosolic proteins. p47Phox was discovered as a protein which became
phosphorylated on activation of normal phagocytes but was absent from the
neutrophils of most of these patients (Segal et al., 1985); p67Phox was
subsequently shown to be missing from the small number of remaining
patients (Volpp et al., 1988). The small GTP-binding protein p21rac is also
thought to be vital for oxidase activation, since it is essential to reconstitute
oxidase activity in cell-free assays (see 1.3.3). Oxidase activity can be
reconstituted with recombinant p47Phox, p67Phox, p21rac and purified (Abo et
al., 1992) or recombinant (Rotrosen et al., 1993) cytochrome bsss-
p47phox phosphorylated in discrete steps on at least seven serine residues
(El Benna et al., 1994), and the phosphorylation events have been correlated
with activation of the oxidase (Okamura et al., 1988, Rotrosen and Leto,
1990). More recently, p67Phox was also shown to become phosphorylated
(Dusi and Rossi, 1993). Both factors translocate to the plasma membrane
when cells are activated (Clark et al., 1990). Two lines of evidence suggest












Figure 1.2 NADPH Oxidase Assembly
Agonist stimulation results in assembly of the NADPH oxidase from (A) its
component parts (the flavocytochrome bsss subunits p9lPhox and p2lPhox and
the cytosolic factors p47Phox, p67Phox and p21rac) to the fully functional
enzyme (B).
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not occur when the cytochrome is absent in X-linked CGD (Heyworth et al.,
1991), and secondly, peptides corresponding to the C-termini of the
flavocytochrome inhibit this translocation (Rotrosen et al., 1990, Nakanishi et
al., 1992).
A further protein which has strong homology with p47Phox, p40Phox, has
been found to co-immunoprecipitate with p67Phox (Wientjes et al., 1993).
p40Phox is not required for activity in the cell-free system, and as yet no CGD
patients have been identified who lack this protein, hence its function is
speculative.
1.3.3 Cytosolic Components of the NADPH Oxidase: Small G-proteins
The ras-related family of small G-proteins act as molecular switches, with the
bound nucleotide modulated between the GTP -on and GDP -off modes by
other regulatory molecules. One such protein, p21rac, is required for
reconstitution of respiratory burst activity in the cell-free system. Upon
stimulation of neutrophils, p21rac dissociates from its complex with a GDI
(GDP-dissociation inhibitor) and translocates to the membrane
simultaneously with p47Phox and p67Phox (Quinn et al., 1993, Abo et al.,
1994). Reduction of p21rac activity by anti-sense oligonucleotides in B
lymphocytes was shown to diminish oxidase activity (Dorsueil et al., 1992).
Additionally, increased oxidase activity was reported in bcr-knockout mice
(Voncken et al., 1995); bcr is a GTPase-activating protein for p21rac, and
diminution of bcr would be expected to result in higher levels of active
p21rac.
The precise role of p21rac in oxidase activation remains to be elucidated. Its
role in actin microfilament reorganisation during membrane ruffling (Ridley
et al., 1992) suggests an involvement with the cytoskeleton, while the
recently described association of p21rac with p21-activated kinase (Prigmore
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et al., 1995) indicates a possible action via a downstream kinase. Neither of
these possibilities, however, explain the need for p21rac in cell-free systems.
1.3.4 Production of Reactive Oxygen Intermediates
The NADPH oxidase catalyses the following reaction:
NADPH + H+ + 202 -> NADP+ + 2H+ + 202"
NADPH produced by the cytosolic hexose monophosphate shunt functions
as an electron donor to effect a one electron reduction of each of two atoms
of molecular oxygen (Babior et al., 1973). The 02" so formed dismutates to
form hydrogen peroxide, a reaction catalysed by superoxide dismutase:
202" + 2H+ —> 02 + H202
In the presence of halide ions (preferentially chloride ions) and H202,
myeloperoxidase released from neutrophil azurophilic granules can catalyse
the generation of hypohalous acids, such as hypochlorous acid:
H202 + HC1 HOC1 + H20
Cytotoxic effects attributable to hypochlorous acid include:
oxidation/decarboxylation of membrane proteins, leading to increased
bacterial cell permeability (Albrich et al., 1986), oxidation of components of
the bacterial respiratory chain (Rakita et al., 1989), membrane peroxidation
(Winterbourn et al., 1992) and formation of chloramine (Bernofsky, 1991).
Even more reactive products such as hydroxyl radical and singlet oxygen
may also be formed, but they are so short-lived that detection is difficult and
their role uncertain (reviewed in Rosen et al., 1995)
10
1.4 Other Neutrophil Functions
1.4.1 Phagocytosis
Once a neutrophil has migrated into the tissues, its primary purpose is to
recognise, phagocytose and destroy microorganisms. Phagocytosis consists
of two steps - recognition, and ingestion into the phagosome. In most cases,
recognition is dependent on opsonisation by specific (immunoglobulins) or
non-specific (complement components) plasma proteins which bind
neutrophil cell surface receptors. For engulfment of an opsonised particle to
occur, pseudopods rich in filamentous actin must form and surround the
particle; this requires actin polymerisation and is inhibited by agents such as
cytochalasins which block this latter process (Zigmond and Hirsch, 1972).
During phagocytosis, the oxidative burst is initiated (1.3) and cytosolic
granules (1.2) fuse with the invaginating plasma membrane, creating a
highly toxic microenvironment. Other metabolic pathways are also activated
by phagocytosis (Delia Bianca et al., 1993) including the synthesis of
bioactive lipids (see 1.4.2) and of cytokines (1.4.3)
1.4.2 Synthesis of Bioactive Lipids
Activation of 1-O-alkyl PC-specific PLA2 liberates lyso PAF and arachidonic
acid from the membrane phospholipid l-0-alkyl-2-arachidonyl-s?i-glycero-3-
phosphocholine (Chilton et al., 1984); transfer of acetate from acetyl CoA to
lyso-PAF yields PAF, whilst arachidonic acid may be metabolised to LTA4
and LTB4. Neutrophils synthesise LTB4 in response to a variety of stimuli,
including fMLP (Clancy et al., 1983); LTB4 stimulates many neutrophil
functions, including chemotaxis (Palmblad et al., 1981), calcium mobilisation
(Nacchache and Sha'afi, 1983) and degranulation (Bokoch and Reed, 1981).
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The effects of PAF on neutrophil functions are considered in greater detail
below (1.7.4).
1.4.3 Cytokine Production
Protein synthesis by neutrophils can be elicited by a variety of agonists
including fMLP, TNFa and GM-CSF (Beaulieu et al., 1992), and several
cytokines are produced including interleukin-1 (IL-1) (Tiku et al., 1986), IL-8
(Bazzoni et al., 1991) and TNFa (Dubravek et al., 1990). Because of the large
numbers of neutrophils recruited to inflammatory foci, the impact of
cytokine synthesis by these cells may be highly significant.
1.5 The Role of the Neutrophil in Host Defence: Neutrophil Dysfunction
Neutrophil disorders may be asymptomatic or characterised by recurrent
infections, especially with pyogenic bacteria. Abnormalities may be
quantitative (neutropenia) or qualitative (disorders of adhesion, chemotaxis,
phagocytosis or killing), and they may be congenital or acquired. Gram-
negative bacilli such as Pseudomonas aeruginosa, Klebsiella species and
Escherichia coli, Gram-positive cocci (Streptococci and Staphylococci) and
fungi (Candida species and Pneumocystis carinii) are common causes of
infection in patients with neutrophil dysfunction.
1.5.1 Neutropenia
The hallmark study of Bodey et al. (1966) demonstrated that the risk of
infection in granulocytopenic patients increases rapidly when the
granulocyte count falls to below 0.5xl09/l, with the majority of life-
threatening infections occurring at <0.1xl09/l. Neutropenia may occur as an
isolated deficiency or be associated with other cytopenias, as in aplastic
anaemia. Neutropenia may be secondary to treatment with cytotoxic drugs,
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autoimmune destruction, or may be congenital, constitutional or idiopathic.
Drug-induced neutropenia is by far the commonest group seen in medical
practice.
1.5.2 Disorders of Leukocyte Migration
1.5.2.1 Defects of Chemotaxis
Neutrophils respond to low concentrations of chemotactic agents such as
C5a and fMLP by undergoing polarisation and directed locomotion along
the chemotactic gradient, facilitating recruitment to inflammatory sites. In a
study of 94 patients with recurrent infections localised to the respiratory
tract or skin, Ottonello et al. (1995) found disordered chemotaxis in 41 cases,
suggesting that this may be a relatively common abnormality. Defects were
found in response to either agent individually or to both; the molecular
mechanisms underlying the disorders were not investigated.
1.5.2.2 Leukocyte Adhesion Deficiency
Just as the study of patients with chronic granulomatous disease has helped
to elucidate the mechanisms underlying the respiratory burst, so the
molecular mechanisms of neutrophil adhesion to the endothelium have been
clarified by the study of various leukocyte adhesion deficiency (LAD) states.
The patients suffer recurrent life-threatening bacterial and fungal infections,
with a persistent peripheral blood granulocytosis and a failure of neutrophils
to migrate to sites of infection. In the majority of cases (those with LAD type
I, Anderson and Springer, 1987) the underlying anomaly is a mutation in the
gene coding for the common p subunit (CD18) of the neutrophil (32 integrins,
which mediate firm adhesion to the endothelial cells (1.8.6) by binding to
their counter-receptor, intercellular adhesion molecule-1 (ICAM-1). A
minority of patients have been described with an identical clinical syndrome
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but normal integrin structure and function; in these cases, designated LAD
type II, the abnormality lies in the glycosylation of a family of glycoproteins,
the selectins, which mediate the initial transient contacts of the neutrophil
with the vascular endothelium (Phillips et al., 1995). Neutrophil adhesion is
discussed in greater detail in Chapter 4.
1.5.3 Disorders of Killing
1.5.3.1 Granule Abnormalities
The commonest disorder affecting neutrophil granules is hereditary
myeloperoxidase deficiency, which occurs in 1/2000-1/5000 people and is
not usually associated with any clinical abnormality or with increased
susceptibility to infection (Kitahara et al., 1981). In contrast, the rare
Chediak-Higashi syndrome, an autosomal recessive condition characterised
by abnormally large neutrophil granules and albinism, is associated with a
predisposition to infection (Rausch et al., 1978).
1.5.3.2 Chronic Granulomatous Disease
As discussed above (1.3) this condition results from abnormalities in the
various components of the NADPH oxidase, with resultant failure to
generate a respiratory burst on phagocytosis (reviewed in Thrasher et al.,
1994). Neutrophils migrate normally and phagocytose microorganisms, but
there is a failure of intracellular killing. Clinically, the syndrome is
characterised by recurrent bacterial and fungal infections, particularly at
epithelial surfaces in direct contact with the environment (skin, mucous
membranes, lung and gut); histology reveals widespread granulomatous
infiltration of tissues, probably resulting from the inability to eliminate
infectious agents. Diagnosis is made by the failure of neutrophils to oxidise
14
nitroblue tetrazolium on stimulation with the phorbol ester, PMA (phorbol
myristate acetate).
This disease results in serious morbidity and early death in many affected
individuals. Treatment is with antibiotics (both prophylactically and to treat
intercurrent infection), antifungals, the administration of immunodulatory
cytokines (particularly interferon-y), and in some cases bone marrow
transplantation.
1.6. The Role of Neutrophils in Tissue Destruction
The neutrophil has been increasingly implicated as a mediator of tissue
injury in a variety of inflammatory conditions such as the adult respiratory
distress syndrome (ARDS) (reviewed by Donnelly and Haslett, 1992),
pulmonary fibrosis (e.g. Behr et al., 1991), vasculitic diseases (reviewed by
Savage and Rees, 1994) and ischaemia-reperfusion injury (reviewed by
Williams, 1994). Although the neutrophil's arsenal of toxins normally
defends the host against invading microorganisms, it has no intrinsic ability
to differentiate between foreign and host antigens and must rely on the
specific arms of the immune response (antibodies, and other cells) to select
its targets. If normal host tissues are wrongly identified as foreign, or if
inflammatory stimuli overwhelm the normal controls preventing generalised
activation, the neutrophil's destructive potential will be inappropriately
elicited. The role of the neutrophil has been studied in great depth in the
adult respiratory distress syndrome (ARDS), which serves as a good model
for other disease states in which the neutrophil is a key player.
1.6.1 The Neutrophil in ARDS
ARDS is a form of acute lung injury characterised by high permeability
pulmonary oedema and refractory hypoxaemia (Ashbaugh et al., 1967)
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following a wide variety of pulmonary and non-pulmonary insults (e.g.
pneumonia, septicaemia, pancreatitis, multiple trauma and gastric
aspiration; Fowler et al., 1983). Despite improvements in supportive care, no
effective specific treatment exists and the mortality from the condition
remains at 50-70% (Rocker et al., 1989); hence the underlying inflammatory
mechanisms are being studied to identify potential therapeutic avenues.
Both morphologic (Bachofen and Weibel, 1977) and bronchoalveolar lavage
(BAL) studies (Fowler et al., 1987, Lee et al., 1981) have demonstrated that
neutrophils are present in large numbers in the lower respiratory tract of
patients with ARDS; Weiland et al. (1986) have correlated the percentage of
neutrophils obtained at lavage with the severity of lung injury.
Additionally, Zimmerman et al. (1983) found evidence of activated
neutrophils in the pulmonary circulation of patients with ARDS. The
neutrophil proteases elastase (Lee et al., 1981) and collagenase (Christner et
al., 1985) have been identified in excess in BAL fluid; these enzymes, and
hydrogen peroxide found in expired air from ARDS patients receiving
assisted ventilation (Baldwin et al., 1986) are thought to derive from
activated inflammatory cells within the damaged lung. Neutrophil
proteases and ROI may interact to cause tissue injury; for example, Cochrane
et al. (1983) demonstrated oxidant-induced inactivation of a-1 proteinase
inhibitor, which neutralises neutrophil elastase, in the BAL fluid from
patients suffering from ARDS.
Multiple animal models of ARDS also support a pathogenic role for the
neutrophil. Drug-induced neutropenia decreased the severity of lung injury
induced by circulating endotoxin (Heflin and Brigham, 1981), hyperoxia
(Shasby et al., 1982a) and microembolisation (Flick et al., 1981, Johnson and
Malik, 1980). Isolated lungs became oedematous when perfused with
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stimulated neutrophils, but not when neutrophils from patients with CGD
were used (Shasby et al., 1982b).
The normal lung contains a 'marginated' pool of neutrophils in a state of
dynamic equilibrium with the circulating pool; this localisation of potentially
destructive cells may explain why the lung is at risk of injury from a variety
of local and distant insults. Inflammatory mediators, particularly bacterial
endotoxin (LPS), reduce neutrophil deformability and enhance pulmonary
vascular sequestration of neutrophils (Haslett et al., 1987), and trace amounts
of LPS synergise with neutrophil chemotactic factors to damage rabbit
pulmonary vascular endothelium (Worthen et al., 1987). Circulating
endotoxin has been associated with the development of ARDS in humans
(Parsons et al., 1989). These factors have led to a proposed mechanism for
the development of ARDS (Haslett and Donnelly, 1992); inflammatory
mediators promote pulmonary sequestration of neutrophils by reducing
deformability and enhancing adhesion receptor expression (see Chapter 4),
and prime them for enhanced release of oxygen radicals and proteases (see
Section 1.7) in a restricted neutrophil-endothelial environment which favours
cell injury.
Despite all the evidence implicating the neutrophil as a key mediator of
tissue injury in ARDS, the syndrome has been reported to occur in
granulocytopenic patients (Braude et al., 1985), suggesting that neutrophil-
independent mechanisms (for example, infection, graft-versus-host disease
and involvement of other cell types such as monocytes/macrophages) can
also lead to ARDS. The fact that ARDS is encountered very infrequently in
neutropenic patients who are prone to recurrent severe gram-negative
infections again suggests that neutropenia may protect against ARDS to a
certain extent. In a study of 14 patients with chemotherapy-induced
neutropenia and ARDS, Rinaldo and Borovetz (1985) noted that the gas-
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exchange abnormalities worsened as the peripheral neutrophil counts
increased towards normal, providing evidence that neutrophils are an
important, but not the sole cause of lung injury in patients with ARDS.
1.7. Neutrophil Priming
Neutrophils do not express their full microbicidal effector functions
(generation of ROI and bioactive lipids, degranulation, etc.) in response to
biological activating agents unless they have first been primed. Priming
refers to the process whereby the response of a cell to a subsequent
(activating) stimulus is potentiated, sometimes greatly, by previous exposure
to a priming agent. The priming agent does not by itself initiate the effector
function(s) and must be presented to the cell before the activating stimulus.
Neutrophil priming was first demonstrated in 1984 by Guthrie et al., who
showed that preincubation of freshly isolated human neutrophils with
bacterial endotoxin did not in itself elicit a respiratory burst, but greatly
enhanced the oxidative response to fMLP, and to a far lesser extent to PMA.
fMLP applied to unprimed neutrophils stimulated only minimal O2"
generation: indeed, since the manipulations required to isolate neutrophils
themselves may cause priming (Haslett et al., 1985) truly unprimed
circulating neutrophils may be totally unresponsive to fMLP-induced
degranulation or O2" generation unless they are exposed to priming agents.
A wide array of substances, both physiological and physicochemical, have
since been shown to act as priming agents (see Table 1.1). The variety of
preincubation times required to obtain a maximally primed response, which
ranges from a few seconds (ATP) to several hours (LPS, GM-CSF,
interferon-y), implies that differing signal transduction routes are utilised by
these agents. In addition to the respiratory burst, priming of the
degranulation response (Fittschen et al., 1988) and of the generation of lipid
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Figure 1.3
Macrophage Endothelial Cell Bacteria
Unprimed neutrophil Primed neutrophil
Stimulus e.g. fMLP
T
Minimal secretion Amplified secretion
of enzymes/ROI of enzymes/ROI
Figure 1.3 Neutrophil Priming
Priming of neutrophils by the products of activated macrophages (e.g. TNFoc,
GM-CSF), endothelial cells (e.g. PAF) and bacteria (e.g. LPS) does not lead
directly to the release of toxic products but results in amplified secretion of




Priming Agent Time for Maximal
Priming
Reference
ATP 15 s Kuhns et al., 1988
Substance P 1 min Lloyds et al., 1993
Ionomycin 2 min Finkel et al., 1987
Inositol hexakisphosphate 2 min Eggleton et al., 1991
L-selectin cross-linking 3 min Waddell et al, 1994
PAF 5 min Vercellotti et al., 1988
CD18 cross-linking 5 min Liles et al., 1995
TNFa 10 min Berkow et al., 1987
Interleukin-8 10 min Daniels et al., 1992
Orthovanadate 10 min Lloyds et al., 1994
Influenza A virus 30 min Busse et al., 1991
LPS 120 min Guthrie et al., 1984
GM-CSF 120 min Weisbart et al., 1986a
Interferon-y 120 min Tennenberg et al., 1993
mediators (principally arachidonic acid (AA), leukotriene B4 (LTB4) and
and PAF; Doerfler et al., 1989 and 1994) has been described. Different
mediators have also been reported to display a different spectrum of
priming activity; for example, unlike LPS, GM-CSF primes the oxidative
burst stimulated by fMLP but not by PMA (Weisbart et ah, 1986a).
Additionally, whilst TNFa produces up to a 20-fold augmentation of the
fMLP-stimulated respiratory burst, weaker priming agents exist, such as
inositol hexakisphosphate (InsP6: Eggleton et al., 1991) and interferon-y
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(Tennenberg et al., 1993) that elicit at best a doubling of the response. A
final complication is that sub-threshold concentrations of classical
'activating' agents such as fMLP can act as primers (English et al., 1981). Any
mechanism proposed to underlie priming must encompass these facts.
1.7.1 Neutrophil Priming in Vivo
Although priming was described initially as an in vitro phenomenon, many
priming agents are biologically relevant inflammatory mediators released in
response to infection, trauma, haemorrhage and inflammatory states.
Circulating endotoxin has been associated with the development of ARDS
(Parsons et al., 1989), and persisting high levels of TNFa and interleukin-6
(IL-6) have been linked to poor outcome in septic shock (Pinsky et al., 1993).
While cytokines are detectable in the bloodstream only in extreme
circumstances, locally generated mediators will upregulate the functional
responses of extravasated neutrophils; indeed, since cross-linking of
neutrophil adhesion receptors is itself a priming stimulus (Waddell et al.,
1994, Liles et al., 1995), the process of extravasation per se may result in a
degree of priming. Additionally, while most studies have concentrated on
isolated agents, a few studies have reported synergy between priming agents
(Elbim et al., 1994, Roberts et al., 1993), a situation which is likely to be more
analogous to the cytokine cascade generated by an inflammatory response.
Two approaches have been used to study priming in vivo; firstly,
investigators have infused priming agents into laboratory animals or human
volunteers and studied granulocyte responses, and secondly, neutrophils
isolated from patients suffering from infection/inflammation have been
functionally assessed.
Continuous infusion of endotoxin into rats was found to prime the
respiratory burst of neutrophils isolated from the liver of the subjects at 3
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hours and to a lesser extent at 30 hours (Mayer and Spitzer, 1991).
Intravenous injection of TNFa into healthy human volunteers resulted in
neutrophil activation with evidence of circulating elastase and lactoferrin
(Van der Poll et al., 1992) or in priming of circulating neutrophils for release
of hypochlorous acid (Wewers et al., 1990). Primed neutrophils have been
identified in the peripheral blood of patients following blunt trauma (Krause
et al., 1988), ARDS (Chollet-Martin et al., 1992) and bacterial (Gram-positive
and Gram-negative) and fungal infection (Bass et al., 1986) and from the
joints of patients with active rheumatoid arthritis (Robinson et al., 1992).
Because of the diversity of the signalling processes that they utilise, and
because of their physiological importance as inflammatory mediators, the
priming of human neutrophils by LPS, TNFa and PAF has been studied in
detail in the work presented in this thesis. These agents will be discussed in
greater detail below, followed by consideration of the pathways potentially
used to transduce the priming signal.
1.7.2 LPS as a Priming Agent
LPS, a complex glycolipid, is the major component of the outer membrane of
Gram-negative bacteria and is released when bacteria die/lyse and when
they multiply. Structurally, LPS consists of a variable polysaccharide
domain covalently bonded to a highly conserved diglucosamine-based
phospholipid, lipid A. Purified lipid A has potent LPS-like agonist activity,
suggesting that it is responsible for most, if not all, of the biological effects of
endotoxin (Galanos et al., 1985). The clinical syndrome of Gram-negative
septicaemia appears to result primarily from excessive stimulation of the
host immune response by LPS. LPS-induced activation of macrophages
results in the production of cytokines such as TNFa and interleukins -1, -6, -8
and -10, which mediate the fever, hypotension and other features of septic
22
shock (Galanos and Freundenberg, 1993). In addition to its effects on
macrophages, endotoxin initiates sequestration of neutrophils in the
pulmonary vasculature; together with its priming activity this may
predispose the pulmonary vascular endothelium to neutrophil-mediated
injury (Haslett et al., 1987).
The initial experiments of Guthrie et al. (1984) required fairly high
concentrations of LPS (>10 ng/ml) to prime neutrophils; Aida and Pabst
(1990) demonstrated that neutrophils washed free of plasma responded only
weakly to LPS, but were primed by as little as 1 ng/ml in the presence of
plasma. The component of plasma required for optimal LPS activity was
identified as lipopolysaccharide binding protein (LBP: Vosbeck et al., 1990),
an acute phase protein synthesised by the liver. The formation of complexes
between LPS with LBP not only allowed priming by lower concentrations of
LPS but also accelerated the process to the extent that a maximal response
could be achieved within a 30 min preincubation of cells with LPS-LBP.
Priming of neutrophils by LPS can be abrogated by antibodies to CD14, a
GPI-linked membrane glycoprotein thought to act as the receptor for the
LPS-LBP complex (Weingarten et al., 1993, Shapira et al., 1995); in addition,
CD14 is present in secretory granule membranes, forming a cellular pool that
can be rapidly deployed to the cell surface in response to degranulating
stimuli (Detmers et al., 1995). Since CD14 lacks a cytoplasmic domain, the
mechanism by which signal transduction occurs is poorly understood. The
P2 integrin, CDllc/CD18, has also been proposed to act as an LPS receptor,
since transfection of this molecule into CHO cells (which lack both the
integrin and CD14) confers serum-independent responsiveness to LPS to




Figure 1.4 Neutrophil Priming by LPS
LPS complexed with LBP interacts with neutrophil CD14; possibly acting via
an as yet unidentified transmembrane receptor, this may result in
upregulation of fMLP receptors and integrins, and the activation of several
signalling pathways (see section 1.8)
1.7.3 TNFa as a Priming Agent
TNFa was originally described as a cytokine capable of inducing tumour
necrosis (Carswell et al., 1975) but was subsequently discovered to modulate
the immune system. It is produced principally by monocytes and
macrophages in response to LPS, but also by lymphocytes, fibroblasts and
even by neutrophils themselves (Dubravek et al., 1990). TNFa mimics many
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of the effects of endotoxin when injected into experimental animals or
human volunteers (Tracey et al., 1986). It is a potent neutrophil priming
agent, upregulating agonist-induced O2" by up to 20-fold (Berkow et al.,
1987). It was therefore initially proposed that LPS priming was mediated by
TNFa secreted by small numbers of contaminating monocytes in neutrophil
preparations; however, Aida and Pabst (1990) demonstrated failure of anti-
TNFa antibodies to inhibit the priming effects of LPS.
Figure 1.5
TNFa trimer Receptor trimer
Figure 1.5 Neutrophil Priming by TNFa
Interaction with trimeric TNFa leads to receptor clustering and activation of
various signal transduction processes, with up-regulation of fMLP receptors
and adhesion molecules. How these changes may lead to the establishment
of the primed state is discussed in 1.8.
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Mature TNFa is a homotrimer composed of 17 kDa subunits, which interact
with 2 distinct receptors of 55 and 75 kDa (TNF-R55/CD120a and TNF-
R75/CD120b; Brockhaus et al., 1990) inducing receptor clustering. Signalling
pathways activated by the interaction of TNFa with its receptors include the
sphingomyelinase-ceramide pathway (see 1.8.10) and the recently described
TNF receptor associated factor (TRAF) proteins (Rothe et al., 1995) which
mediate activation of the transcription factor NF-kB.
1.7.4 PAF as a Priming Agent
The chemical structure of PAF (l-alkyl-2-acetyl-sn-glycero-3-
phosphocholine) was elucidated in 1979 by, among others, Demopoulus et
al. (1979); in addition to platelets, neutrophils, mononuclear cells, eosinophils
and liver cells are all responsive to this lipid mediator (Chao and Olson,
1993). The initial rate-limiting step in its production is the hydrolysis of
arachidonate-containing membrane phopholipids by phopholipase A2 to
yield arachidonic acid and lyso-PAF (Chilton et al., 1984); activation of
phospholipase A2 requires both phosphorylation of the enzyme, and a
calcium-dependent translocation from cytosol to membrane (Lin et al., 1993).
Lyso-PAF is converted to PAF by Ca2+/calmodulin-dependent
acetyltransferase, and PAF interacts with a G-protein-linked, 7-
transmembrane receptor, which has been cloned (Nakamura et al., 1991).
PAF does not stimulate the respiratory burst directly except at very high
concentrations, but is a potent priming agent (Vercellotti et al., 1988),
efficacious after brief preincubations (<1 min). Endothelial monolayers
treated with thrombin prime neutrophils layered on top by the production of
PAF, suggesting that this is a biologically relevant priming effect (Vercellotti
et al., 1989). In an in vivo study of endotoxic shock, elevated plasma levels
of both TNFa and PAF were required to produce severe hypotension (Sun et
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al., 1990), further emphasising the in vivo significance of PAF as a biological
mediator.
1.8 Signalling Pathways in Neutrophil Priming
Since the respiratory burst provoked by fMLP is the most readily primable'
neutrophil function, it is also the most studied. However, other neutrophil
functions can also be primed (degranulation: Haslett et al., 1985, Fittschen et
al., 1988, and the synthesis of bioactive lipids including PAF and leukotriene
B4, Doerfler et al., 1989), and other stimuli may activate primed neutrophils
(e.g. opsonised zymosan, PAF, PMA etc.). Studies concentrating on one
system cannot automatically be extrapolated to all priming situations. Since
priming and activation are so closely linked, and since most priming agents
can activate neutrophils either when applied in high concentrations or when
applied to adherent neutrophils, most investigators have concentrated on
signalling mechanisms known to be involved in the generation of oxidative
burst activity.
1.8.1 Modulation of Agonist Receptors
Upregulation of the number and/or affinity of agonist receptors could
augment subsequent responses to the same agonist. fMLP and other
chemoattractants bind to G-protein-coupled receptors containing seven
membrane-spanning segments. The effects of priming agents on fMLP
receptors have been studied by several authors, with conflicting results
(Table 1.2).
Such results need to be interpreted with caution. O'Flaherty et al. (1991)
demonstrated that TNFa increased fMLP binding to neutrophils, but this
effect lagged behind the cytokine's priming of fMLP-induced degranulation
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Berkow et al., 1987
O'Flaherty et al„ 1991
Guthrie et al., 1984
Vosbeck et al, 1990
Howard et al., 1990
Weisbart et al., 1986b
Roberts et al., 1993
Tennenberg et al., 1993
and hence could not be responsible for priming. In the study by Roberts et
al., (1993) priming of the respiratory burst by IL-8 was maximal at 10-50
ng/ml, but no increase in fMLP receptor number was detectable at
concentrations below 100 ng/ml. Berkow et al. (1987) noted that TNFa
induced a 30% increase in fMLP receptor number, which did not reach
statistical significance; the associated priming of the oxidative response was
280%. Thus effects on fMLP receptors can be dissociated from priming.
Neutrophils possess granule-associated fMLP receptors (section 1.3) that are
mobilised to the cell surface on degranulation, and the presence of increased
surface fMLP-binding may reflect exocytosis rather than priming.
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Few investigators have quantified the effects of priming on other
chemoattractant/agonist receptors; however, the study by O'Flaherty et al.
(1991) revealed that TNFa-priming of the degranulation response to PAF
and LTB4 was associated with a reduction in surface LTB4 receptors and only
a transient increase in PAF receptors, again arguing against a critical role for
receptor modulation in priming.
1.8.2 Heterotrimeric GTP-binding Proteins
As stated above, chemoattractant receptors are coupled to heterotrimeric G-
proteins, which consist of a- and Py-subunits. Agonist-binding induces a
conformational change in the receptor, activating the G-protein by allowing
GTP to replace GDP bound to the a-subunit; the subunits dissociate and are
free to interact with downstream effectors (Neer and Clapham, 1988; see
Figure 1.6). The intrinsic GTP-ase activity of the a-subunit hydrolyses GTP
to GDP, and a-GDP recombines with free Py, ending the activation cycle.
Whilst many different subunits have been identified, in neutrophils the
predominant a-subunit is Gia2 (Goldsmith et al., 1987); the closely related
Gia3 (Itoh et al., 1988) is also present. The identity of the Py subunits, and the
exact identity of the G-protein(s) coupling the fMLP receptor to its various
effectors are unknown.
Both Gia2 and Gia3 are substrates for pertussis toxin, which ADP-ribosylates
and so inactivates them. Pertussis toxin abolishes superoxide production
induced by fMLP, making it impossible to use the toxin to study priming of
this response. Flowever, responses to PMA or arachidonic acid are not
suppressed; Berkow and Dodson (1988) demonstrated that the slight
priming effect of TNFa on PMA-induced 02" production was not abolished





Figure 1.6 Signalling by G-protein-linked Receptors
Binding of agonist to the pocket formed by the 7 transmembrane
components of the receptor induces a conformational change, altering the
interaction with the associated G-protein. As a result, GTP replaces the GDP
bound to the a-subunit, and the subunits dissociate to interact with
downstream effectors. The intrinsic GTP-ase activity of the a-subunit
hydrolyses GTP to GDP, releasing inorganic phosphate, and the G-protein is
reconstituted from the free individual components.
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abolished GM-CSF priming of arachidonic acid-induced oxidative activity,
whilst DiPersio et al. (1988) observed no effect on the same process. Clearly
pertussis toxin is not an ideal tool for the investigation of the role of G-
proteins in priming.
For G-proteins to interact with receptors, they must be present at the plasma
membrane. A few groups have investigated the effects of priming agents on
G-protein translocation and function. A study by Klein et al. (1992)
demonstrated enhanced membrane G-protein expression in HL-60 cells (a
leukaemia cell line) following incubation with interferon-y; however, a 24
hour pretreatment was required which does not correlate with priming.
Yasui et al. (1992) demonstrated that LPS 10 ng/ml in the presence of 1%
serum (45 min, 37°C) increased the amount of G;a2 present in neutrophil
membranes; other concentrations and incubation times were not studied, but
these incubation conditions were shown to prime the respiratory burst.
Durstin et al. (1993) showed that incubation with GM-CSF induced
translocation of Gia2 from granule membranes to the neutrophil plasma
membrane; this was significant at 5 min and maximal by 40 min; no effect on
Qa3 was found. No priming data was presented in this second study; it
should be noted that maximal priming with GM-CSF has been demonstrated
(Weisbart et al., 1986) to require 2 hours. Klein et al. (1995) demonstrated
that TNFa (100 U/ml, 10 min) increased the amount of fMLP receptor-
associated Gi^ and Gja3 in the neutrophil membrane and confirmed
enhanced G-protein activity on fMLP-stimulation. Taken together, these
data suggest that a translocation of G-proteins to the neutrophil membrane
might contribute to neutrophil priming, but more detailed analyses are
required.
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1.8.3 Phospholipase C Activation
The P2 isoform of PIC is activated by dissociated G-protein (3y-subunits (Katz
et al., 1992) and the (31 isoform by a-subunits (Rhee and Choi, 1992) to
hydrolyse its membrane phospholipid substrate PtdIns(4,5)P2. This reaction
generates Ins(l,4,5)P3 (the signal for release of Ca2+ from intracellular stores)
and DAG, an activator of protein kinase C; DAG can also be generated, often
in a more sustained fashion, by the action of phospholipase D (see below,
1.8.4). The PIC-y isoform is activated by tyrosine phosphorylation (Rhee,
1991) but the functional significance of this isoform in neutrophils is unclear
at present.
1.8.3.1 Ins(l,4,5)P3 Accumulation
The application of fMLP to a neutrophil population results in a rapid but
transient elevation of Ins(l,4,5)P3, with a peak at 10-15 sec and thereafter a
rapid return to basal levels. Despite a clear demonstration that the resultant
calcium transient is an essential ingredient in activation of the respiratory
burst (Dewald et al., 1988), remarkably few studies have focused on the
potential for this second messenger pathway to be upregulated in the
priming process. Both unchanged (Corey and Rosoff 1989, Bourgoin et al.,
1990) and increased (Macphee, 1992) resting and stimulated Ins(l,4,5)P3
levels have been reported in GM-CSF-primed cells. Grimminger et al. (1991)
reported that botulinum C2 toxin (which ADP-ribosylates G-actin,
preventing actin filament assembly) primed neutrophils for superoxide
production, and enhanced total inositol phosphate accumulation in response
to PAF, fMLP and LTB4, but stated that the increase was exclusively
attributable to increased InsPi accumulation, with no effect on Ins(l,4,5)P3.
All of these studies utilised cells which had undergone lengthy (> 2 h)
labelling with [3H] inositol to enable quantification of the separate inositol
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phosphates; such procedures could affect neutrophil responses, and no
studies have employed the recently developed mass assay (Challiss et al.,
1988) to measure Ins(l,4,5)P3 accumulation.
1.8.3.2 Elevation of [Ca2+]i
Binding of Ins(l,4,5)P3 to its intracellular receptor induces a conformational
change and results in efflux of Ca2+ from intracellular stores; emptying of the
stores may activate influx of Ca2+ from the external medium (capacitative
Ca2+ entry: Putney, 1986). fMLP, PAF and other agonists induce
PtdIns(4,5)P2 hydrolysis and hence cause elevations in the [Ca2+]j.
Neutrophils depleted of Ca2+ do not undergo a respiratory burst (Dewald et
al., 1988), and Hallett et al. (1990) identified a threshold [Ca2+]j of 250 nM;
the oxidase of individual neutrophils always became activated when this
threshold was exceeded. Whilst it is generally accepted that a rise in [Ca2+]i
is an essential step in activation, its role in priming is less clear. Calcium
ionophores such as ionomycin act as priming agents, and Finkel et al. (1987)
correlated the elevation of [Ca2+]; with the degree of priming in response to
ionomycin. Priming agents may act by recruiting more cells into a 'calcium
responsive' population (Eisner et al., 1992). However, as can be seen from
Table 1.3, there are conflicting reports on the effects of individual priming
agents on resting and stimulated [Ca2+]j. It is generally agreed that TNFa
does not mobilise Ca2+ or augment the Ca2+ transient generated in response
to other agonists, and similar results have been reported for other agents
such as substance P. Despite consistent reports that PAF mobilises Ca2+ and
may augment the stimulated transient, Koenderman et al. (1989) reported
that PAF-induced priming was only partially inhibited under [Ca2+]i-
buffering conditions, and these observations were confirmed by Walker et al.
(1991). Finally, in experiments by Wymann et al. (1987) application of fMLP
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Table 1.3
Priming Agent/ [Ca2+]i Reference
Ca2+ Indicator (Basal) (Stimulated)
LPS/fura2 T T Forehand et al., 1989
LPS/fura2 —> Doerfler et al., 1989
LPS/fluo-3 T T Yee and Christou, 1993
LPS/fura2 not done Klein et al., 1990
TNFa/quin2 Yuo et al., 1989
TNFoc/fura2 Lloyds et al., 1995
PAF/fura2 T Vercellotti et al., 1988
PAF/fura2 T T Worthen et al., 1988
GM-CSF/quin2 Sullivan et al., 1987
GM-CSF/fura2 T T Naccache et al., 1988
GM-CSF/fura2 T McColl et al., 1991
Substance P/fura2 —> —> Lloyds et al., 1993
ATP/quin2 T -» Kuhns et al., 1988
Orthovanadate/ Lloyds et al., 1994
fura2
2 min after a low concentration of PMA (1.6 nM) resulted in enhanced
chemiluminescence approximately 2 s before a rise in fura-2 fluorescence,
suggesting that priming of the oxidative burst does not rely on enhanced
calcium fluxes. Taken together, these results seem to suggest that neither
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increased baseline nor stimulated [Ca2+]i are essential for priming, although
such effects may contribute to the priming mechanism of some agents.
1.8.3.3 DAG and Protein Kinase C
Phorbol esters such as PMA bind to and activate the classical
serine/threonine kinase protein kinase C (cPKC) family of enzymes
(Castagna et al., 1982), inducing phosphorylation of several substrates
including p47Phox and activating the NADPH oxidase. PKC translocates to
the cell membrane within seconds of stimulation by agents such as fMLP
(Christiansen, 1988); at the membrane, DAG produced by the actions of
phospholipase C and/or D, in conjunction with the membrane phospholipid
phosphatidylserine, activate the kinase (Lee and Bell, 1991). Synthetic DAGs
and phorbol esters activate the respiratory burst suggesting that PKC is
involved in at least one of the activation pathways (Robinson et al., 1985).
Neutrophils have been shown to possess at least two PKC isoforms, the
calcium-dependent (3i-PKC (the most abundant isoform) and the calcium-
independent rpPKC (Majumdar et al., 199land 1993). PMA in sub-activating
concentrations primes neutrophils, indicating a possible role for PKC in the
priming process.
The effects of priming agents on the PKC-activator DAG are somewhat
controversial. Tyagi et al. (1989) reported that GM-CSF (100 pM) alone
produced only a small increase in neutrophil DAG mass but markedly
increased DAG accumulation in response to fMLP, and Bourgoin et al. (1990)
also described an augmented DAG response to the chemotactic peptide in
GM-CSF-primed neutrophils. In contrast, Bauldry et al. (1991a) found that
treatment of polymorphonuclear cells with TNFa did not induce DAG
formation, and that in the absence of cytochalasin B there was no
enhancement of the response to fMLP in TNFa-treated cells.
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Whilst some studies have suggested that priming may enhance DAG
generation, several studies have failed to show translocation/activation of
PKC in primed cells; hence LPS (Forehand et al., 1989), TNFa (Berkow and
Dodson, 1988) and GM-CSF (Sullivan et al., 1987) all failed to induce PKC
translocation under priming conditions. Despite these findings, Thelen et al.
(1990) demonstrated enhanced phosphorylation of the myristolated, alanine-
rich C kinase substrate (MARCKS) in cells primed with LPS or TNFa;
however, this action was delayed with respect to priming, and the
enhancement was blocked by cycloheximide (priming by these agents is not
dependent on protein synthesis, see 1.8.10 below). The increased detection
of the phosphorylated MARCKS was attributed to LPS- and TNFa-induced
synthesis of the kinase substrate rather than to increased kinase activity, and
is unlikely to be relevant to priming. Thus the weight of evidence is against
augmented PKC activation playing a significant role in priming.
1.8.4 Phospholipase D Activation
Phospholipase D catalyses the hydrolytic cleavage of the terminal
phosphodiester bond of PC or Ptdlns(Px) to yield phosphatidic acid (PA)
and choline or Ins(Px); fMLP-mediated stimulation of PC-specific PLD in
neutrophils was demonstrated by Cockcroft (1984). PA is converted to DAG
by phosphatidate phosphohydrolase (Billah et al., 1989), and this results in a
second, usually more sustained phase of DAG generation than that resulting
from the activation of PIC (Truett et al., 1988, Billah et al, 1989). The role of
DAG in activating PKC has been discussed (1.8.3.3); PA is involved in
activation of the NADPF1 oxidase (Bonser et al., 1989, Morel et al., 1991) and
in changes in the actin cytoskeleton (Fla and Exton, 1993).
Bourgoin et al. (1990) and Bauldry et al. (1991a) studied the effects of
priming (with GM-CSF and TNFa, respectively) on phospholipase D
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activity; both demonstrated that while treatment of cells with the priming
agent alone did not result in accumulation of PA, the subsequent fMLP-
induced accumulation was augmented and prolonged in primed cells. In the
latter study, PA production was found to correlate closely with the amount
of 02" generation that occurred, suggesting that enhancement of PLD activity
could play a role in priming.
1.8.5 Phospholipase A2 Activation
Phospholipase A2 releases free AA from cellular phospholipids (Walsh et al.,
1983) in what is believed to be the rate-limiting step in the synthesis of
biologically active eicosanoids (Van den Bosch, 1980). Priming agents can
enhance the synthesis of bioactive lipids (AA, PAF, LTB4) in response to
activating stimuli (Bauldry et al., 1991b, DiPersio et al., 1988, Doerfler et al.,
1989); additionally, activation/translocation of PLA2 has been suggested as a
potential mechanism of priming. Smith and Waite (1992) demonstrated that
a PLA2 activity was translocated from the cytosolic fraction to the plasma-
membrane fraction in LPS-primed neutrophils; Doerfler et al. (1994)
confirmed this finding and in addition demonstrated that LPS induced the
phosphorylation of PLA2, an event previously correlated with PLA2
activation (Lin et al., 1993). Fouda et al. (1995) also demonstrated that LPS
induced the phosphorylation of PLA2, and detected a small but significant
release of arachidonic acid by LPS alone in addition to its priming effect.
Enhanced AA availability was proposed to explain the priming by GM-CSF
of IL-8-stimulated lipid mediator release, since IL-8 itself lacks the ability to
promote the release of endogenous AA (McDonald et al., 1993). However
LPS-priming of LTB4 release was noted only in response to PMA, calcium
ionophore or opsonised zymosan, and not to fMLP (Doerfler et al., 1989),
and none of the above studies have linked PLA2 activation with priming of
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the respiratory burst. Worthen et al. (1988) correlated LPS-induced synthesis
of intracellular PAF with priming of the respiratory burst, and suggested
that PAF could be responsible for the priming of the respiratory burst by
LPS; however, Stewart et al. (1991) demonstrated that neither blockade of
PAF receptors (WEB 2086) nor inhibition of LTB4 synthesis (CGS8515)
influenced the priming of fMLP-mediated O2" generation by TNFa or GM-
CSF. Finally, Ely et al. (1994) showed that TNFa-primed release of AA and
O2" are independent events, since when released under physiological
conditions AA was unable to stimulate or modulate O2" release. It therefore
seems unlikely that PLA2 is responsible for the priming of the respiratory
burst, although it may be an important messenger for enhanced lipid
mediator release.
1.8.6 Neutrophil Adhesion Molecules and the Cytoskeleton
Intravascular sequestration of neutrophils at inflamed sites and migration
through the vascular endothelium depends on the sequential regulation of
expression and function of the cell adhesion molecules (members of the
immunoglobulin superfamily, integrins and selectins; see Chapter 4). Once
in the extracellular environment, neutrophils interact with extracellular
matrix proteins predominantly through cell surface integrins. These
receptors interact with the cytoskeleton, integrating the extracellular milieu
with the cell interior.
The vascular selectins (CD62-P/P-selectin and CD62-E/E-selectin) and the
constitutively-expressed leukocyte antigen CD62-L (L-selectin) mediate the
initial, low affinity 'rolling' interaction between the neutrophil and the
vascular endothelium (Bevilacqua and Nelson, 1993, Carlos and Harlan,
1994, Albeda et al., 1994). While low concentrations of many secretagogue
agonists have been shown to induce loss of CD62-L from the neutrophil
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surface (Kishimoto et al., 1989, Griffin et al., 1990), this event has not been
studied in parallel with neutrophil priming. Cross-linking of CD62-L by
sulfatides or by monoclonal antibodies has, however been shown to prime
neutrophils (Waddell et al., 1994), suggesting a close link between the
processes of transmigration and priming.
Firm adhesion is principally a function of the leukocyte P2_integrins,
particularly CDllb/CD18 (Mac-1), whose expression and function are
upregulated by a number of secretagogue agonists (Smith et al., 1989).
Cross-linking of the CD18 integrin component with monoclonal antibodies
has also been demonstrated to lead to neutrophil priming (Liles et al., 1995),
although again, upregulation of integrins has not been correlated directly
with the establishment of the primed state. Activation of respiratory burst
activity by TNFa has been shown to be dependent on the engagement of
neutrophil integrins (Nathan et al., 1989a). Interaction of integrins with
ligand (ICAM-1) results in receptor clustering and activation of signalling
pathways (Rosales and Juliano, 1995) including Ca2+ transients,
phosphorylation of the focal adhesion kinase (pl25FAK) which is involved in
cytoskeletal organisation, stimulation of the Na+/H+ antiport, and possibly
activation of the mitogen activated protein kinase (MAPK - see 1.8.7). Thus
agonists which regulate neutrophil adhesion molecules may also influence
the hyperresponsive state of the primed neutrophil (Figure 1.7).
In resting blood neutrophils, only about 20-30% of the cellular actin is in the
polymerised form, and most of this is present in a filamentous network
adjacent to the plasma membrane, with which it can interact via integral
membrane proteins (Sheterline et al., 1984). Stimulation results in the rapid
assembly of actin polymer (F-actin) from the monomeric G-actin pool,
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Figure 1.7 Signalling by Integrins
ICAM-l-integrin interaction results in clustering of integrin molecules and
activates a series of signal transduction sequences. Changes in Ca2+, pH (via
the activation of the Na+/H+ antiport), phosphorylation (of pl25FAK and
MAPK) and gene induction (in monocytes) have all been observed after
integrin engagement.
polymerisation has been shown to be enhanced by co-incubation with IL-8
and other cytokines (Brom et al., 1991), by pre-incubation with InsP6
(Crawford and Eggleton, 1992) and by preincubation with LPS (Howard et
al., 1990). However, other studies have refuted the link between actin
polymerisation and priming; for example, Lloyds and Hallett (1993)
demonstrated that activating, but not priming concentrations of substance P
induced actin polymerisation directly (the effect on fMLP-induced
polymerisation was not documented) and Grimminger et al. (1991)
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demonstrated that treatment of neutrophils with botulinum C2 toxin (which
ADP-ribosylates G-actin) suppressed fMLP-initiated actin polymerisation
but enhanced fMLP-induced O2" generation. Thus while adhesion molecules
may play an as yet undefined role in priming transmigrating neutrophils,
chemoattractant-induced actin polymerisation does not appear to be an
essential component of this process.
1.8.7 Protein Phosphorylation and Neutrophil Priming
Protein phosphorylation is an important regulatory mechanism utilised by
cytokines in signal transduction. Although most protein phosphorylation
occurs on serine and threonine residues, tyrosine phosphorylation also plays
an important role in the control of cellular function. The cytosolic oxidase
component p47Phox becomes extensively phosphorylated on oxidase
activation, the phosphorylation targets consisting of a group of serines in the
carboxy-terminus of the peptide (El Benna et al., 1994); the phosphorylation
of S379 in particular has been shown to be critical to oxidase activation
(Faust et al., 1995). Although the kinase(s) responsible for this crucial
phosphorylation event have not been identified, one possible candidate is
the serine kinase mitogen activated protein kinase (MAPK), which must
itself be activated by phosphorylation on both serine and tyrosine residues
(Anderson et al., 1990).
Activation of neutrophils by fMLP and other stimuli is associated with
increased tyrosine phosphorylation of multiple substrates (Rollet et al., 1994).
Tyrosine phosphorylation has also been described in response to several
priming agents, including GM-CSF (McColl et al., 1991), TNFa (Akimaru et
al., 1992, Berkow and Dodson, 1988, Floyds et al., 1995), Substance P (Floyds
et al., 1995) and PAF (Gomez-Cambronero et al., 1991). In several of these
















(eg other receptors) Cytosolic targets
(eg PLA2,
MAPKK, Raf-1)p90rsk
Figure 1.8 MAPK Signalling Cascade
Ligand-receptor interaction leads to activation of the small GTP-binding
protein Ras via the adapter molecule Grb2 and the guanine nucleotide
exchange factor SoS. Ras activates the serine/threonine kinase Raf-1, which
can phosphorylate MAPK kinase (MAPKK); the latter phosphorylation can
also be carried out by MEKK and possibly other kinases. Phosphorylation
of both tyrosine and threonine residues of MAPK by MAPKK is required for
full MAPK activation. Targets of MAPK include p90rsk, a serine/threonine
kinase whose substrates include transcription factors and ribosomal S6
protein, PLA2, receptors, nuclear and cytoskeletal targets, and MAPKK and
Raf-1 (negative feedback).
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role in priming (although the study with GM-CSF demonstrated that
tyrosine phosphorylation was detectable at 1-5 min and maximal at 15-30
min, clearly earlier than the establishment of maximal priming).
Furthermore, manipulation of tyrosine phosphorylation levels within
neutrophils by inhibition of tyrosine phosphatases (e.g. by orthovanadate) or
tyrosine kinases (e.g. by genistein) resulted in priming and inhibition of
priming respectively (Lloyds and Hallett, 1994).
Phosphorylation of MAPK has been reported secondary to priming
concentrations of LPS (Fouda et al., 1995), GM-CSF (Okuda et al., 1992,
Raines et al., 1994, Gomez-Cambronero et al., 1992) and PAF (Gomez-
Cambronero et al., 1991). However, a study by Waterman and Sha'afi (1995)
demonstrated that, although TNFa induced tyrosine phosphorylation of a 40
kDa protein that was initially thought to be MAPK, this phosphoprotein
could not be identified using sera against known members of the MAPK
family. Thus not all phosphoproteins with appropriate molecular mass can
be assumed to be MAPK, and positive identification (e.g. by
immunoprecipitation) as in all the above studies, is required to clarify the
situation.
1.8.8 PtdIns(3,4,5)P3 in Neutrophil Priming
In human neutrophils fMLP stimulation causes a rapid accumulation of the
novel phospholipid PtdIns(3,4,5)P3 (Traynor-Kaplan et al., 1988 and 1989)
due to the action of the enzyme PI3K on the membrane phospholipid
PtdIns(4,5)P2 (Stephens et al., 1991). Initial reports demonstrated activation
of PI3K by membrane-bound receptor tyrosine kinases resulting from
recruitment of pll0-p85 heterodimers to signalling complexes (Auger et al.,
1989); this process was shown to be mediated by the SH2 domains of the
regulatory p85 subunit that bind specific phosphotyrosine residues on the
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activated receptors (Rordorf-Nikolic et al., 1995). A separate PI3K isotype
pllOy, which does not associate with p85 but which is activated by both a
and (3y G-protein subunits, has also been cloned from human myeloid cells
(Stoyanov et al., 1995).
fMLP-induced PtdIns(3,4,5)P3 accumulation in human neutrophils was
shown to be rapid (peak at approximately 10 sec, Stephens et al., 1993b),
inhibited by pertussis toxin but not by genistein (Corey et al., 1993) and
associated with little (Stephens et al., 1993b) or no (Vlahos and Matter, 1992)
increase in PI3K activity detected in anti-phosphotyrosine antibody
immunoprecipitates. The fungal metabolite wortmannin inhibited both
forms of PI3K (Arcaro and Wymann, 1993, Okada et al., 1994a and 1994b,
Stoyanov et al., 1995) and abolished the respiratory burst in response to
fMLP without directly affecting NADPH oxidase activity (Baggiolini et al.,
1987, Dewald et al., 1988). This evidence implicates PI3K, probably the
recently described pllOy isoform, in the signal transduction process linking
receptor stimulation with oxidase activity.
The role of PI3K in priming is unknown. The priming agent GM-CSF was
shown to stimulate the accumulation of PtdIns(3,4,5)P3 in neutrophils; this
response was maximal at 3 min, and was not delineated beyond 5 min
(Corey et al., 1993), whereas priming with GM-CSF requires a more
prolonged incubation, as discussed above. The GM-CSF response was
inhibited by genistein but not by pertussis toxin, and was associated with the
formation of protein tyrosine kinase-coordinated signalling complexes. In
the same study, a second priming agent, TNFa, was reported not to affect
PtdIns(3,4,5)P3 accumulation in neutrophils. PAF and ATP, both of which
rapidly prime neutrophils, have also been shown to lead to rapid

























Figure 1.9 Signalling via PI3K
A). Receptors with intrinsic tyrosine kinase activity undergo
autophosphorylation, and the phosphorylated tyrosine residues permit
interaction with SH2 domains of the p85/pll0 isoform of PI3K (receptors
lacking tyrosine kinase activity may associate with src-type non-receptor
kinases). The activated enzyme catalyses the conversion of PtdIns(4,5)P2 to
PtdIns(3/4/5)P3.
B). Association of ligand with G-protein-linked receptor results in G-protein
subunit dissociation; the pllOy PI3K isoform possesses a pleckstrin
homology (PH) domain, allowing interaction with, and activation by, the G-
protein subunits.
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no studies detailing the effect of priming agents on fMLP-stimulated
Ptdlns(3,4/5)P3 accumulation have been published. The downstream targets
of Ptdlns(3,4/5)P3 are uncertain, but may include the small GTP-binding
proteins ras (Hu et al., 1995) and p21rac (Hawkins et aL, 1995), and PKC
(Singh et aL, 1993, Nakanishi et aL, 1993, Toker et al., 1994). In addition to its
role in signalling the respiratory burst, PI3K has been implicated in the
control of actin polymerisation (Eberle et aL, 1990) and early endosome
fusion (Jones and Clague, 1995). Considerable research is ongoing in this
rapidly expanding field.
1.8.9 Role of the Sphingomyelin Pathway in Neutrophil Priming
Recent evidence suggests that TNFa may employ the sphingomyelin
pathway to effect a variety of its biological effects (reviewed in Kolesnick
and Golde, 1994). Hydrolysis of plasma membrane sphingomyelin by
sphingomyelinase (activated by interaction of TNFa trimers with p55
receptors, inducing receptor clustering) yields ceramide. Ceramide acts as a
second messenger, stimulating a serine/threonine ceramide-activated
protein kinase to transduce the cytokine signal, in part via the MAPK and
stress-activated protein kinase (SAPK) cascades. Both ceramide and
exogenous sphingomyelinase mimicked TNFa action and induced apoptosis
in HF-60 cells and in the monocytic cell line U937 (Obeid et aL, 1993, Jarvis et
al., 1994). However, despite a report that sphingosine mobilises intracellular
calcium in human neutrophils (Wong and Kwan-Yeung, 1993), Yanaga and
Watson (1994) demonstrated that neither sphingomyelinase nor cell-
permeable ceramide analogues stimulated or primed the neutrophil
respiratory burst; furthermore, in the latter study, TNFa did not elevate the
levels of ceramide-l-phosphate (produced from ceramide by the action of
ceramide kinase). Thus it seems that in mature neutrophils, the
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sphingomyelin pathway has a rather limited role, if any, in signal
transduction, and is not a mediator of TNFa-induced priming. No reports
have implicated this pathway in signalling by other priming agents.
1.8.10 Role of Protein Synthesis in Neutrophil Priming
A study by Hughes et al. (1987) demonstrated that the low rates of protein
biosynthesis detectable in resting neutrophils could be augmented fivefold
by treatment with 100 nM fMLP, while this agonist concentration induced
only 8% of maximal (by 1 pM fMLP) O2" production. These authors
speculated that protein synthesis could have a role in priming (although
most reports suggest that 100 nM fMLP induces maximal or near-maximal
O2" production). Tennenberg et al. (1993) demonstrated that the protein
synthesis inhibitor cycloheximide prevented priming by interferon-y, and
studies by Newberger et al. (1988) and Cassatella et al. (1990) revealed that
incubation of neutrophils with interferon-y (for 3 hrs in the latter study) led
to increased synthesis of the oxidase component p9lPhox. LPS was also
shown to elevate p9lPhox levels (Cassatella et al., 1990), but cycloheximide
had no effect on neutrophil priming by either LPS (Guthrie et al., 1984) or by
GM-CSF (DiPersio et al., 1988). The rapidity of priming secondary to
agonists such as PAF, ATP and TNFa renders a role for protein synthesis
extremely unlikely. Thus protein synthesis is not likely to be important in
neutrophil priming except in the case of interferon-y, and the role of this
cytokine as a priming agent has been challenged by Pabst (1994) who




The principal aim of the work presented in this thesis was to investigate the
signalling mechanisms involved in human neutrophil priming. During the
course of this investigation, the following approaches were pursued.
1. Initial experiments were undertaken to determine the conditions for
optimal priming of the respiratory burst using the inflammatory mediators
LPS, TNFa and PAF as priming agents.
2. Since neutrophil adhesion and priming are closely linked (Nathan et al.,
1989a, Waddell et al., 1994, Liles et al., 1995) the effects of these priming
agents on the expression and function of cell surface adhesion molecules
(particularly CDllb and CD62-L) were examined.
3. A detailed study of the effects of priming on the magnitude and kinetics
of membrane Gia2 upregulation was then performed (Gi«2 is the most
abundant neutrophil G-protein (Goldsmith et al., 1987) and is functionally
coupled to the fMLP-receptor (Gierschik et al., 1989)).
4. Finally, the potential role of inositol phospholipids in neutrophil priming
was investigated. Both Ins(l,4,5)P3 and PtdIns(3,4,5)P3 seem to be essential
for the neutrophil respiratory burst (Dewald et al., 1988), hence an extensive
series of experiments was designed to study these two mediators in the
context of neutrophil priming.
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Chapter 2: Materials and Methods
2.1 Materials
The following reagents were all obtained from the Sigma Chemical
Company (Poole, Dorset UK). fMLP was dissolved in dimethyl
sulfoxide/phosphate-buffered saline (DMSO/PBS; 5 mg fMLP in 70 pi
DMSO made up to 11.35 ml with PBS) and stored at 1 mM at -20°C. LPS
(from E. Coli serotype OIILB4, y-irradiated) was dissolved in PBS at 1
mg/ml, sonicated (ultrawave sonic bath, Belmont Instruments, Glasgow,
Scotland) for 10 min and stored at -20°C; individual aliquots were further
sonicated on thawing, immediately prior to use. Cytochrome C (prepared
from horse heart) was stored at -20°C and dissolved in PBS pre-warmed to
37°C immediately prior to use. Superoxide dismutase (SOD) was dissolved
in PBS at 7500 U/ml and stored at -20°C. PAF was dissolved in analar
ethanol at 10 mM and stored at -80°C. Dextran-500 (molecular weight
500,000) was dissolved in sterile 0.9% saline (6% w/v) and stored at 4°C.
Inositol hexakisphosphate (InsP6, phytic acid, di-potassium salt) was
dissolved immediately prior to use at 1 mM in PBS with 25 mM HEPES (N-2-
hydroxylethylpiperazine-N'-ethane sulphonic acid, required to maintain pH
7.0-7.4). Dimethoxybenzidine (o-dianisidine HC1) dissolved at 1.25 mg/ml
in distilled water was aliquoted and stored at -20°C. Adenosine
triphosphate (ATP), sphingomyelinase (from Bacillus cereus, 50 U/gl in 50%
glycerol/PBS, 50 mM Tris-HCl, pH 7.5), human albumin solution (10%),
phorbol myristate acetate (PMA, dissolved at 1 mg/ml in DMSO and stored
at -20°C), fura-2-tetraacetoxymethylester (fura 2-AM, dissolved in DMSO at
1 mM and stored at -20°C) and Nonidet P40 were also supplied by Sigma, as
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was sterile, endotoxin-free PBS, pH 7.4, and PBS with 1.2 mM Ca2+ and 0.8
mM Mg2+, pH 7.4 (PBS with divalent cations).
Human recombinant TNFa diluted in 1 ml sterile PBS was purchased from
Genzyme (Cambridge, MA), stored at -80°C, and diluted further in PBS in
accordance with the individual batch activity immediately prior to use.
Percoll was obtained from Pharmacia Fine Chemicals (Uppsala, Sweden).
C6-ceramide (a cell-permeable ceramide analogue) from Matreya, Pleasant
Gap, PA, was stored at 100 |iM in ethanol at -20°C. Inositol 1,4,5-
trisphosphate (Ins(l,4,5)P3) was acquired from Research Biochemicals
International (St Albans, Hertfordshire, UK), diluted in distilled water to 10
mM and stored at -80°C. Creatinine phosphokinase (Boehringer Mannheim,
Lewes, East Sussex, UK) was dissolved in water at 2.5 units/ml and stored in
aliquots at -80°C. Sterile 3.8% sodium citrate was from Phoenix
Pharmaceuticals, Gloucestershire, UK. One-micron Fluoresbrite fluorescent
latex microspheres were supplied by Polysciences (Warrington, PA).
Mouse monoclonal antibodies (mAb) to CDllb (44), CDllc (3.9), and CD35
(Ell) were obtained from Serotec (Oxford, UK); anti-CD62-L (Leu-8) was
from Becton Dickinson (Oxford, UK). Mouse mAb anti-CDlla (WAC 70)
was generously donated by Dr J. Ross (Department of Surgery, Edinburgh
University); fluorescein isothiocyanate (FITC)-conjugated F(ab')2 fragments
of rabbit anti-mouse immunoglobulin were from Dako (Buckinghamshire,
UK). Rabbit antibody to Gia2 (SPG, directed against the C-terminal
decapeptide of Gia2) was the generous gift of Professor Graham Milligan
(Department of Biochemistry, University of Glasgow, Scotland); horseradish
peroxidase-conjugated donkey anti-rabbit antibody was from the Scottish
Antibody Production Unit (Dundee, Scotland). All antibodies were titrated
to determine optimal binding concentrations.
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[32P]Pi (40 mCi/ml in HC1- and carrier-free aqueous solution),
[3H]Ins(l,4,5)P3 (17-20 Ci/mmol), and [y-32P]GTP (2 pCi/pl) were supplied
by DuPont New England Nuclear (Stevenage, UK). Partisphere SAX HPLC
columns were from Whatman Chromatography (Maidstone, UK) and
polyethyleneimine (PEI) TLC plates were from CamLab (Cambridge, UK).
Sterile phosphate-free HEPES-buffered Planks solution (100 mM NaCl, 10
mM KC1, 1 mM MgCl2, 10 mM glucose, 1.5 mM CaCl2, 30 mM P1EPES, pPI
7.4) was prepared and supplied by GIBCO (Life Technologies, Renfrewshire,
Scotland). All other chemicals were of molecular, reagent or cell culture
grade and were obtained from BDH (Leicestershire, UK).
2.2 Isolation of Human Neutrophils by Dextran Sedimentation and
Plasma/Percoll Density Gradient Centrifugation
Human neutrophils were purified according to the method of Haslett et al.
(1985), utilising sterile, LPS-free (Chromagenix Limulus amoebocyte lysis
assay kit) reagents and plastic ware (Falcon, Oxford, UK). Freshly drawn
blood from healthy volunteers was anticoagulated (4 ml sterile 3.8% sodium
citrate/36 ml blood) and centrifuged (300y, 20 min); the platelet-rich plasma
supernatant was centrifuged (2500y, 20 min) to obtain platelet-poor plasma
(PPP) or used to prepare autologous serum by the addition of CaCl2 (final
concentration 20 gM) at 37°C. Pelleted cells from the initial centrifugation
were subjected to dextran sedimentation (5 ml 6% dextran-500 plus 25 ml
0.9% saline per tube, gently mixed and allowed to stand for 30-40 min).
Leukocyte-rich plasma was aspirated from the sedimented red cells,
centrifuged (500 g, 6 min), resuspended in 2 ml PPP and underlayered with 2
ml 42%, and 2 ml 51% plasma/Percoll (prepared from 90% Percoll in 0.9%
saline, and PPP). Gradients were spun at 275g for 10 min and




Figure 2.1 May-Grunwald-Giemsa-stained Cytospin Preparation of
Human Neutrophils Isolated on Plasma/Percoll Gradients
Freshly drawn, anticoagulated human blood was subjected to sedimentation
with 6% dextran prior to centrifugation through discontinuous 43%/51%
plasma/Percoll gradients exactly as described in 2.2. Polymorphonuclear
cells were harvested from the 42%/51% interface and washed sequentially in
PPP, calcium-free PBS and PBS with calcium and magnesium. 100 (il of the
resulting cell suspension (approximately 107/ml) was spun (300g, 3 min)
onto a glass slide by means of a cytocentrifuge, and the resulting cytoprep
was stained with May-Grunwald-Giemsa. Photograph courtesy of Miss
Joanna Murray (Rayne Laboratory, University Medical School, Teviot Place,
Edinburgh).
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Mononuclear cells sedimented to the PPP/41% Percoll interface. Purified
cells were washed sequentially in PPP, PBS, and PBS with calcium and
magnesium; cell concentration was adjusted according to haemocytometer
counts. All procedures were carried out at room temperature. Cells
prepared by this method were routinely >99.9% viable (trypan blue
exclusion), non-activated (minimal fMLP-stimulated superoxide anion (02~)
generation in the absence of a priming agent) and >95% pure as assessed by
examination of May-Grunwald-Giemsa-stained cytocentrifuge preparations;
mononuclear cell contamination was <0.1%. Since all polymorphonuclear
leukocytes have very similar buoyant densities, density gradient
centrifugation does not separate eosinophils or basophils from neutrophils;
however, preparations generally contained <3% eosinophils, and if >5%
eosinophils were present the cells were discarded. Basophils were seldom
observed.
2.3 Measurement of Superoxide Anion Generation
Superoxide generation was quantified by the superoxide dismutase-
inhibitable reduction of cytochrome C. Purified neutrophils isolated as
detailed above were immediately resuspended at 11.1 x 106/ml in PBS with
calcium and magnesium, and 90 |il aliquots were transferred to 2 ml LPS-free
(Limulus assay) polypropylene Eppendorf tubes and placed in a Haake
shaking water bath (100 cycles/min) pre-heated to 37°C. Thermal
equilibrium was established (approximately 5 min) and priming agents or
appropriate control buffers were added in a volume of 10 jliI for a designated
time period. The incubation volume was subsequently adjusted to 1 ml by
the addition of pre-warmed freshly prepared cytochrome C (final
concentration 1.2 mg/ml in PBS with calcium and magnesium), fMLP (final
concentration 100 nM) or PMA (final concentration 1 ng-1 gg/ml) or vehicle
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(final DMSO concentration < 0.1%, v/v), with superoxide dismutase 375 U
present in one of each set of quadruplicate samples. Shaking at 37°C was
maintained for a further 10 min, at which time samples were placed on ice
and centrifuged at 4°C, 10,000g for 5 min. The optical density of the
supernatants was determined at 550 nm using a Pye-Unicam 8700 scanning
spectrophotometer (with the baseline provided by 1.2 mg/ml cytochrome
C), and the superoxide dismutase-inhibitable reduction of cytochrome C
converted to nmols superoxide produced/106 cells using the extinction
coefficient 21.0 x 103M"1cm-1; the value obtained for the superoxide
dismutase-containing samples was subtracted from the corresponding
sample values to eliminate oxidation due to other respiratory burst products.
2.4 Assessment of Neutrophil Shape-Change
Neutrophil shape-change may be an indication of priming (Haslett et al.,
1985). The percentage of shape-changed neutrophils within a population
was estimated by means of the concomitant increase in forward scatter as
measured by flow cytometry. Freshly isolated neutrophils (5 x 106 in 450 pi
PBS with calcium and magnesium) were incubated at 37°C in 2 ml
polypropylene Eppendorf tubes in a shaking water bath, with agonists
(fMLP, TNFa, LPS, PAF or appropriate vehicle controls) added in a volume
of 50 pi. On completion of the incubation, cells were fixed by the addition of
0.5 ml 0.5% glutaraldehyde in PBS. Shape-change (5000 cells per sample)
was determined using an EPICS Profile II (Coulter Electronics, Luton, UK)
flow cytometer; shape-changed cells were defined as those with a forward
scatter value greater than 90% of non shape-changed (rounded) cells. Fixed
cells were also examined by light microscopy to verify the results obtained
by flow cytometry; shape-change was defined as any deviation from





Figure 2.2 Assessment of Neutrophil Shape-Change by Flow Cytometry or
Polarising Light Microscopy
Neutrophils isolated on plasma/Percoll gradients (2.2) were incubated at
37°C at a density of 5xl06/ml with fMLP 100 nM (B and D) or vehicle (A and
C) for 15 min and fixed with 0.5% glutaraldehyde. A and B represent the
forward scatter profiles of the fixed samples as assessed by flow cytometry;
C and D illustrate the corresponding control (rounded) and fMLP-treated
(shape-changed) cells seen by polarising light microscopy. Photographs
courtesy of Dr Jiamin Qu (Department of Cellular Physiology, Babraham
Institute, Cambridge).
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2.5 Analysis of the Expression and Function of Neutrophil Cell Surface
Adhesion Molecules
2.5.1 Determination of Neutrophil Adhesion Molecule Expression by
Flow Cytometry
Expression of cell surface adhesion molecules was studied by indirect
immunofluorescence, with primary monoclonal antibody (mAb) directed
against the antigen of interest and FITC-conjugated second antibody bound
to the primary antibody detected cytofluorimetrically. Purified human
neutrophils were resuspended (107 cells/ml in PBS with divalent cations)
and incubated at 37°C in a shaking water bath, with priming agents or
appropriate vehicle controls added to give a total volume of 500 pi. After
designated incubation times, sample volumes were adjusted to 1 ml by the
addition of PBS or fMLP (100 nM final concentration). Following a further
10 min incubation at 37°C, the reactions were stopped by placing the cells on
ice. Indirect immunofluorescence analysis was then performed as follows.
Neutrophils (5xl05/well) were transferred to pre-chilled flexiwell plates
(Becton Dickinson, Oxford, UK) and pelleted by centrifugation at 220g for 2
min. Cells were resuspended in 25 pi of saturating concentrations of
primary mAb and incubated for 30 min at 4°C. Cells were then washed (x3)
with PBS containing 0.2% bovine serum albumin (BSA) and 0.1% sodium
azide, and incubated a further 30 min at 4°C with FITC-conjugated rabbit
anti-mouse antibody (diluted 1 in 25 in PBS). Cells were again washed (x3)
and then fixed in 1% formaldehyde. Samples were analysed using an EPICS
Profile II (Coulter), and mean fluorescence values from a minimum of 2000
cells determined.
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2.5.2 Determination of the Functional Capacity of Neutrophil CDllb by
Binding of Albumin-Coated Latex Beads
The ability of neutrophils to bind albumin-coated latex beads was used as an
index of CDllb function. Fluorescent latex microspheres (2.5% v/v stock
solution) were washed three times in sterile PBS, resuspended and incubated
at room temperature in human serum albumin (10 mg/ml) for ten minutes,
and again washed three times in PBS. The resultant albumin-coated latex
beads were resuspended at 0.75% (v/v) in PBS. 175 pi aliquots of freshly
isolated neutrophils (107/ml) were incubated in 2 ml Eppendorf tubes in a
shaking water bath at 37°C, with agonists added in a volume of 25 pi to
obtain the appropriate final agonist concentrations. 15 min prior to the
termination of incubation (with 0.5 ml of 0.5% glutaraldehyde), 25 pi
albumin-coated fluorescent latex beads were added to each reaction tube; for
time-points of less than 15 min, the beads were added before the agonist. 30
min after the addition of glutaraldehyde, non-adherent beads were removed
by three consecutive washes with PBS, and bead binding to PMN was
assessed by cytofluorimetry (7500 cells analysed per sample).
2.6 Analysis of G-Protein Translocation and Activity in Control, Primed
and Stimulated Human Neutrophils
2.6.1 Preparation of Neutrophil Membranes
A combination of nitrogen cavitation (cell disruption achieved by exposure
to high pressure within a sealed chamber followed by rapid
depressurisation) and high speed density gradient centrifugation was used
to obtain neutrophil membranes; this method has previously been shown to
yield ~ 75% plasmalemmal and 25% Golgi membranes with only minor
contamination from endoplasmic reticulum, cytosol and granule membranes
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(O'Flaherty et al., 1990, O'Flaherty and Rossi, 1993). Fresh human
neutrophils were incubated (107/ml) in the presence or absence of priming
agents; reactions were stopped by pelleting the cells at 4°C followed by
resuspension (2xl07/ml) in ice-cold relaxation buffer (100 mM KC1, 3 mM
NaCl, 3.5 mM MgCl2, 1 mM ATP, 10 mM PIPES, pH 7.3). The neutrophils
were then subjected to nitrogen cavitation (400 p.s.i. nitrogen pressure, 4°C,
20 min) in a nitrogen bomb (Parr Instrument Company, Molline, USA), and
the resulting cavitate was spun at 800g for 5 min at 4°C to remove
undisrupted cells and debris. The supernatant was layered over 81% and
53% Percoll gradients prepared by mixing Percoll with dilution buffer - 1 M
KC1, 30 mM NaCl, 35 mM MgCl2, 10 mM ATP, 100 mM PIPES, 12.5 mM
EGTA according to the following formula: lower (81%) gradient 13.2 ml
Percoll, 1.5 ml dilution buffer/0.05 M HC1, 0.3 ml distilled water; upper
(53%) gradient 5.1 ml Percoll, 1.5 ml dilution buffer/0.05 M NaOH, 8.4 ml
distilled water; the gradients were centrifuged at 42,000y for 20 min (4°C) in
a Beckman J2-MC centrifuge equipped with a JC-21 rotor. Plasma
membranes were harvested from the upper interface layer, with granule
membranes sedimenting to the lower interface. The plasma membrane
fraction was resuspended in relaxation buffer and centrifuged for a further
60 min at 42,000y. The protein content of the washed membranes was
estimated using the BCA protein assay kit (Pierce); protein yields ranged
from 0.1 - 0.2 mg/108 neutrophils. Aliquots (0.2-0.4 mg protein/ml) were
stored at -80°C prior to use.
2.6.2 Detection of G-Proteins in Membrane Fractions byWestern Blotting
Membrane proteins were separated according to size by SDS PAGE,
transferred to nitrocellulose, and G-proteins were visualised using a
horseradish peroxidase-linked antibody detection system. The resolving gel
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comprised 1.6 ml 50% glycerol in H2O, 8 ml 30% acrylamide plus 0.8% bis-
acrylamide, 6 ml buffer 1 (1.5 M Tris, 0.4% SDS, pH 8.8), 90 pi 10%
ammonium persulphate (freshly prepared), 8.2 ml H2O and 8 pi Temed; this
solution was cast between clean gel plates and overlaid with 2 ml 0.1% SDS
to exclude air, thereby promoting setting. When the resolving gel had set
(about 2 hrs), the 0.1% SDS was poured off and the stacking gel (1.5 ml 30%
acrylamide plus 0.8% bis-acrylamide, 3.75 ml buffer 2 (0.5 M Tris base, 0.4%
SDS, pH 6.8) 150 pi 10% ammonium persulphate, 9.75 ml H2O and 8 pi
Temed) was layered over it. A gel comb was inserted into the stacking gel,
which was allowed to set for about 2 hours, when the comb was removed.
Neutrophil membrane proteins (5 pg or 10 pg) prepared and stored as
described above were precipitated by the addition of 10 pi 2% Na
deoxycholate, 250 pi trichloroacetic acid (TCA) and 750 pi H2O, pelleted and
resuspended in 15 pi 1 M Tris base plus 20 pi Laemmeli loading buffer. The
gel was placed in a gel tank with gel running buffer (72 g glycine, 15 g Tris
base and 50 ml 10% SDS made up to 5 1 with dh^O) and the protein samples
loaded with a 50 pi Hamilton syringe into the wells; markers of standard
molecular weight were included on each gel. Electrophoresis (50 volts, 20
milliamps) was carried out overnight or until the dye front had run off the
gel. The gel was carefully removed from the plates, discarding the stacking
gel element, and placed in blotting buffer (72 g glycine, 15 g Tris base, 1 1
methanol, the whole made up to 5 1 with dH20). A nitrocellulose membrane
was placed over the gel, and the gel plus membrane was sandwiched
between 3 mm filter paper and foam. The gel sandwich was placed in a
blotting tank, covered with blotting buffer, and the electrophoresed proteins
were transferred to the nitrocellulose (100 volts, 20 milliamps for 90-120
min). Even sample loading was confirmed by staining the nitrocellulose blot
with 24% Ponceau-S in 3% TCA; the red dye was removed by washing in
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blotting buffer and subsequently dH^O, and the nitrocellulose was placed in
5% gelatin in PBS for 2-3 hrs at 37°C to block the remaining areas of the
membrane. After thorough washing with water the immunoblot was
incubated overnight at 37°C with primary rabbit antibody (SPG, directed
against the C-terminal decapeptide of Gia2, supplied by Professor Graham
Milligan) in 1% gelatin/0.2% Nonidet P40/PBS. The primary antibody was
removed and the immunoblot washed (water, 0.2% NP40 in PBS, and PBS)
prior to a further 3 hr incubation with horseradish peroxidase-conjugated
donkey anti-rabbit IgG diluted 1 in 250 in 1% gelatin/0.2% Nonidet
P40/PBS. The nitrocellulose was washed as above, and developed by the
addition of 0.02% O-dianisidine in PBS (50 ml) plus 10 pi 40% hydrogen
peroxide solution.
2.6.3 Assay of GTPase Activity in Membrane Fractions
GTPase activity was determined by the hydrolysis of [y-32P]GTP to free 32Pi
in the presence or absence of 100 pM GTP. The reaction mixture (final
volume 100 pi) contained 0.05 pCi [y-32P]GTP, 10 mM creatinine phosphate,
10 U creatinine phosphokinase, 1 mM ATP, 0.1 mM App(NH)p, 1 mM
ouabain, 100 mM NaCl, 5 mM MgCl2, 2 mM dithiothreitol, 0.1 mM EDTA, 40
mM Tris base and 500 nM GTP, and the reaction was initiated by the
addition of 4 pg membrane protein. For each sample, three sets of triplicate
incubations were performed, with the addition of 100 nM fMLP to one set of
triplicates and of 100 pM GTP to a further set. Reactions were terminated
after 10 min at 37°C by the addition of ice-cold 5% activated charcoal in 10
mM phosphoric acid; the charcoal was pelleted (13,000g, 5 min) and the free
32Pi present in the supernatant was determined by scintillation counting.
High affinity GTP hydrolysis was calculated by subtraction of values
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obtained in the presence of 100 gM GTP, and results expressed as pmol free
Pi generated per mg protein per minute.
2.7 Determination of Ins(l,4,5)P3 Mass
Ins(l,4,5)P3 mass was measured using the radioreceptor assay of Challiss et
al. (1988) with minor modifications. The assay utilises an Ins(l,4,5)P3
binding protein derived from bovine adrenal cortex (BAC), which is a rich
source of a single, high affinity [3H]Ins(l,4,5)P3 binding site; the
displacement of [3H]Ins(l,4,5)P3 by free Ins(l,4,5)P3 from this site forms the
basis of the assay.
2.7.1 Preparation of Ins(l,4,5)P3 Binding Protein
Binding protein for use in the Ins(l,4,5)P3 radioreceptor assay (see below)
was prepared from decapsulated, demedullated bovine adrenal glands
obtained from the local abattoir, as described by Challiss and co-workers
(1988). The adrenal cortical tissue from 8-12 glands (60-80 g, kept at 4°C)
was homogenised (Polytron tissue homogeniser, Polytron, Switzerland) in 8
volumes of homogenisation buffer (20 mM NaHCCh, 1 mM dithiothreitol,
pH 7.8) and centrifuged (Beckman J2-MC) at 5000y, 4°C for 10 min. The
supernatant was aspirated and stored at 4°C while the pellet was re-
homogenised in 4 volumes of buffer and the centrifugation step repeated.
The 2 supernatant fractions were pooled and spun at 38,000y, 4°C for 20 min,
and the pelleted protein resuspended in homogenisation buffer at 20 mg/ml
(Pierce BCA protein assay kit, using bovine serum albumin as standard in
accordance with the manufacturers' instructions) prior to aliquoting and
storage at -20°C.
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2.7.2 Preparation of Neutralised TCA Extracts from Human Neutrophils
Because of their negative charge and tendency to form protein associations,
inositol polyphosphates partition poorly into the aqueous phase; in an acidic
environment their negative charge and ability to form salt bridges is
suppressed, enabling fuller partitioning and recovery. Hence a TCA
extraction protocol was employed.
Neutrophils were suspended in PBS with divalent cations at a density of
32.2xl06/ml, and 225 pi aliquots were placed in 2 ml polypropylene tubes in
a shaking water bath at 37°C and allowed to reach thermal equilibrium.
Priming agents (final concentrations: TNFa 200 U/ml, LPS 100 ng/ml or
PAF 100 nM) or appropriate vehicle controls were added (25pl), and priming
allowed to proceed for the appropriate time prior to stimulation with fMLP
(final concentration 1-100 nM fMLP) or PBS (50 pi). Reactions were stopped
at 0-120 s by the addition of 60 pi ice-cold 3 M TCA, and samples allowed to
extract at 4°C for 20 min. The TCA extracts were vortex-mixed, spun at
13,000# for 5 min at 4°C, and 300 pi supernatant combined with 75 pi EDTA
10 mM, pH 7 0. Samples were removed from ice prior to the addition of 300
pi freshly prepared 1,1,2-trichlorotrifluoroethane (freon)/tri-n-octylamine
(1:1, v/v), vigorous vortexing and centrifugation at 15,000# for 5 min to
allow phase partitioning. The pH of 200 pi of upper (aqueous) phase was
adjusted to 7.0 by the addition of 40 pi 60 mM NaHCCL, and the neutralised
extracts stored at 4°C prior to analysis.
2.7.3. Ins(l,4,5)P3 Mass Assay
Incubations were performed in 4 ml LP3 tubes at 4°C in a final volume of 120
pi; all standards and samples were analysed in duplicate. 30 pi sample, or 30
pi distilled, deionised H2O containing standard amounts of D-Ins(l,4,5)P3




Figure 2.3 Inositol 1,4,5-trisphosphate Mass Assay: Standard Curve
Ins(l,4,5)P3, 0-300 nM, was incubated at 4°C for 60 min with 0.6 mg
Ins(l,4,5)P3-binding protein and 8,000-10,000 d.p.m. [3H]Ins(l,4,5)P3 as
described in section 2.7.3. Bound and free [3H]Ins(l,4,5)P3 were separated by
filtration through Whatman GF/B filters; bound [3H]Ins(l,4,5)P3 retained by
the filters was quantified by liquid scintillation counting. Data represent the
means of duplicate samples, and standard errors (<4.6% of the mean) lie
within the data points. ED5o=12.5 nM; non-specific binding=0.9%;
[3H]Ins(l,4,5)P3 bound in the absence of unlabelled Ins(l,4,5)P3 (Bo)=2% of
total radioactivity added.
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to determine the non-specific binding, were combined with 30 pi ice-cold
buffer (100 mM Tris/HCl, 4 mM EDTA, pH 7.8) and 30 pi [3H]Ins(l,4,5)P3 in
dh^O (8,000-10,000 d.p.m. per 30 pi). The reactions were commenced by the
addition of 30 pi (0.6 mg protein) BAC Ins(l,4,5)P3 binding protein with
gentle vortexing, and allowed to reach equilibrium (60 min at 4°C).
Separation of bound from free [3H]Ins(l,4,5)P3 was achieved by filtration
through Whatman GF/B filters, washing with 4 x 3 ml of ice cold filtration
buffer (25 mM Tris/HCl, 1 mM EDTA, 5 mM NaHC03, pH 7.8). Individual
filter discs were placed in scintillation vials, covered with 4 ml Emulsafe
scintillation fluid, and following a 12 hour extraction period the radioactivity
associated with bound [3H]Ins(l,4,5)P3 was determined by liquid
scintillation counting. Unknown Ins(l,4,5)P3 concentrations were derived
from the internally generated standard curve using a Packard
radioimmunoassay programme (Securia II). Standard curves (see Figure 2.3)
were highly reproducible, with an ED50 of 13-4+0-9 nM and a non-specific
binding of 0-85+0 08% (n=6).
2.8 Quantification of [32P]Phosphatidylinositol 3,4,5-trisphosphate
Accumulation in Human Neutrophils
Lipids from [32P]Pi-labelled neutrophils primed with TNFa and stimulated
with fMLP were extracted, deacylated and separated by TLC and/or anion
exchange HPLC to allow quantification of [32P]PtdIns(3,4,5)P3.
2.8.1 Priming and Stimulation of [32P]P;-Labelled Neutrophils
Neutrophils take up [32P]Pi poorly, and since little PtdIns(3,4,5)P3 is present
even in stimulated cells, a high specific activity was required for adequate
labelling. Loading of cells with [32P]Pi was optimised by performing the
incubation in sterile phosphate-free HEPES-buffered Hanks solution (100
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mM NaCl, 10 mM KC1,1 mM MgC^, 10 mM glucose, 1.5 mM CaC^, 30 mM
HEPES, pH 7.4). Freshly isolated neutrophils were washed twice in
phosphate-free buffer, resuspended at 108 cells in 2.25 ml and incubated with
5 mCi [32P]Pj in 125 pil water, together with an equal volume (125 pi) of
sterile 1-8% saline to maintain isotonicity. The cells were incubated at 37°C
in a shaking water bath for 70 min, washed (2 x 10 ml phosphate-free buffer)
and resuspended in 1.2 ml phosphate-free buffer. The cells were then
aliquoted (100 pi) into 2 ml Eppendorf tubes, incubated for 30 min with
TNFa (40 pi, final concentration 200 U/ml) or buffer and stimulated for 10 s
or 60 s with fMLP (40 pi, final concentration 100 nM). Reactions were
stopped by the addition of 675 pi methanol/chloroform (2:1, v/v).
2.8.2 Measurement of fMLP-stimulated PtdIns(3,4,5)P3 in TNFa-primed
and Unprimed Human Neutrophils
Samples prepared as detailed above were acidified by the addition of 158 pi
2.4 M HC1 containing 5 mM tetrabutylammonium sulphate and partitioned
using 675 pi chloroform. The lower phase was removed, washed with 658 pi
synthetic upper phase (methanols M HCkchloroform, 48:47:3, v/v/v), and
dried under vacuum. The lipids were deacylated to render them water-
soluble by the addition of 200 pi of monomethylamine reagent (prepared by
bubbling monomethylamine gas into a 4:3:1 (v/v/v) mixture of methanol:
water: n-butanol in a marked vessel placed in dry-ice bath
(monomethylamine gas is explosive at room temperature) to increase the
liquid volume 1.625-fold; aliquots of the reagent were stored at -80°C in
tightly sealed tubes and removed immediately prior to use) to each sample.
Following vigorous vortexing, the samples were placed in a 53°C water bath
for 30 min, with further vortexing at 15 min. Samples were again dried
under vacuum, and the deacylated lipids were extracted in the presence of
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200 (xl phytate hydrolysate (12 pg phosphorus per sample) with 240 pi n-
butanol/light petroleum/ethylformate (20:4:1, v/v/v). The lower phase was
removed and dried under vacuum and the [32P]glycerophosphoesters were
redissolved in 2 pi 20 mM HC1, 1 mM K2PO4 and chromatographed on
polyethyleneimine-cellulose plates [Stephens et al., 1993]: the plates were
developed in 0.48 M HC1, and the radioactivity in GroPInsP3 and GroPInsP2
spots quantified by means of a phosphoimager (Molecular Dynamics). To
separate isomers of [32P]glycerophosphoesters (i.e. GroPIns3P from
GroPIns4P or GroPIns(4,5)P2 from GroPIns(3,4)P2), the
[32P]glycerophosphoesters were redissolved in 2 ml H2O and resolved by
anion-exchange chromatography; a Partisphere 5-SAX column was eluted at
1 ml/min with a gradient of 2.5 M NaH2PC>4 (pH 3.8) with NaOH 0-100%,
samples being collected every 30 s
To confirm that the above [32P]-labelling protocol did not induce neutrophil
priming, cells from the same preparation were incubated under identical
conditions in parallel with the above samples and assayed for O2" release
rather than [32P]PtdIns(3,4,5)P3. After confirming that the [32P]Pj labelling
protocol did not induce priming or affect the subsequent degree of
activation, the [32P]Pi component was replaced by sterile H2O in subsequent
parallel assays to assess 02~ generation.
2.8.3 Effects of TNFa and fMLP on Neutrophil PI3K Activity in Anti-
phosphotyrosine Immunoprecipitates.
Human neutrophils (3xl07/ml in PBS with divalent cations) were incubated
in the presence of TNFa 200 U/ml or vehicle for 30 min and stimulated with
fMLP 100 nM or vehicle for 60 s. The reactions were terminated by
centrifugation at 4°C (4 s, 15,000g) and snap-freezing in liquid nitrogen.
Immunoprecipitation and measurement of PI3K activity were carried out by
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Dr L. Stephens (Department of Cell Signalling, Babraham Institute,
Cambridge).
Samples were resuspended in 1 ml ice-cold lysis buffer (137 mM NaCl, 2.7
mM KC1,1 mM MgCl2,1 mM CaCl2,1% (w/v) NP40, 10% (w/v) glycerol, 1
mg/ml BSA, 20 mM Tris, 0.5 mM orthovanadate, and protease inhibitors (0.2
mM PMSF 10 pg/ml leupeptin, pepstatin and aprotinin, Sigma) pH 8.0),
vortexed and placed on ice for 10 min.. Following centrifugation (30 min,
4500 g, 0°C), 0.8 ml aliquots were mixed with 8 jul antiphosphotyrosine
monoclonal antibody (PY20, ICN) and 40 pi of a 1/1 suspension of protein
A-sepharose CL4B beads (Pharmacia) pre-equilibrated for 2 hr in lysis
buffer. After 2 hr at 0°C the beads were washed at 4°C as follows: three
times with lysis buffer, twice with 0.5 mM LiCl, 0.1 mM Tris, pH 8.0, once
with 0.15 mM NaCl, 10 mM Tris, 1 mM EDTA, pH 7.6 and once with 20 mM
F1EPES, 1 mM DTT, 5 mM MgCl2, pH 7.6. The supernatants were discarded
and 40 pi ice-cold assay buffer (20 mM (3-glycerophosphate, 5 mM
pyrophosphate, 30 mM NaCl, 1 mM DTT, pH 7.2) and 20 pi Ptdlns/cholate
(3 mg/ml Ptdlns, 1% cholate in assay buffer) were added and the samples
transferred to a 37°C water-bath. After 5 min, 40pl of a solution containing 3
pM ATP, 7.5 mM MgCl2 and 0.25 mCi/ml [y-32P]ATP (Amersham) was
added to initiate the assy. The reactions were quenched at 15 min by the
addition of 500 pi chloroform/methanol/H20 (97.88 ml
chloroform/methanol, 1/2 (v/v) plus 2.12 ml H2O) and the samples were
mixed thoroughly. Finally, 489 pi chloroform and 114 pi 2.4 M HC1, 5 mM
tetrabutylammonium sulphate were added, and the extraction procedure
was completed exactly as described in (2.8.2) above. The extracted lipids
were finally deacylated and resolved by HPLC (2.8.2).
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Chapter 3: Priming of Human Neutrophil Superoxide Anion
Generation
3.1 Introduction
Priming refers to the process whereby a greatly enhanced activation
response is seen following the sequential addition of priming and activating
agents. Activation of a primed neutrophil causes translocation of the
cytosolic components of the NADPH oxidase enzyme system (p47Phox,
p67Phox and the GTP-binding protein p21rac) to the neutrophil membrane (to
which the flavocytochrome bsss is already localised) and the resultant
generation of reactive oxygen species (the 'respiratory burst', Chapter 1.3),
prominent amongst which is the superoxide anion (O2"). Oxidase activity
can be estimated by measuring several different parameters: 1) the increase
in oxygen consumption using an oxygen electrode, (e.g. Berkow et al., 1987),
2) luminol- or lucigenin-enhanced chemiluminescence (e.g. Macphee et al.,
1993), 3) fluorimetric measurement of hydrogen peroxide production (e.g.
Nathan, 1987) and 4) measurement of superoxide production as a) the
superoxide dismutase-inhibitable reduction of cytochrome C (e.g. Guthrie et
al., 1984), as b) the production of formazan by reduction of nitroblue
tetrazolium (e.g. Yanaga and Watson, 1994), or c) cytofluorimetrically as the
reduction of dihydrorhodamine (e.g. Stocks et al., 1995). In general the
preferred method is that of cytochrome C reduction, since it is both simple
and quantitative (1 nmol O2" reduces 1 nmol cytochrome C, producing an
increase in the absorbance at 550 nm); it measures extracellular Cb~ release,
the fraction most likely to lead to tissue injury.
The importance of neutrophil O2" generation in the microbicidal process is
emphasised by the hereditary condition chronic granulomatous disease;
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mutations in the genes encoding individual components of the NADPH
oxidase result in defective production of CV, and patients suffer from
recurrent life-threatening infections (Finn et al., 1990). Inappropriate or
excessive O2" production may be involved in a number of disease processes:
for example, ischaemia-reperfusion injury (Grisham et al., 1986), ARDS (e.g.
Braude et al., 1986) and vasculitis (Keogan et al., 1991). Furthermore, O2"
generation is the most 'printable' of the neutrophil's array of responses;
production induced by the bacterial peptide fMLP, for example, is minimal
in unprimed cells, but can be increased 10-20 fold by prior exposure of the
neutrophil population to the more potent priming agents (e.g. Guthrie et al.,
1984, Berkow et al., 1987, and see below). In contrast, fMLP-induced
degranulation (Fittschen et al., 1988) and production of bioactive lipids (e.g.
leukotriene B4, Doerfler et al., 1989) are enhanced to a much lesser extent by
priming. Some pharmacological agents, such as the phorbol ester PMA
(which activates PKC directly) cause near-maximal O2" generation alone,
with only a slight increase on priming. The augmentation of the fMLP-
induced O2" response is thus the 'gold-standard' for assessment of neutrophil
priming.
Priming activity has been ascribed to a wide variety of substances; in this
work I have focused on those with a probable physiological/pathological
role. Bacterial lipopolysaccharide (LPS, endotoxin) was the first neutrophil
priming agent to be recognised (Guthrie et al., 1984): TNFa and PAF are also
well-established priming agents under certain conditions (Table 3.1).
Inositol hexakisphosphate (phytic acid) has recently been suggested to act as
a priming agent (Eggleton et al., 1991) - since large stores of this compound
exist in mammalian cells (5-15 pM, Szewergold et al., 1987) and are released
from dying or effete cells, this is a potentially important mechanism for
modulation of local inflammatory processes. Finally, controversy exists
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Table 3.1
Concentration- and Time-dependence for Priming of Human Neutrophil
02~ Generation by a Series of Priming Agents
Agent Concentration Range;Time PMN Reference
LPS 10 ng-1 pg/ml; 30-120 min Human Guthrie et al., 1984
TNFoc 10-500 U/ml; 5-60 min Human Berkow et al., 1987
GM-CSF 0.1-100 nM; 60-240 min Human Weisbart et al, 1986a
PAF 10 nM-1 pM; 1-60 min Human Engleberger et al., 1987
Ionomycin 10 nM-1 pM; 1-10 min Human Finkel et al., 1987
concerning the effects of PDGF on multiple neutrophil functions (see Section
3.8). The aims of the work presented in this chapter were to confirm or
refute these substances as priming agents, and to establish optimal
conditions for priming in terms of agonist-specific requirements for time to
prime, and agonist concentration.
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3.2 Priming of O2" Generation by LPS
3.2.1 LPS Priming of fMLP- and PMA-mediated O2" Generation
Incubation with the formylated bacterial tripeptide fMLP alone produced
only minimal O2" release from human neutrophils, but its effects were
augmented (primed) by preincubation with LPS under the conditions
documented (Figures 3.1-3.3). In contrast, the phorbol ester PMA induced a
massive release of O2" (greater than the primed fMLP response), that was not
primed to any great extent by LPS (Figure 3.1) even when sub-maximal
concentrations of PMA (<10 ng/ml) were employed. fMLP, rather than
PMA or related phorbol esters, was therefore used in the majority of
subsequent experiments.
3.2.2 Serum-dependence of LPS Priming
The biological effects of LPS are profoundly affected by the serum factor
lipopolysaccharide-binding protein (LBP) which combines with LPS to
promote interaction with CD14 (Tobias et al., 1986), thought to be involved
in transducing the signal to the cell interior. In the absence of this serum
factor, responses to LPS are diminished both in terms of magnitude and
rapidity of onset. To assess the serum-dependence of the LPS effect in our
system, fMLP-stimulated O2" generation was determined in LPS-primed and
unprimed cells in the presence or absence of 1% autologous serum (heat-
inactivated at 56°C for 30 min to eliminate the effects of complement
components). As can be seen from Figure 3.2, serum greatly augmented the
priming effect of LPS at 1 hour (13.9-fold versus 7.2-fold augmentation of the
response to fMLP alone); however, C>2~ generation by control (unprimed,
unstimulated) cells and by cells treated with fMLP or with LPS alone was
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Figure 3.1 LPS Priming of fMLP- and PMA-stimulated O2" Generation in
Human Neutrophils.
Human neutrophils (106 in 90 |il PBS with calcium and magnesium) were
incubated for 60 min in the presence (hatched bars) or absence (open bars) of
LPS 100 ng/ml at 37°C in a shaking water bath. After 1 hr the incubation
volume was adjusted to 1 ml by the addition of pre-warmed cytochrome C
(final concentration 1.2 mg/ml) and agonists. Graph A documents the
effects of LPS pre-treatment on fMLP- (100 nM, 10 min) and PMA- (10
ng/ml, 10 min) induced 02~ generation, and graph B the effects of LPS on
PMA- (1 ng-1 pg/ml, 10 min) induced 02" generation, measured by the
superoxide-dismutase-inhibitable reduction of cytochrome C as described in




































Figure 3.2 Effect of Serum on LPS Priming of fMLP-stimulated 02"
Generation in Human Neutrophils
Human neutrophils (106 in 90 jil PBS with calcium and magnesium) were
incubated at 37°C in the presence (hatched bars) or absence (open bars) of
1% heat-inactivated autologous serum, with or without LPS 100 ng/ml for 1
hr prior to the addition of pre-warmed cytochrome C (final concentration 1.2
mg/ml) and of fMLP (final concentration 100 nM) or vehicle in a final
volume of 1 ml. SOD (375 U) was included in one of each set of
quadruplicate incubations, and 02" generation was quantified by the
superoxide dismutase-inhibitable reduction of cytochrome C as described in
(2.3). Data represent mean+sem of 3 separate experiments, each performed
in triplicate.
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priming/stimulatory effect of serum, the majority of further experiments
were carried out in the absence of serum; experiments in which serum was
included incorporated additional serum controls.
3.2.3 Concentration-dependence of LPS Priming
A concentration-response curve for LPS priming of fMLP-stimulated O2"
generation was constructed utilising concentrations of LPS ranging from 1
ng/ml to 1 gg/ml in the absence of serum. From Figure 3.3 it can be seen
that increasing concentrations of LPS induced a near-maximal response at
100 ng/ml (EC50 35+14 ng/ml); elevating the concentration of LPS to 1
jug/ml resulted in little increase in the degree of priming achieved, but some
direct activation of O2" production in the absence of fMLP was observed.
LPS 100 ng/ml was hence selected to prime neutrophils in the majority of
future experiments.
3.3 Priming of O2" Generation by TNFa and by PAF
Both TNFa and PAF have been reported to prime neutrophils (Berkow et al.,
1987; Engleberger et al., 1987). TNFa was found to be a potent and effective
priming agent (Figure 3.4); preincubation with this cytokine for 30 min
augmented fMLP-stimulated O2" generation at 20-20000 U/ml (EC50 >
216±48 U/ml); however the higher activities also induced CP" release in the
absence of further stimulation. It should be noted that neutrophils were
non-adherent, being kept in suspension by the use of a shaking water-bath
and by the use of polypropylene surfaces; TNFa is a powerful activating
agent for adherent neutrophils (Nathan, 1987). TNFa 200 U/ml was used in
further experiments, since this activity induced priming with minimal direct
activation. PAF was also found to be a powerful priming agent (EC50 >

















Figure 3.3 LPS Priming of fMLP-stimulated Superoxide Anion Generation
in Human Neutrophils: Concentration-response
Human neutrophils (106 in 90 pi PBS with calcium and magnesium) were
incubated at 37°C in the presence (hatched bars) or absence (open bars) of
LPS 0-1 fig/ml, for 1 hr prior to the addition of cytochrome C (final
concentration 1.2 mg/ml) and of fMLP (final concentration 100 nM) or
vehicle in a final volume of 1 ml. SOD (375 U) was included in one of each
set of quadruplicate incubations, and superoxide release was determined by
the superoxide dismutase-inhibitable reduction of cytochrome C as
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Figure 3.4 TNFa Priming of fMLP-stimulated O2" Generation in Human
Neutrophils: Concentration-response
Human neutrophils (106 in 90 pi PBS with calcium and magnesium) were
incubated at 37°C in the presence (hatched bars) or absence (open bars) of
TNFa 0-20,000 U/ml for 30 min prior to the addition of pre-warmed
cytochrome C (final concentration 1.2 mg/ml) and of fMLP (final
concentration 100 nM) or vehicle in a final volume of 1 ml. SOD 375 U was
included in one of each set of quadruplicate incubations, and superoxide
release measured as described in (2.3). Data represent meanlsem of 3
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Figure 3.5 PAF Priming of fMLP-stimulated 02" Generation in Human
Neutrophils: Concentration-response
Human neutrophils (106 in 90 jil PBS with calcium and magnesium) were
incubated at 37°C in the presence (hatched bars) or absence (open bars) of
PAF 0-1 jiM, for 10 min prior to the addition of cytochrome C (final
concentration 1.2 mg/ml) and of fMLP (final concentration 100 nM) or
vehicle in a final volume of 1 ml. SOD (375 U) was included in one of each
set of quadruplicate incubations. After 15 min cells were pelleted at 4°C and
the optical density of the supernatants at 550 nm determined by scanning
spectrophotometry; superoxide generation was calculated as described in
(2.3). Data represent mean+sem of 3 separate experiments, each performed
in triplicate.
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to little observable stimulation of the respiratory burst, whilst concentrations
as low as 1 nM were seen to prime. 100 nM PAF was used in subsequent
experiments, since this concentration induced a degree of priming similar to
that seen with LPS 100 ng/ml and with TNFa 200 U/ml.
3.4 Time-course for the Priming of Neutrophil O2" Generation by LPS,
TNFa and PAF
To determine the optimal time-intervals required to establish the primed
state for each agonist, freshly isolated neutrophils were incubated for 0-120
min with LPS 100 ng/ml (in the presence and absence of 1% autologous
heat-inactivated serum), TNFa 200 U/ml or PAF 100 nM, prior to
determination of the stimulated O2* response. These comparisons were all
made using a single population of neutrophils. Figure 3.6 illustrates that the
onset of priming was most rapid in the case of PAF, an effect being observed
after a preincubation of only 1 min; the priming effect was maximal at 10-60
min and had declined somewhat by 120 min. Incubation with TNFa also
primed neutrophils rapidly, priming being apparent by 10 min and maximal
by 30-60 min. The inclusion of serum caused a profound alteration in the
time-course of LPS-induced priming (Figure 3.6); in its absence, priming was
not observed before 60 min had elapsed and was on-going at 120 min, but
when both LPS and serum were present priming was seen at 30 min and was
maximal by 60 min.
3.5 Lack of Effect of Recombinant Platelet-derived Growth Factor (PDGF)
on Human Neutrophil O2" Generation
Conflicting reports exist concerning the effects of PDGF on multiple
neutrophil functions (see 3.8, below); we therefore examined the ability of
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Figure 3.6
Figure 3.6 Time-course for PAF-, TNFa-, and LPS-induced Priming of
fMLP-stimulated O2" Generation in Human Neutrophils
Human neutrophils (106 in 90 pi PBS with calcium and magnesium) were
incubated for 0-120 min at 37°C with the following priming agents: PAF 100
nM ft, TNFa 200 U/ml (0), LPS 100 ng/ml (o) and LPS 100 ng/ml + 1%
heat-inactivated serum (A). At the appropriate times, the incubation
volumes were adjusted to 1 ml by the addition of cytochrome C and fMLP
(final concentrations 1.2 mg/ml and 100 nM respectively) for 10 min; cells
were pelleted at 4°C and the optical density of the supernatants determined
at 550 nm. 02" release was calculated as described in (2.3). Data represent
mean±sem for n=23 experiments, each performed in duplicate.
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Figure 3.7
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Figure 3.7 The Effects of PDGF on Basal, fMLP-stimulated and LPS-
primed Human Neutrophil 02~ Generation
Human neutrophils (106 in 90 pi PBS with calcium and magnesium) were
incubated at 37°C in the presence or absence of recombinant human PDGF-
AB (rhPDGF-AB) 20 ng/ml for 30 min; following this period some cells were
further incubated with LPS 100 ng/ml for 1 hr. At the end of the designated
incubation periods, pre-warmed cytochrome C (final concentration 1.2
mg/ml) and fMLP (100 nM final concentration; hatched bars) or vehicle
(open bars) were added, bringing the final incubation volume to 1 ml. Cells
were pelleted at 4°C after 10 min, and the release of 02~ was quantified by
measuring the optical density of the supernatants at 550 nm. Data represent
the mean+sem of 3 separate experiments performed in triplicate.
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recombinant human PDGF-AB (which interacts with both a- and (3-PDGF
receptors) to influence the respiratory burst of human neutrophils. As can be
seen from Figure 3.7, PDGF failed to either prime or activate the respiratory
burst, and it did not influence the priming response to LPS 100 ng/ml.
3.6 Effects of Inositol Hexakisphosphate on Neutrophil 02" Generation
Despite the presence of high concentrations of InsP6 in mammalian cells (up
to 15 |iM, Szewergold et al., 1987) its physiological role remains uncertain.
Recently it has been reported to act as a neutrophil priming agent (Eggleton
et al., 1991); dying and effete cells at a site of inflammation could hence
release sufficient quantities of this substance to act as a local mediator of
neutrophil function. We therefore sought to validate and enlarge on the
original studies. Since InsPg is acidic in solution, it was dissolved in PBS/25
mM HEPES, which was confirmed to maintain the pH of the reaction
medium within the physiological range (7.2-7.4) for InsP6 concentrations of
up to 100 pM. A 2 min preincubation time was selected because previous
work in our laboratory has shown that InsPg 100 pM for 0.5-2 min
significantly augmented fMLP-induced shape change (E. Kitchen, personal
communication). In spite of these precautions, InsP6 100 pM exhibited only
weak priming activity (see Figure 3.8) to both fMLP- and PMA-stimulated
O2" release; higher concentrations of InsP6 resulted in >80% cell death as
assessed by trypan blue positivity. However, in contrast to the modest
priming effect of InsP6 alone, incubation of neutrophils with InsPg for 2 min
prior to priming with LPS 100 ng/ml significantly enhanced the effect above
that seen with LPS alone (Figure 3.9).
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Figure 3.8
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Figure 3.8 Effects of InsPg on Human Neutrophil fMLP- and PMA-
stimulated 02" Generation
Pre-warmed human neutrophils (106 in 90 pi PBS with calcium and
magnesium) were incubated in the presence or absence of 100 |iM InsP6 (in
PBS with 25 mM HEPES) for 2 min at 37°C prior to stimulation with fMLP
100 nM or PMA 10 ng/ml (hatched bars) or the appropriate vehicle control
(open bars) in the presence of cytochrome C 1.2 mg/ml (final volume 1 ml)
for 10 min. 02" release was determined by means of the superoxide
dismutase-inhibitable reduction of cytochrome C (measurement of the
absorbance of the supernatants at 550 nm). Data represent the mean+sem of





























Figure 3.9 Effect of InsPg on LPS-induced Priming of fMLP-stimulated 02"
Generation
Pre-warmed human neutrophils (106 in 80 pi) were incubated in the presence
or absence of Ins P6 100 pM for 2 min prior to the addition of LPS 100 ng/ml
or PBS (agonists added in 10 pi) for 60 min. The incubation volume was
adjusted to 1 ml by addition of pre-warmed cytochrome C (final
concentration 1.2 mg/ml) and fMLP 100 nM (hatched bars) or vehicle (open
bars). Superoxide release was determined by the superoxide dismutase-
inhibitable reduction of cytochrome C. Data represent the mean±sem of 3
separate experiments, each performed in triplicate.
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3.7 Effects of LPS, TNFa and PAF on Human Neutrophil Shape-Change
Neutrophils exposed to activating agents undergo shape-change, initially
manifested by protrusion of small pseudopodia, followed by uropod
formation and the adoption of a fully polarised morphology. Since it has
been suggested that shape-change may correlate with priming (Haslett et al.,
1985), we have examined the effects of the three priming agents LPS, TNFa
and PAF on shape-change. The results are documented in Figures 3.10-3.11.
All three agonists induced shape-change in a concentration-dependent
fashion, but the results do not correlate completely with the data obtained
for priming of O2" release; TNFa is more potent than the other agents as an
inducer of shape-change, but concentrations of LPS and PAF (10 ng/ml and
10 nM respectively) which have little effect on shape-change will prime for
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Figure 3.10 Effects of PAF, TNFa and LPS on Neutrophil Shape-Change
Freshly-isolated human neutrophils (5x106 in 450 pi) were incubated at 37°C
in the presence of vehicle (open bars), priming agents (PAF 0-1 pM (10 min),
TNFa 0-2000 U/ml (30 min), LPS 0-1 pg/ml (120 min), hatched bars) or
fMLP 100 nM (10 min, closed bars) prior to fixation with 500 pi 2.5%
glutaraldehyde. Shape-change was assessed by flow cytometry, as described








Figure 3.11 Effects of TNF on Neutrophil Shape-change
Figure legend overleaf.
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Figure Legend for Figure 3.11
Effects of TNFa on Neutrophil Shape-Change
Freshly-isolated human neutrophils (5xl06 in 450 pi) were incubated at 37°C
in the presence of TNFa 2 U/ml (B), 20 U/ml (C), 200 U/ml (D) or PBS
control (A) for 30 min prior to fixation with 500 pi 2.5% glutaraldehyde.
Shape-change was assessed by flow cytometry, as described in 2.5;
neutrophil forward scatter (horizontal axis) was plotted against event




The principal aim of the work presented in this chapter was to establish
optimum conditions for priming of freshly prepared human neutrophils. As
a prerequisite to this aim, a method of neutrophil isolation resulting in
minimal basal activation/priming was required. A previous study (Haslett
et al., 1985) has demonstrated that exposure to trace amounts of LPS during
the separation procedure (LPS was found to be present in the gradient
medium Ficoll) can prime neutrophils, and that red cell lysis procedures also
affect neutrophil responses; hence we chose to utilise dextran sedimentation
and plasma/Percoll gradient separation, a method which obviates the need
for a red cell lysis step and which, in the above quoted study, compared
favourably with the traditional Ficoll-Hypaque method in terms of the
induction of shape change and O2" release. The results presented in this
chapter demonstrate that we have obtained pure neutrophil populations
with minimal basal O2" generation and, more importantly, minimal fMLP-
induced O2" production (invariably < 5 nmol/106 cells, and usually < 3
nmol/106 cells, Figures 3.1-3.9). These results compare favourably with
those of other authors, whose results may include fMLP-stimulated values of
> 10 nmol O2VIO6 cells (see, for example, Wozniak et al., 1993, Berkow and
Dodson 1988, Klein et al., 1995). High values for fMLP-stimulated O2"
release will 'dilute' the effect of priming agents, reducing the fold-increase in
the stimulated respiratory burst seen on priming, and hampering the
investigation of the signalling pathways involved. Whilst a theoretical
population of totally unprimed human neutrophils might fail to respond to
fMLP altogether, this does not seem to be a currently achievable situation,
but by using an isolation technique yielding a pure, minimally primed
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population of control cells, we were in a strong position to investigate
mechanisms of priming.
LPS, TNFa and PAF were all seen to prime neutrophils for CV release in a
time- and concentration-dependent fashion, consistent with previous results
(compare Figures 3.3-3.6 with Table 3.1); higher concentrations of LPS and
TNFa activated the NADPFI oxidase directly in addition to their priming
activity. However, considerable variation in biological activity was noted
between different batches of LPS from the same company (for example,
compare the efficacy of 100 ng/ml LPS in Figure 3.1A with that illustrated in
Figure 3.3); therefore in subsequent experiments all batches of LPS were
tested for the ability to prime O2" release. Since neutrophils remained in
contact with serum or PPP until the final two washing procedures during
preparation, it is possible that the responses to LPS were influenced by trace
concentrations of serum protein (i.e. LBP) not removed by these washes;
however, washing procedures were standardised, and consistent results
were achieved whilst using each individual batch of LPS. Difficulties were
also experienced with variation in the activity of TNFa (U/mg protein, as
assessed by cytotoxicity towards mouse L929 cells) varying by > 2
logarithmic orders of magnitude between batches from the same supplier.
To circumvent this problem, in agreement with the majority of published
literature, TNFa was calibrated in terms of activity (U/ml) rather than in
ng/ml. To achieve consistent and reliable priming, the following conditions
were selected for use in subsequent experiments: LPS 100 ng/ml for 60-120
min, TNFa 200 U/ml for 30 min and PAF 100 nM for 10 min; similar degrees
of priming in the absence of direct activation were regularly obtained under
these circumstances.
TNFa exerts its multiplicity of biological effects by interaction with 2 distinct
receptors of 55 kDa and 75 kDa (TNF-R55 and TNF-R75 respectively;
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Brockhaus et al., 1990). In general, the TNF-R55 is the predominant
signalling moiety, while TNF-R75 seems to fulfil an accessory role in
enhancing or synergising TNF-R55 effects (Vandenabeele et al., 1995).
Richter et al. (1995) demonstrated that both TNFa receptors are involved in
the TNFa-induced activation of the respiratory burst of adherent
neutrophils, possibly acting in accordance with the ligand-passing model of
Tartaglia et al. (1993) whereby TNFa binds first to the high affinity TNF-R75,
producing a high local ligand concentration, and then dissociates to bind the
TNF-R55 and mediate intracellular signalling. The distinction between cells
in suspension and adherent cells is particularly relevant in the case of TNFa,
as highlighted by the studies of Nathan et al. (1987, 1989a); it was
demonstrated that cells in suspension did not produce H2O2 in response to
either TNFa or TNF(3, but that neutrophils plated on polystyrene surfaces
coated with serum, fibronectin, vitronectin, laminin or human umbilical vein
endothelial cells (HUVEC), underwent a massive and sustained (70-80 min)
secretory response to this cytokine after a lag period of approximately 30
min. This effect was found to be dependent on the engagement of
neutrophil integrin receptors (Nathan et al., 1989b) and could be abolished
by disruption of microfilament integrity with cytochalasins during the lag
period. This phenomenon was not felt to represent priming, however, since
its establishment was dependent on the simultaneous rather then
consecutive presence of the two 'stimuli' (adherence and the cytokine).
Similar findings were reported for GM-CSF and GCSF but not for LPS
(Nathan 1989a). These studies emphasise the importance of keeping cells in
suspension during the priming period; this was achieved in our experiments
by the use of polypropylene Eppendorf tubes and a shaking water-bath
operating at 100 horizontal cycles per min. Under these conditions, cells
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remained in suspension (macroscopically and microscopically) for periods in
excess of 2 hrs.
InsP6 alone had no effect on basal O2" release and caused only a very minor
(1.8±0.3-fold, n=6) enhancement of fMLP-stimulated O2" generation; these
results are in agreement with those of Eggleton et al. (1991), but it was felt
that this effect was too slight to allow InsP6 to be a useful tool in the study of
the mechanisms of priming. The synergy with LPS priming (Figure 3.9) is of
interest, since at an inflamed site multiple agonists will be present; in view of
the plentiful stores of InsP6 present in mammalian cells high local
concentrations may be achieved at inflammatory foci and this interaction
may become physiologically relevant.
PDGF has been reported to influence neutrophil adhesion molecule
expression (Garcia-Aguilar et al., 1989); however it has been suggest that
many or perhaps all of the effects on neutrophil function previously ascribed
to PDGF may be due to contaminants such as (3-thromboglobulin and
platelet factor-4 (Deuel et al., 1981, Allegrezza-Giulietti et al., 1991), which
co-purify with PDGF. In addition, Shure and co-workers (1992) have
demonstrated that, despite previous reports (Ferns et al., 1990, Siegbahn et
al., 1990), PDGF-AA induced monocyte chemotaxis only in the presence of
lymphocytes or IL-1; contaminating mononuclear cells and their products
represent a potential source of error in studies where impure neutrophil
preparations have been used. In order to circumvent these problems and to
clarify the role of PDGF as a mediator of neutrophil function, we have
examined the effects of recombinant human PDGF-AB (which activates both
PDGF-a and -P receptors) on pure populations of freshly isolated human
neutrophils. As demonstrated in Figure 3.7, PDGF had no significant effects
on either basal or stimulated O2" generation. In addition, PDGF failed to
influence the priming effects of LPS (Figure 3.7). We have subsequently
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shown (Qu et al., 1995) that PDGF does not affect neutrophil shape change,
CDllb/CD18 or CD62-L expression, Ins(l,4,5)P3 accumulation or the
phosphorylation of MAPK; and indeed that neutrophils do not possess
functional receptors for this peptide. PDGF has therefore been excluded
from further studies on neutrophil priming.
fMLP alone induced dramatic shape-change in > 90% of neutrophils (Figures
2.3 and 3.10); exposure to priming agents produced less dramatic shape-
change, with formation of small pseudopodia (Stocks et al., 1995). TNFa was
the most potent agonist studied in inducing both shape-change and a primed
O2" response (Figures 3.4, 3.10 and 3.11); the correlation with priming
activity was not absolute, however, since for LPS and PAF lower
concentrations of agonist were required to induce priming than to cause
shape-change.
These three agonists utilise differing methods of signal transduction; PAF
interacts with a classical G-protein-coupled receptor, whilst binding of TNFa
to its receptor induces receptor trimerisation and tyrosine kinase activity.
LPS interacts with CD14 to initiate signal transduction; this interaction is
promoted by the formation of LPS-LBP complexes but is thought to occur,
albeit more slowly, in the absence of serum-derived factors (Shapira et al.,
1995). Thus three agonists, acting via different signal transduction
pathways, achieve a final common effect (i.e. priming), suggesting a
convergence of the transduction pathways. The pathways operative during
the induction of priming with these three agents have therefore been further
studied in an attempt to define a mechanism/effect common to all priming
agents.
In summary, the ideal conditions for priming with LPS, TNFa and PAF
within our system have been established by optimisation of the primed,
fMLP-stimulated release of O2". The putative role of PDGF as a mediator of
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neutrophil function has been refuted, and InsP6 has been found to have only
modest and transient priming effects (although it does synergise with LPS).
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Chapter 4: The Effects of Priming Agents on the Expression
and Function of Neutrophil Adhesion Molecules
4.1 Introduction
To reach a site of infection or inflammation, circulating neutrophils must
adhere to, and subsequently migrate through the vascular endothelium.
Under normal circumstances, the endothelium constitutes a barrier that
confines leukocytes to the circulation, although factors such as flow
disturbances and (especially) collisions with erythrocytes promote contact
with endothelial cells (Schmid-Schonbein et al., 1980). Adjacent to an
inflamed focus however, leukocytes roll along the endothelium with reduced
velocity, and a proportion of the rolling population becomes arrested, spread
and firmly adherent in preparation for migration between endothelial cell
junctions. This process is dependent on the co-ordinated and sequential
regulation of expression and function of a series of cell adhesion molecules.
Inflammatory cytokines render endothelial cells 'stickier' to leukocytes by
upregulating the expression of intercellular adhesion molecule-1 (ICAM-1),
P-selectin (CD62-P) and E-selectin (CD62-E) (Dustin et al., 1986, Geng et al.,
1990, Bevilacqua et al., 1987). Rolling is a reversible, low-affinity interaction
mediated by the vascular selectins (CD62-P and CD62-E) and the
constitutively-expressed leukocyte antigen CD62-L (reviewed by Bevilacqua
and Nelson, 1993, Carlos and Harlan, 1994, Albeda et al., 1994). Research
into selectin ligands is ongoing; recently identified native ligands (reviewed
by Hogg and Berlin, 1995) include GlyCAM-1, CD34 and MAdCAM-1,
which bind CD62-L; PSGL-1, a ligand for CD62-P and probably CD62-E, and
a higher-affinity CD62-E ligand, ESL-1. Firm adhesion is principally a
function of the leukocyte (32-integrins, particularly CDllb/CD18 (Mac-1),
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whose expression and function are upregulated by a number of secretagogue
agonists (Kishimoto et al., 1989, Jutila et al., 1989). The endothelial counter-
receptor for CDllb/CD18 is ICAM-1 (Smith et al., 1989, Dustin et al., 1986);
defective or deficient (32-integrin expression results in a failure of leukocyte
recruitment and recurrent infections (leukocyte adhesion deficiency, LAD;
Anderson and Springer, 1987, Kishimoto et al., 1987). As discussed further
below (4.7), ligation and clustering of leukocyte integrins leads not only to
adhesive events ('outside-in' signalling) but also to cytoskeletal
reorganisation and the generation of a series of intracellular signals
controlling adhesion-induced changes in cell physiology (reviewed by Clark
and Brugge, 1995). Finally, other molecules may have less specific roles; for
example, it has been suggested that large, negatively charged glycocalyx
molecules such as CD43 (leukosialin) may interfere with receptor-ligand
interactions, and may prevent tight contact between large membrane areas
due to electrostatic repulsion between negative charges present on the
surface of leukocytes (Lichtman and Weed, 1970) and endothelial cells
(Pelikan et al., 1979). Shedding of such molecules would be expected to
promote adhesion, and in CD43-deficient mice T-cell adhesion has been
shown to be enhanced in comparison with that seen in wild-type litter mates
(Manjunath et al., 1995).
The actual passage of leukocytes through the endothelial barrier is poorly
understood; depending on the inflammatory stimulus and the responding
cell, integrins may be involved (Babi et al., 1995, Chuluyan et al., 1993), and
shedding of CD62-L seems to precede diapedesis (Kuhns et al., 1995). CD31
(PECAM-1), which is localised to the intercellular junctions between
endothelial cells, also appears to be involved, as illustrated by the ability of
anti-PECAM-1 antibody to block transmigration (Muller et al., 1993,
Vaporciyan et al., 1993). Furthermore, Ca2+ fluxes control cell shape at these
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junctions, suggesting that endothelial cell signalling can influence the
passage of leukocytes (Huang et al., 1993). A schematic representation of
leukocyte emigration is shown in Figure 4.1.
It is well recognised that many inflammatory mediators, including certain
priming agents, can influence neutrophil adhesive properties by
upregulating integrin expression and function and causing shedding of
CD62-L (Kishimoto et al., 1989, Jutila et al., 1989); however these studies
have focused largely on the effects of high (often supraphysiological) agonist
concentrations, with little emphasis on the possible relationship between
priming and the regulation of adhesion. The fact that integrins (and possibly
also selectins; see section 4.7) have been implicated in signal transduction,
possibly synergising with other activating pathways, provided a further
inducement to embark on a detailed study of the effects of priming agents
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4.2 Concentration-dependent Effects of LPS, TNFa and PAF on Human
Neutrophil Surface Adhesion Molecule Expression
Flow cytometric analysis of human neutrophils incubated with LPS, TNFa or
PAF demonstrated that, in common with fMLP, all the priming agents
examined caused a concentration-dependent increase in the expression of
CDllb, CDllc, and CD35 (Figures 4.2-4.4 and Table 4.1) and reduced CD62-
L and, to a lesser extent, CD43 expression (Figures 4.2-4.4); the upregulation
of CDllb, CDllc and CD35 paralleled each other closely in all experiments,
suggesting similar underlying mechanisms of release. Examination of the
concentration-dependency of the above effects revealed important
differences in the patterns of receptor modulation induced by the individual
agonists. For example, LPS-induced downregulation of CD62-L (EC50 53±6
ng/ml) occurred at 10 ng/ml (serum-free conditions) in the absence of
significant detectable alterations in CDllb (ECso>204±49 ng/ml; see Figure
4.5), CDllc, CD35 or CD43 expression. In contrast, low concentrations of
PAF upregulated CDllb (EC50 38+12 nM), CDllc and CD35 without any
concomitant reduction in the expression of CD62-L (EC50 102.1+23 nM; see
Figure 4.5), whilst TNFa was more nearly equipotent in inducing increased
CDllb (EC50 103.8±25 U/ml), CDllc and CD35 expression and CD62-L loss
(EC50 71.4+24 U/ml). High concentrations of LPS and PAF (1 fig/ml and 1
|iM respectively) were more potent than fMLP in promoting loss of CD43,
while TNFa had little effect on the expression of this antigen.
Thus the pattern and the concentration-dependence of modulation of both
integrin and selectin expression appears to differ markedly between priming
agents. Since LPS, TNFa and PAF prime the respiratory burst with greatly
different kinetics (see Figure 3.6), we next examined the time-course of action
of these agents on the expression of two key elements of the adhesion





























































000 0 01 10 100 000 0
[LPS (ng/ml)]
Figure 4.2. Effects of LPS on CDlla, CDllb, CD62-L and CD43 Expression
Neutrophils (5xl06/ml) were pre-incubated with (hatched bars) or without
(open and closed bars) LPS 1-1000 ng/ml for 60 min. Positive and negative
controls received fMLP (final concentration 100 nM, 10 min, closed bars) or
vehicle (open bars) respectively. Cells were incubated at 4°C for 30 min with
mouse mAb to CDlla, CDllb, CD62-L and CD43 and subsequently with
FITC-conjugated rabbit anti-mouse antibody. Mean fluorescence was
measured by flow cytometry; data (mean+sem, n=5,) are expressed as % of





























2 20 200 2000 0 0
[TNF (U/ml)]
id V






































2 20 200 2000 0
Figure 4.3. Effect of TNFa on CDlla, CDllb, CD62-L and CD43 Expression
Neutrophils (5xl06/ml) were pre-incubated with (hatched bars) or without
(open and closed bars) TNFa 2-2000 U/ml for 30 min. Positive and negative
controls received fMLP (final concentration 100 nM, 10 min, closed bars) or
vehicle (open bars) respectively. Cells were incubated at 4°C for 30 min with
mouse mAb to CDlla, CDllb, CD62-L and CD43 and subsequently with
FITC-conjugated rabbit anti-mouse antibody. Mean fluorescence was
measured by flow cytometry; data (mean±sem, n=3,) are expressed as % of
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Figure 4.4 Effects of PAF on CDlla, CDllb, CD62-L and CD43 Expression
Neutrophils (5xl06/ml) were pre-incubated with (hatched bars) or without
(open and closed bars) PAF 1-1000 nM for 10 min. Positive and negative
controls received fMLP (final concentration 100 nM, 10 min, closed bars) or
vehicle (open bars) respectively. Cells were incubated at 4°C for 30 min with
mouse mAb to CDlla, CDllb, CD62-L and CD43 and subsequently with
FITC-conjugated rabbit anti-mouse antibody. Mean fluorescence was
measured by flow cytometry; data (mean±sem, n=3,) are expressed as % of

























Figure Legend for Figure 4.5
Figure 4.5 Differential Effects of LPS and PAF on Neutrophil CDllb and
CD62-L Expression
Neutrophils (5xl06/ml) were pre-incubated with (A and B) PAF 10 nM
(continuous lines) or buffer (stippled lines) for 10 min or with (C and D) LPS
10 ng/ml (continuous lines) or buffer (stippled lines) for 60 min. Cells were
subsequently incubated at 4°C for 30 min with mouse mAb to CDllb (A and
C) or CD62-L (B and D) and then with FITC-conjugated goat anti-mouse
antibody (30 min). Mean fluorescence was measured by flow cytometry



















Table 4.1 Effects of LPS, TNFa and PAF on CDllc and CD35 Expression
Neutrophils (5xl06/ml) were incubated with LPS (60 min), TNFa (30 min) or
PAF (10 min) at the concentrations indicated. Cells were then incubated at
4°C for 30 min with mouse mAb to CDllc or CD35, washed and further
incubated with FITC-conjugated rabbit anti-mouse antibody. Mean
fluorescence was determined by flow cytometry; data (meanisem, n=3,) are
expressed as % of unprimed, unstimulated values. * denotes a significant
difference (p<0.05 by Student's paired t-test) from control.
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4.3 Time-course of LPS, TNFa and PAF-induced Effects on Human
Neutrophil CDllb and CD62-L Expression
To document further the differences between priming agents with respect to
surface adhesion molecule expression, the effects of optimal priming
concentrations of PAF (100 nM), TNFa (200 U/ml) and LPS (100 ng/ml ±
serum) on CDllb and CD62-L expression were determined over 0-120 min
(Figures 4.6 and 4.7).
Incubation with PAF 100 nM produced a rapid (already apparent at 1 min)
and profound upregulation of neutrophil CDllb expression, reaching a
plateau by 5-10 min (Figure 4.6); this time-course was virtually identical to
that seen with 100 nM fMLP (not shown). LPS (100 ng/ml) resulted in a far
more gradual increase in CDllb expression, still ongoing at 120 min; this
effect was greatly accelerated by the addition of 1% heat-inactivated
autologous serum (Figure 4.6) or by increasing the concentration of LPS to 1
pg/ml (not shown). TNFa 200 U/ml induced CDllb upregulation with a
time-course intermediate between PAF and LPS.
Loss of CD62-L was studied in parallel, with similar results being obtained.
While CD62-L shedding at 60 min was clearly a very sensitive indicator of
LPS-exposure (Figure 4.2), there was a considerable lag before this effect
becomes apparent (Figure 4.7); as with the effect on CDllb, the inclusion of
serum (or increasing the concentration of LPS, not shown) accelerated CD62-
L loss. PAF-induced CD62-L loss, in keeping with its effect on CDllb, was
extremely rapid, but less complete than that eventually achieved by other
agonists (consistent with the concentration-response data); the effects of





Figure 4.6 Time-course of LPS-, TNFa- and PAF-induced Human
Neutrophil CDllb Upregulation
Neutrophils (5xl06/ml) were incubated with LPS 100 ng/ml (q), LPS 100
ng/ml + 1% heat-inactivated serum (0), TNFa 200 U/ml (o), PAF 100 nM (A)
or 1 % heat-inactivated serum alone (x) for 0-120 min. At the appropriate
time-points, cells were transferred to chilled flexiwell (4°C) plates and
incubated with mouse mAb to CDllb for 30 min, washed, and incubated
with FITC-conjugated rabbit anti-mouse antibody. Mean fluorescence was
determined by flow cytometry; data (mean of n=3 duplicate measurements,
errors (<5%) not shown to preserve clarity) from 1 representative experiment




Figure 4.7 Time-course of LPS-, TNFa- and PAF-induced Human
Neutrophil CD62-L Loss
Neutrophils (5xl06/ml) were incubated with LPS 100 ng/ml (q), LPS 100
ng/ml + 1% heat-inactivated serum (0), TNFa 200 U/ml (o), PAF 100 nM (A)
or 1 % heat-inactivated serum alone (x) for 0-120 min. At the appropriate
time-points, cells were transferred to chilled flexiwell (4°C) plates and
incubated with mouse mAb to CD62-L for 30 min, washed, and incubated
with FITC-conjugated rabbit anti-mouse antibody. Mean fluorescence was
determined by flow cytometry; data (mean of n=3 duplicate measurements,
errors (<5%) not shown to preserve clarity) from 1 representative experiment
of 5 are shown. PBS alone had no significant effect on CD62-L expression
(not shown).
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4.4 Effects of LPS, TNFa and PAF on fMLP-induced Modulation of
Human Neutrophil Surface Adhesion Molecule Expression
Since priming agents dramatically augment fMLP-induced 02" release, we
sought to determine whether such agonists similarly modulate fMLP-
induced changes in surface adhesion molecule expression. Figures 4.8-4.10
demonstrate that incubation of neutrophils with LPS (1-1000 ng/ml), TNFa
(2-200 U/ml) or PAF (1-1000 nM) had little influence on subsequent changes
in CDlla or CDllb expression induced by fMLP 100 nM; only TNFa 2000
U/ml led to a small but significant potentiation of CDllb detection.
However, the higher concentrations of all 3 priming agents (LPS 100 ng/ml
and above, TNFa 200 U/ml and above, and PAF 1 pM) all augmented fMLP-
induced CD62-L loss, and to a lesser extent, CD43 loss (Figures 4.8-4.10).
4.5 Effect of LPS, TNFa and PAF on Human Neutrophil Binding of
Albumin-coated Latex Beads (ACLB): Concentration-Response
Although only a subset of CDllb/CD18 molecules may mediate adhesion
(Diamond and Springer, 1993), newly-recruited integrins may be relevant to
adhesion and locomotion (Hughes et al., 1992). Integrin function can be
regulated by changes that affect ligand affinity (perhaps secondary to a
conformational change, Landis et al., 1993) as well as by altered surface
expression. Functional upregulation of CDllb has been shown to result in
increased binding of albumin-coated latex beads (ACLB) (Simon et al., 1995);
to ascertain whether the above changes in CDllb expression correlate with
changes in integrin function, we quantitated the percentage of neutrophils
binding FITC-conjugated ACLB after exposure to agonists by flow cytometry
(Figures 4.11 and 4.12).
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Figure 4.8 Effects of LPS on fMLP-induced Human Neutrophil Adhesion
Molecule Expression
Neutrophils (5xl06/ml) were incubated with LPS (1 ng-1 pg/ml) for 60 min
(hatched bars) prior to the addition of fMLP (final concentration 100 nM, 10
min). Cells were then treated at 4°C for 30 min with mouse mAb to CDlla,
CDllb, CD62-L and CD43, washed and further incubated with FITC-
conjugated rabbit anti-mouse antibody. Mean fluorescence was determined
by flow cytometry; data (mean±sem , n=5,) are expressed as % of the fMLP
response. * denotes a significant (p<0.05 by Student's paired t-test) difference
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Figure 4.9 Effects of TNFa on fMLP-induced Human Neutrophil
Adhesion Molecule Expression
Neutrophils (5xl06/ml) were incubated with TNFa 2-2000 U/ml for 30 min
(hatched bars) prior to the addition of fMLP (final concentration 100 nM, 10
min). Cells were then treated at 4°C for 30 min with mouse mAb to CDlla,
CDllb, CD62-L and CD43, washed and further incubated with FITC-
conjugated rabbit anti-mouse antibody. Mean fluorescence was determined
by flow cytometry; data (mean+sem , n=5,) are expressed as % of the fMLP
response. * denotes a significant (p<0.05 by Student's paired t-test) difference
from fMLP alone (closed bars).
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Figure 4.10
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Figure 4.10 Effects of PAF on fMLP-induced Human Neutrophil Adhesion
Molecule Expression
Neutrophils (5xl06/ml) were incubated with PAF 1-1000 nM for 10 min
(hatched bars) prior to the addition of fMLP (final concentration 100 nM, 10
min). Cells were then treated at 4°C for 30 min with mouse mAb to CDlla,
CDllb, CD62-L and CD43, washed and further incubated with FITC-
conjugated rabbit anti-mouse antibody. Mean fluorescence was determined
by flow cytometry; data (mean±sem , n=5,) are expressed as % of the fMLP
response. * denotes a significant (p<0.05 by Student's paired t-test)
difference from fMLP alone (closed bars).
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above (ECso>263±49 ng/ml); the effect was slightly more pronounced at 120
min than at 60 min (Figure 4.11). In contrast, TNFa, PAF and LPS with
serum were all highly potent, inducing functional CD lib upregulation even
at very low concentrations (EC50 12+3.5 U/ml, 30.8±5.1 nM and 1.8±0.2
ng/ml respectively); in addition, the maximal increases in bead binding
were similar to that seen with fMLP 100 nM, compared to the weaker effect
of LPS alone.
4.6 Effect of LPS, TNFa and PAF on Human Neutrophil Binding of
Albumin-coated Latex Beads (ACLB): Time-course
The time-course for functional upregulation of CDllb closely reflected that
for increased surface expression (compare Figures 4.7 and 4.13). The effect of
PAF on the binding of ACLB was already considerable at 1 min, reached a
maximum at 15 min and subsequently declined (Figure 4.13). TNFa (200
U/ml), and LPS 100 ng/ml in the presence of 1% heat-inactivated serum
caused increased binding, delayed in onset compared to PAF, reaching
maximum and sustained levels at 30 min . In the absence of serum, LPS
alone had little effect until 60 min had elapsed, and an ongoing effect at 120
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Figure 4.11 Effects of LPS on the Binding of ACLB to Human Neutrophils:
Concentration-response
Neutrophils (107/ml, 175 pi) were incubated with vehicle (open bars), LPS
0.1-1000 ng/ml (hatched bars) alone (60 min and 120 min) or with 1% heat
inactivated serum (30 min), or with fMLP 100 nM (10 min, closed bars); 25 pi
ACLB (0.75% in PBS, see 2.5.2) were added 15 min prior to the termination of
the incubation (with 0.5 ml 0.5% glutaraldehyde). Cells were subsequently
washed three times with PBS to remove non-adherent beads, and the % of
neutrophils with adherent beads was determined by flow cytometry. Data
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Figure 4.12 Effects of TNFa and PAF on the Binding of ACLB to Human
Neutrophils: Concentration-response
Neutrophils (107/ml, 175 |il) were incubated at 37°C with vehicle (open
bars), TNFa (0.2-2000 U/ml, 30 min, hatched bars), PAF (0.1-1000 nM, 10
min, hatched bars) or fMLP (100 nM, 10 min, closed bars). 25 pi ACLB
(0.75% in PBS, prepared as described in 2.5.2) were added 15 min prior to the
termination of the incubation (0.5 ml 0.5% glutaraldehyde); for incubations
with PAF, ACLB were added 5 min before the agonist. Cells were
subsequently washed three times with PBS to remove non-adherent beads,
and the % of neutrophils with adherent beads was determined by flow





Figure 4.13 Effects of LPS, TNFa and PAF on the Binding of ACLB to
Human Neutrophils: Time-course
Neutrophils (107/ml, 175 pi) were incubated at 37°C with LPS 100 ng/ml
with (0) or without () 1% heat-inactivated autologous serum, TNFa 200
U/ml (o), PAF 100 nM (A), 1% heat-inactivated serum alone (x) or PBS
alone (+) for the times indicated. 25 pi ACLB (0.75% in PBS, prepared as
described in 2.5.2) were added 15 min prior to the termination of the
incubation (0.5 ml 0.5% glutaraldehyde); for incubations of <15 min, ACLB
were added before the agonist. Cells were subsequently washed three times
in PBS to remove non-adherent beads, and the % of neutrophils with
adherent beads was determined by flow cytometry. Data from one
representative experiment of 5 are shown. Each point is the mean of 3
determinations; errors (<10%) are not shown to preserve clarity.
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4.7 Discussion
The results presented in this chapter have demonstrated that priming agents
can modify the expression and function of neutrophils adhesion molecules
involved in the transmigratory process at concentrations that do not directly
stimulate extracellular 02~ release as assessed by the cytochrome C reduction
assay. To minimise endothelial damage, a transmigrating neutrophil ideally
should not be activated, but should be primed for enhanced responsiveness
on arrival at the inflammatory focus. The above data suggest that exposure
of a marginated intravascular neutrophil to low concentrations of LPS, TNFa
or PAF at the inflamed site may modulate the adhesive properties of the cell
to promote passage through the endothelium in addition to their priming of
secretagogue function. The presence of higher concentrations of these agents
within the local vascular space or adjacent to the endothelium could result in
full (premature) neutrophil activation and ensuing endothelial damage
(Smedley et al., 1986).
Our results showed interesting differences in the regulation of adhesion
molecule expression by the different priming agents. For example, while
PAF 1-10 nM was sufficient to upregulate CDllb expression and function
(and to prime cells for superoxide release, see Figure 3.5), significant loss of
CD62-L was only observed with > 100 nM PAF, whilst LPS induced CD62-L
shedding at lower concentrations than were required for the upregulation of
the [32-integrins. Thus there appears to be a dissociation between
mobilisation of CDllb/CD18 to the neutrophil surface, a process mediated
by exocytosis of specific granules (O'Shea et al., 1985, Stevenson et al., 1987),
and the proteolytic shedding of CD62-L (Jung et al., 1990, Jutila et al., 1991).
Differential regulation of neutrophil integrins and CD62-L has been reported
previously; Molad et al. (1994) reported that occupancy of Fey receptors by
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BSA/anti-BSA immunocomplexes increased expression of CDllb/CD18
without altering CD62-L expression, and Stocks et al. (1995) from our own
group described similar findings with antibody to carcinoembryonic antigen;
in contrast, preferential loss of CD62-L was observed by Diaz-Gonzalez et al.
(1995) in response to a variety of non-steroidal anti-inflammatory drugs.
Taken together, these results suggest agonist-specific 'fine-tuning' of
neutrophil adhesive behaviour during inflammation.
The kinetics of CDllb upregulation and CD62-L shedding were also very
different for the three agents studied, and correlated well with the
previously established times required to induce priming (compare Figures
4.6, 4.7 and 4.13 with Figure 3.6). Responses to PAF were in all cases very
rapid (observable at 1 min). In the absence of serum, priming and receptor
modulation in response to LPS required 60-120 min, while the introduction
of 1% serum resulted in these effects being seen at 30 min or earlier (Figures
4.6, 4.7 and 4.13, and Figure 3.6) i.e. with a similar kinetic profile to TNFa.
Interestingly, LPS has been shown to induce intracellular PAF accumulation
in neutrophils over a time-period similar to that required to establish the
primed state (Worthen et al., 1988), suggesting that at least some of the
effects of LPS may be indirect. Our results have also demonstrated that
integrin function and expression can be dissociated and independently
regulated; the effects of PAF on CDllb function (Figure 4.13) declined at
later time-points despite sustained levels of expression (compare Figure 4.13
with Figure 4.6).
Adhesion molecules have recently been recognised to participate in
signalling events. Integrin receptor engagement and clustering leads to the
formation of focal adhesions, with integrins linking to intracellular
cytoskeletal components (Otey et al., 1990). Clustering of integrin molecules
(induced by ligand-binding) has been shown to elevate intracellular pFI
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(Schwarz et al., 1991), activate phospholipase C thus elevating intracellular
Ca2+ and diacylglycerol (and hence activating protein kinase C) (Somogyi et
al., 1994), and to stimulate various kinases including focal adhesion kinase
(Lipfert et al., 1992) and mitogen-activated protein kinase (MAPK, Cheng et
al., 1994). Selectin cross-linking may also transduce messages; intracellular
Ca2+ release (Laudana et al., 1994), induction of cytokine mRNA (Crockett-
Torabi et al., 1995, Laudana et al., 1994) and even potentiation of 02~
production (Waddell et al., 1994) have all been reported. Whilst the
upregulation of neutrophil integrin expression by priming agents could be
relevant to signalling in cells adherent to matrix proteins, occupancy of
integrin receptors is likely to be limited in cell suspensions, making a major
role in the priming system under study unlikely. Since priming agents
induce CD62-L shedding rather than cross-linking, this process is also an
unlikely candidate for a major role in signalling for the primed state.
Receptor shedding may be required to induce unresponsiveness to
extracellular stimuli or to dissociate cells from ligands during the
transmigration process; it may also represent a mechanism for the
production of soluble receptors which in turn impart signals to other cells
(Tedder, 1991). Soluble forms of molecules such as CD62-L are present in
normal plasma (Schleiffenbaum et al., 1992), and may be relevant to host
defence. For example, in patients at risk of ARDS, a significant association
has been found between reduced levels of circulating soluble CD62-L and
progression to ARDS (Donnelly et al., 1994). Our data indicate that priming
agents may contribute to levels of soluble neutrophil-derived CD62-L,
particularly in the vascular micro-environment.
Contemporary models of leukocyte trafficking apply to the systemic
circulation, whence neutrophils have been shown to transmigrate principally
via the post-capillary venules (Allison et al., 1955, Bjork et al., 1985).
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However, the current paradigms cannot be applied to the lung, since the
principle site of leukocyte emigration appears to be the pulmonary
capillaries (Downey et al., 1993). Given the marked differences between
these two vascular compartments (e.g. lower intravascular pressure in the
pulmonary circulation, pulsatile flow in the pulmonary capillary bed, and
the smaller diameter of the pulmonary capillaries) there will always be close
apposition of neutrophils to the pulmonary vascular endothelium, with
ample time for interactions (the median transit time of neutrophils through
the pulmonary capillary bed has been estimated at 120 sec by Hogg et al.,
1994). Thus processes controlling neutrophil migration may have different
effects at these two sites; for example, neutrophil adherence in the
pulmonary circulation can occur by either CD18-dependent or -independent
mechanisms, according to the inflammatory stimulus (Doerschuk et al., 1990;
Hellewell et al., 1994).
In summary, priming concentrations of LPS, TNFa and PAF induced
agonist-dependent and dissociable changes in human neutrophil adhesion
molecule expression and function; the time-courses of these alterations
paralleled those for the induction of priming. These data provide strong
support for the hypothesis that modulation of adhesion molecule expression
may constitute an important mechanism by which priming agents modify
granulocyte recruitment as well as granulocyte responses to activation.
119
Chapter 5. The Role of the G-Protein Gi«2 in Neutrophil
Priming
5.1 Introduction
Diverse extracellular signals including hormones, growth factors,
neurotransmitters and primary sensory stimuli (photons, chemical odorants)
all utilise a signal transduction system first identified by Rodbell et al. (1971)
consisting of 3 components: receptor, G-protein and effector. The
heterotrimeric G-proteins are made up of a-, (3- and y-subunits and function
to couple the serpentine or seven transmembrane receptors (including most
neutrophil chemoattractant receptors) to downstream signalling pathways
(Neer, 1995). More than 200 receptors, plus at least 21 a-subunits, 4 (3-
subunits and 6 y-subunits have been identified (Hepler and Gilman, 1992).
Although the same (3y-subunit complex can associate with different a-
subunits to form the heterotrimer, the identity of the a-subunit is currently
used to define an individual G-protein oligomer.
The a-subunits can be divided into 4 classes: Gs, Gi, Gq and G12; neutrophils
express members of the Gs (Bokoch, 1987), Gi (Goldsmith et al., 1987, Uhing
et al., 1987) and Gai2 (Strathmann and Simon, 1991) classes, and also unique
pertussis toxin-insensitive G-proteins from the Gq class such as Gai5 and
Gai6 (Wilkie et al., 1991 Amatruda et al., 1991,), which may mediate
activation of PLC(3 (Smrcka et al., 1991). The identities of the |3- and y-
subunit isoforms expressed in neutrophils are currently unknown.
Binding of ligand to a seven transmembrane receptor leads to G-protein
activation manifested by an increase in the amount of bound GTP and
leading to dissociation of the a- and (3y-subunits (see 1.8.2). Traditionally,
the a-subunit has been regarded as the 'business end' of a G-protein, because
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it binds and hydrolyses GTP and interacts with downstream effectors; the (3y-
subunit was previously considered to act solely as a membrane anchor for
the heterotrimer. However, a growing body of evidence now supports the
idea that free Py-subunits can interact functionally with effectors, including
the muscarinic cholinoceptor-regulated K+ channel in the heart (Logothetis
et al., 1987) and an unidentified PLC isoform in neutrophil-differentiated
HL-60 cells (Camps et al., 1992).
The effects of certain priming agents on neutrophil (or HL-60 cell) G-protein
translocation and function have been investigated; all of the quoted studies
have used a single priming agent, and all but one have examined a single
time-point. Klein et al. (1992) first demonstrated that a 24 hr incubation with
interferon-y enhanced both detection of Gia2 and G;a3 and GTPase activity in
HL-60 membranes; however, studies in HL-60 cells cannot automatically be
extrapolated to neutrophils, and there is some doubt as to whether
interferon-y is a true neutrophil priming agent (Pabst, 1994). Yasui et al.
(1992) showed that LPS at a concentration of 10 ng/ml in the presence of 1%
serum increased the amount of Gja2 detected in neutrophil membranes at 45
min; identical incubation conditions primed the neutrophil respiratory burst,
but no other conditions were examined. A study by Durstin et al. (1993)
revealed that GM-CSF-induced translocation of Gia2 (but not Gia3) was
significant at 5 min and maximal by 40 min, but no priming data was
included. Finally, Klein et al. (1995) demonstrated that incubation of
neutrophils with TNFa (100 U/ml for 10 min) increased the detection of
membrane-associated Gja2 and Gio3, and confirmed enhanced G-protein
activity on fMLP-stimulation. The aim of the work presented in this chapter
was to extend these studies by examining the relationship between G-protein
translocation/activation and neutrophil priming induced by LPS, TNFa and
PAF.
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5.2 Time-course of Neutrophil Plasma Membrane Gja2 Upregulation in
Response to PAF, TNFa and LPS
In preliminary experiments, Gja2 detection in isolated, untreated neutrophil
plasma membranes was found to be stable with time; therefore, in view of
the limited availability of membrane protein, time-matched control samples
were not analysed in these experiments. All three priming agents increased
the amount of Gia2 detected in equivalent neutrophil plasma membrane
fractions, but the kinetics of this effect were agonist-dependent (Figures 5.1-
5.3). For example, 100 nM PAF induced a maximal response (of greater
magnitude than that seen with the other agents) within 2 min (Figure 5.1)
whilst an incubation of 120 min was required to induce a significant
response to LPS 100 ng/ml in the absence of serum (Figure 5.3). A 10 min
exposure to TNFa 200 U/ml did cause an increase in plasma membrane
Gia2, but this was sub-maximal with a further increase becoming apparent
by 60 min (Figure 5.2). Comparison with the respective times required to
induce priming of agonist-stimulated O2" release (see Figure 3.6) revealed
very similar agonist-dependent time-courses.
5.3 Concentration-dependence of Neutrophil Plasma Membrane Gia2
Upregulation in Response to PAF, TNFa and LPS
Even very low concentrations of PAF (1 nM) induced a major upregulation
of membrane Gia2 expression, with increasing effect up to lpM (the highest
concentration examined). A similar concentration-dependent increase in
membrane-associated Gia2 was observed with TNFa and LPS, although the
degree of upregulation was less marked with these two agents even when
the incubation times for all three agonists were selected to obtain a maximal
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Figure 5.1 Time-course of Neutrophil Plasma Membrane GjK2
Upregulation in Response to PAF
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Figure 5.2 Time-course of Neutrophil Plasma Membrane
Upregulation in Response to TNFa
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Figure 5.3 Time-course of Neutrophil Plasma Membrane
Upregulation in Response to LPS
For Figure legend see page 126.
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Figure Legends for Figures 5.1-5.3
Figure 5.1 Time-course of Neutrophil Plasma Membrane Gia2
Upregulation in Response to PAF
Human neutrophils incubated with PAF 100 nM for 0-60 min were disrupted
by nitrogen cavitation; the plasma membrane fraction was separated by
Percoll gradient centrifugation, and analysed by immunoblotting for Gia2 (as
described in sections 2.6.1 and 2.6.2). A single representative immunoblot
(A) and mean + sem densitometry data from n=3 experiments (B) are shown.
Figure 5.2 Time-course of Neutrophil Plasma Membrane Gja2
Upregulation in Response to TNFa
Human neutrophils incubated with TNFa 200 U/ml for 0-60 min were
disrupted by nitrogen cavitation; the plasma membrane fraction was
separated by Percoll gradient centrifugation, and analysed by
immunoblotting for Gia2 (as described in sections 2.6.1 and 2.6.2). A single
representative immunoblot (A) and mean ± sem densitometry data from n=3
experiments (B) are shown.
Figure 5.3 Time-course of Neutrophil Plasma Membrane Gja2
Upregulation in Response to LPS
Human neutrophils incubated with LPS 100 ng/ml for 0-120 min, were
disrupted by nitrogen cavitation; the plasma membrane fraction was
separated by Percoll gradient centrifugation, and analysed by
immunoblotting for Gia2 (as described in sections 2.6.1 and 2.6.2). A single
representative immunoblot (A) and mean ± sem densitometry data from n=3
experiments (B) are shown.
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[PAF (nM)] [TNFa (U/ml)]
[LPS (ng/ml)]
Figure 5.4 Upregulation of Neutrophil Plasma Membrane Gia2 in response
to PAF, TNFa and LPS: Concentration-dependence
Human neutrophils incubated with PAF 0-1000 nM (10 min), TNFa 0-2000
U/ml (30 min) or LPS 0-1000 ng/ml (120 min) were disrupted by nitrogen
cavitation; the plasma membrane fractions were separated by Percoll
gradient centrifugation, and analysed by immunoblotting for Gia2 (sections
2.6.1 and 2.6.2). Results represent mean ± sem densitometry data from n=3
experiments for each priming agent.
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concentration-response data for O2" priming (Figures 3.3-3.5) reveals that
increases in Gitt2 stimulated by PAF and TNFa clearly occur at lower agonist
concentrations (EC50 for LPS, TNFa and PAF 58.1±18.2 ng/ml, 3.4±2.6 U/ml
and 3.7+1.8 nM respectively) than those which augment O2" release (EC50
for LPS, TNFa and PAF 35±14 ng/ml, >216±48 U/ml and >24±16 nM
respectively), and the magnitude of the G;a2 upregulation is also
considerably less than that of the primed superoxide response.
5.4 Effects of PAF, TNFa and LPS on Basal and fMLP-stimulated GTP
Hydrolysis in Human Neutrophil Membranes
To confirm that the enhanced expression of membrane Gia2 detected above is
active in coupling receptor to effector, basal and stimulated GTP hydrolysis
were measured in identically prepared membranes from unprimed and
primed cells. Since insufficient membrane protein was available from the
previous experiments to perform this analysis, incubation conditions
resulting in maximal membrane G-protein expression (PAF 100 nM for 10
min, TNFa 200 U/ml for 30 min and LPS 100 ng/ml for 120 min) were used
to prepare fresh membrane samples. As can be seen from Figure 5.5, while
all three priming agents enhanced both basal and fMLP-stimulated GTP
hydrolysis, the greatest effect on the fMLP-stimulated response was seen
with PAF, while LPS and TNFa only induced a very modest increase in
membrane GTP hydrolytic activity. In addition, the enhancement of GTP
hydrolysis observed following incubation with priming agents was of lesser
magnitude than the enhancement of Gja2 expression (compare Figures 5.1-
5.4 with Figure 5.5). This suggests that either not all the G-protein recruited
to the plasma membrane was fully active or that Gia2 does not represent the




Figure 5.5 Effects of PAF, TNFa and LPS on Basal and fMLP-stimulated
GTP Hydrolysis in Human Neutrophil Membranes
Human neutrophils incubated with buffer (open bars) or priming agent
(hatched bars) were disrupted by nitrogen cavitation; the plasma membrane
fraction was separated by Percoll gradient centrifugation, and hydrolysis of
[y-32P]GTP was determined (by quantitating the release of free [32P]Pi, see
2.6.3). (A) PAF 100 nM (10 min), (B) TNFa 200 U/ml (30 min) and (C) LPS




The results presented in this chapter have demonstrated that the three
priming agents studied (PAF, TNFa and LPS) all enhanced the detection in
isolated neutrophil plasma membranes of Gia2, the most abundant
neutrophil G-protein. This enhancement occured rapidly (within 2 min) in
response to PAF but was delayed in onset (120 min) when LPS was used,
whilst the effects of TNFa were near-maximal by 10 min. The time-course
for Gia2 upregulation was thus shown to reflect the times required for each
agent to prime neutrophils in vitro (Chapter 3, Figure 3.6), suggesting
initially that enhanced signal transduction via G-proteins coupled to the
fMLP receptor could contribute to priming in a mechanistic way. Indeed,
this has been the precise conclusion of three previous studies examining the
effects of single priming agents (LPS, GM-CSF and TNFa) on Gia2
distribution and function (Yasui et al., 1992, Durstin et al., 1993 and Klein et
al., 1995). The data shown in Fig 5.5 also confirmed that membranes from
primed neutrophil possess increased GTP-ase activity and hence that at least
some of the recruited Gja2 was functional.
The use of nitrogen cavitation to obtain purified plasma membranes has
previously been shown to minimise exposure to lysosomal hydrolytic
enzymes and to yield membrane vesicles free of other subcellular organelles
(Klempner et al., 1980, Borregaard et al., 1983). However, even though this
technique represents an improvement on previous methods employing
mechanical shear forces to disrupt cells, it clearly has the potential to disrupt
significantly subcellular organisation. In intact cells, some sets of receptors,
G-proteins and effectors may be compartmentalised into microdomains and
not have access to other sets; making membrane preparations from
erythrocytes increases the mobility of membrane proteins by more than an
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order of magnitude (Beth et al., 1986). Thus caution must be applied in
extrapolating results obtained from isolated membrane preparations to
intact, functioning cells.
Potential sources of the additional G;a2 recruited to the neutrophil plasma
membrane include the cytosol, specific granule stores and de novo protein
synthesis. Yasui et al. (1992) demonstrated that LPS in the presence of serum
increased the level of Gi«2 present in the membrane fraction but not in whole
cell preparations of human neutrophils, and Durstin et al. (1993) made a
similar observation in GM-CSF-treated neutrophils, G-protein recruitment in
the latter study being unaffected by the protein synthesis inhibitor
cycloheximide. These data, together with the rapidity of the response to PAF
and TNFa, suggest that redistribution of Gja2, rather than synthesis of
additional protein, accounts for the increased presence of pre-formed Gia2
within the plasma membrane fraction.
Intracellular granule membranes serve as a reservoir of proteins whose
mobilisation to the cell surface during limited exocytosis plays an important
role in leukocyte chemotaxis and activation, and the specific granule fraction
has been identified as an important intracellular reserve of fMLP receptors
Fletcher and Gallin, 1983), adhesion molecules (Bainton et al., 1987) and as a
translocatable pool of cytochrome bsss (Calafat et al., 1993). Rotrosen et al.
(1988) demonstrated by Western blotting of fractionated human neutrophils
that Gia was present in the plasma membrane and specific granule-enriched
fraction; approximately 60% of total pertussis toxin substrate localised to the
plasma membrane, 35% to the specific granule-enriched fraction and 5% to
the cytosol. These figures tally well with those of Durstin et al. (1993). Both
authors additionally noted that treatment with agonist (fMLP or GM-CSF)
resulted in increased plasma membrane-associated G-protein concomitant
with an equivalent decrease in the granule-associated G-protein. It should
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be noted, however, that both studies employed human neutrophils isolated
from peripheral blood using Ficoll-Hypaque gradients and hypotonic lysis,
which may in itself induce priming (Haslett et al., 1985) and hence affect
cellular G-protein distribution. Finally, the data of Rotrosen et al. (1988)
suggested that the intracellular reserve of fMLP receptors might be
functionally coupled to Gia before translocation to the plasma membrane.
The structural and functional upregulation of Gi«2 could therefore represent
a selective degranulation response to the priming agents. The time-course of
membrane-associated Gi«2 upregulation correlated well with increased
detection of surface CDllb (see Figure 4.5), an event also felt to reflect
degranulation, although enhanced levels of plasma membrane Gio2 were
seen at slightly lower agonist concentrations than those inducing CDllb
translocation (Chapter 4, Figures 4.2-4.4 versus Figure 8.4). The small
fraction of cytosolic Gia2 is a further potential source of translocatable
protein; reversible palmitoylation of an N-terminal cysteine residue is
thought to modulate Ga membrane affinity, and mutation of these
palmitoylation sites may result in an alteration in the distribution of the
proteins between the particulate fraction and the supernatant (reviewed by
Milligan et al., 1995). However, the influence of palmitoylation on
neutrophil G-proteins is as yet unknown.
The diversity of G-protein subunits imparts great versatility to G-protein-
mediated signalling (Simon et al., 1991). In neutrophils, the G; family is
represented by only two of its members, Gia2 and Gja3, the main pertussis
toxin substrates in these cells (Falloon et al., 1986, Murphy et al., 1987, Uhing
et al., 1987), whilst G0 is absent (Murphy et al., 1987). Activation of Gs, for
example by stimulation of (3-adrenoceptors, results in inhibition of O2"
generation (Mueller et al., 1991). A member of the Gq family, Gai6, is
specifically expressed in haemopoeitic cells (Amatruda et al., 1991); however,
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levels of Gai6 diminish with neutrophilic differentiation; furthermore Gai6 is
not a pertussis toxin substrate and has not been shown to functionally couple
to the fMLP receptor, hence it is unlikely that this G-protein plays an
important role in the priming of O2" generation in the mature neutrophil.
Functional coupling of the fMLP receptor to both G;a2 and G;a3 was
demonstrated in myeloid-differentiated HL-60 cells by Gierschik et al. (1989),
and Klein et al. (1995) demonstrated that fMLP receptors were functionally
coupled to the increased Gia detected in TNFa-treated neutrophil
membranes, implicating this G-protein family in the signal transduction
process of the primed respiratory burst. Although increased plasma
membrane Gia2 expression was seen in response to three diverse priming
agents, and the time-course of this event correlated with the priming effect of
these agents, the maximal upregulation of Gia2 expression observed in the
experiments presented above was less than threefold compared to the
tenfold or greater enhancement of fMLP-stimulated O2" release seen in
similarly primed cells (Chapter 3, Figures. 3.3-3.5). In addition, the much
greater effect of PAF observed on Gia2 expression was not mirrored by a
similarly greater augmentation of O2" priming. These findings both suggest
that mechanisms other than modulation of Gia2 distribution are involved in
the priming response.
In summary, PAF, TNFa and LPS increase the level of membrane-associated
Gia2 with a time-course which correlates closely with priming of fMLP-
stimulated O2" generation but not with either the magnitude or the efficacy
rank order for the individual priming agents.
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Chapter 6: The Role of Inositol 1,4,5-Trisphosphate in
Neutrophil Priming
6.1 Introduction
The enhanced turnover of inositol lipids in response to receptor activation is
one of the major mechanisms utilised by cells for transmembrane signalling.
The initial event in this pathway is the phosphodiesteric cleavage of the
integral plasma membrane phospholipid phosphatidylinositol 4,5-
bisphosphate (PtdIns(4,5)P2) by phosphoinositide-specific phospholipase C
(PIC) to yield the second messengers inositol 1,4,5-trisphosphate
(Ins(l,4,5)P3) and diacylglycerol (DAG). The physiological significance of
phosphoinositide hydrolysis was not fully appreciated until Michell (1975)
predicted a link between this event and calcium signalling; eight years later,
Streb et al. (1983) demonstrated Ins(l,4,5)P3-induced Ca2+ release from
intracellular Ca2+ stores, subsequently shown to be mediated by an
Ins(l,4,5)P3-gated Ca2+ channel (reviewed by Berridge, 1993). DAG was
shown to activate protein kinase C (reviewed by Nishizuka, 1984).
Changes in [Ca2+]i homeostasis have been widely implicated in the priming
process. In particular, Forehand et al. (1989) demonstrated that priming with
LPS caused an increase in basal [Ca2+]i and augmented the size and duration
of the fMLP-induced [Ca2+]i transient. Further support for a role for [Ca2+]i
in neutrophil priming was provided by Finkel et al. (1987) who correlated
cytosolic Ca2+ (manipulated by means of the calcium ionophore ionomycin)
with priming for enhanced fMLP-triggered 02~ release. Yee and Christou
(1993) studied this phenomenon by flow cytometry in LPS-primed, fluo-3-
AM-loaded neutrophils, demonstrating that in the primed population a
higher percentage of individual cells responded to low concentrations of
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fMLP (< 10 nM) with calcium transients, which were also prolonged with
respect to those seen in unprimed cells. The importance of calcium
transients in the activation of the NADPH oxidase was emphasised by the
work of Hallett et al. (1990), who demonstrated a tight coupling in
individual neutrophils between an elevation of [Ca2+]i above a threshold of
250 nM and 02~ production. However, this may not represent the sole
signalling route leading to priming, since in another report, TNFa was found
neither to elevate basal [Ca2+]j nor to affect fMLP-stimulated Ca2+ transients
(Yuo et al., 1989).
In neutrophils the major route of PIC (the (32 isoform, see Chapter 1.8.3)
activation is via an interaction with the dissociated (3y-subunit of a
heterotrimeric G-protein, released following the binding of ligand to the
coupled transmembrane receptor (Camps et al., 1992, Katz et al., 1992).
Both LPS and PAF have been shown to stimulate PtdIns(4,5)P2 hydrolysis
directly in macrophages (Prpic et al., 1987, Huang et al., 1988), maximal
Ins(l,4,5)P3 levels being achieved at 10-15 s with both agonists, followed by a
slow decline (5-10 min). PAF also elevated Ins(l,4,5)P3 and Ca2+ in
neutrophils (Molski et al., 1988, Grimminger et al., 1991), but few studies
have addressed the possibility that priming agents may enhance Ins(l,4,5)P3
responses to secretagogue agonists. Such a possibility would be supported
by the aforementioned studies demonstrating that certain priming agents
enhanced fMLP-mediated Ca2+ release and by the observation that GM-CSF
enhanced Ptdlns synthase activity in neutrophils (Macphee, 1992). A
precedent exists for the potentiation of PIC activation; Marin et al. (1991)
demonstrated that somatostatin, which is ineffective alone, enhanced the
production of inositol phosphates and prolonged the elevation of [Ca2+]i in
cultured striatal astrocytes stimulated with ai-adrenergic agonists.
Since we have demonstrated that the priming agents LPS, TNFa and PAF
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caused translocation of G[a2 to the neutrophil plasma membrane in a time-
and concentration-dependent fashion closely correlated with their priming
properties (Chapter 5), and since Ca2+ has been implicated in neutrophil
activation (Dewald et al., 1988), we chose to study the potential role of
enhanced Ins(l,4,5)P3 formation in neutrophil priming. In particular, we
wished to elucidate whether enhanced fMLP-induced Ins(l,4,5)P3 generation
could underlie primed 02" release, as the fMLP receptor is coupled (at least
in HL-60 cells) to PIC via Gia2 andG^ (Uhing et al., 1987, Gierschik et al.,
1989).
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6.2 Efficacy of Priming of Human Neutrophils at High Cell Density (7xl06
/225|il)
The use of the Ins(l,4,5)P3 mass assay necessitated the use of approximately
7xl06 neutrophils per assay point; attempts to analyse neutrophil Ins(l/4/5)P3
mass under the conditions previously used to establish priming of the 02~
(i.e. lxlO6 cells per assay point) by freeze-drying the neutralised extracted
lipids and redissolving in a smaller volume proved unsuccessful, generating
inconsistent and poorly reproducible Ins(l,4,5)P3 values even from duplicate
samples (not shown). We therefore confirmed that priming was effective
under the conditions to be used in this assay (5-10 fold increase in the fMLP-
triggered 02~ response, Figure 6.1).
6.3 The Effects of LPS, TNFa and PAF on Peak fMLP-stimulated
Ins(l,4,5)P3 Accumulation in Human Neutrophils.
It was established in preliminary experiments (not shown, but see
subsequent time-course data, Figures 6.5-6.8) that maximal Ins(l,4,5)P3
accumulation following stimulation with fMLP 100 nM was achieved at 10 s;
sub-maximal responses with lower concentrations of fMLP (1 and 10 nM)
demonstrated similar kinetics. We therefore determined Ins(l,4,5)P3 mass in
control and primed neutrophils at 10 s after exposure to 1-100 nM fMLP;
priming was achieved using the conditions previously demonstrated to be
effective (Figure 6.1). The results of these experiments are shown in Figures
6.2-6.4. In unprimed cells, formylated peptide elevated the Ins(l,4,5)P3 mass
detected at 10 s in a concentration-dependent fashion, with an EC50 = 10 nM
and a maximal response (2.3-3 fold increase) to 100 nM fMLP. Increasing the
concentration of fMLP did not further augment Ins(l,4,5)P3 accumulation
(not shown). Incubation of neutrophils with 100 nM PAF alone for 5 min
resulted in a significant elevation of Ins(l,4,5)P3 mass above that seen in
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Figure 6.1
Control LPS TNFa PAF
Treatment
Figure 6.1 Priming of Human Neutrophil 02" Release at High Cell Density
Human neutrophils (7.2xl06 in 225 |il PBS with calcium and magnesium)
were incubated at 37°C with or without priming agents (LPS 100 ng/ml, 120
min; TNFa 200 U/ml, 30 min; or PAF 100 nM, 10 min) prior to the addition
of cytochrome C (1.2 mg/ml final concentration) and of fMLP (final
concentration 100 nM, hatched bars) or vehicle (open bars) in a final volume
of 1 ml. SOD (375 U) was included in one of each set of quadruplicate
incubations and 02" release determined by the superoxide dismutase-
inhibitable reduction of cytochrome C as described in (2.3). Data represent




Figure 6.2 Effects of LPS Priming on Human Neutrophil Ins(l,4,5)P3 Mass
in Resting and fMLP-stimulated Cells
Neutrophils (7.2xl06 in 225 pi PBS with calcium and magnesium) were
incubated with (hatched bars) or without (open bars) LPS 100 ng/ml (added
in 25 pi for 120 min at 37°C) prior to stimulation with fMLP 1-100 nM (50 pi)
or vehicle; the reactions were stopped at 10 s by the addition of 60 pi ice cold
3 M TCA with vortexing. The samples were allowed to extract at 4°C for 30
min and were then partitioned with freon/octylamine (1:1, v/v) as described
in (2.7.2). The upper phases (150 pi) were neutralised (60 mM NaHCOs, 40
pi), and the Ins(l,4,5)P3 mass of the neutralised extracts determined exactly
as described (2.7.3). Results represent the mean+sem of 5 separate




Figure 6.3 Effects of TNFa Priming on Human Neutrophil Ins(l,4,5)P3
Mass in Resting and fMLP-stimulated Cells
Neutrophils (7.2xl06 in 225 pi PBS with calcium and magnesium) were
incubated with (hatched bars) or without (open bars) TNFa 200 U/ml
(added in 25 pi) for 30 min at 37°C, prior to stimulation with fMLP 1-100 nM
(50 pi) or vehicle; the reactions were stopped at 10 s by the addition of 60 pi
ice cold 3 M TCA with vortexing. The samples were allowed to extract at
4°C for 30 min and were then partitioned with freon/octylamine (1:1, v/v)
as described in (2.7.2). The upper phases (150 pi) were neutralised (60 mM
NaHCOs, 40 pi), and the Ins(l,4,5)P3 mass of the neutralised extracts
determined exactly as described (2.7.3). Results represent the mean±sem of 5
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Figure 6.4 Effects of PAF Priming on Human Neutrophil Ins(l,4,5)P3 Mass
in Resting and fMLP-stimulated Cells
Neutrophils (7.2xl06 in 225 |il PBS with calcium and magnesium) were
incubated with (hatched bars) or without (open bars) PAF 100 nM (added in
25 pi) for 10 min at 37°C, prior to stimulation with fMLP 1-100 nM (50 |il) or
vehicle; the reactions were stopped at 10 s by the addition of 60 pi ice cold 3
M TCA with vortexing. The samples were allowed to extract at 4°C for 30
min and were then partitioned with freon/octylamine (1:1. v/v) as described
in (2.7.2). The upper phases (150 pi) were neutralised (60 mM NaHCCh, 40
pi), and the Ins(l,4,5)P3 mass of the neutralised extracts determined exactly
as described (2.7.3). Results represent the mean+sem of 3 separate
experiments each performed in triplicate. * denotes p<0.05 (Student's paired
t-test).
141
control (unprimed) cells (Figure 6.4); changes in resting Ins(l,4,5)P3 mass
following priming with LPS 100 ng/ml (120 min) or with TNFa 200 U/ml
(30 min) did not reach statistical significance (Figures 6.2 and 6.3).
Significant differences in fMLP-stimulated Ins(l,4,5)P3 accumulation were
detected between unprimed cells and cells primed with PAF and TNFa
when 1 nM fMLP was used as the stimulus; however the small augmentation
of fMLP-induced Ins(l,4,5)P3 accumulation observed at these low fMLP
concentrations was not significantly different from that seen with priming
agent alone (Figures 6.3 and 6.4). Priming did not affect Ins(l,4,5)P3
accumulation in response to fMLP at 10 s to higher concentrations of agonist
(Figures 6.2-6.4).
Since priming appeared to have little effect on Ins(l,4,5)P3 responses to fMLP
measured at 10 s, we decided to examine the kinetics of Ins(l,4,5)P3
accumulation in greater detail, to exclude an effect on the rapidity of onset or
duration of phosphoinositide hydrolysis or any independent influence of
priming agents on Ins(l,4,5)P3 metabolism. PAF (a known Ca2+-mobilising
agent) and TNFa (which does not mobilise Ca2+) were selected for use in the
following time-course experiments.
6.4 The Effects of TNFa on the Time-course of fMLP-stimulated
Ins(l,4,5)P3 Accumulation
The effects of TNFa on fMLP-stimulated Ins(l,4,5)P3 mass were determined
at time points ranging from 0-10 min, using both 100 nM fMLP (the
concentration used to illustrate priming of 02~ generation) and 1 nM fMLP
(at which concentration a significant difference was detected between
primed and unprimed cells, Figure 6.3) as the stimulating agent. The results
depicted in Figures 6.5 and 6.6 illustrate that TNFa exerts minimal effects on
the time-course of Ins(l,4,5)P3 accumulation. No significant differences in
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Figure 6.5
Figure 6.5 Effects of TNFa Priming on 100 nM fMLP-stimulated
Ins(l,4,5)P3 Accumulation in Human Neutrophils.
Neutrophils (7.2xl06 in 225 pi PBS with calcium and magnesium) were
incubated with (circles) or without (squares) TNFa 200 U/ml for 30 min at
37°C, prior to stimulation with fMLP 100 nM (closed symbols) or vehicle
(open symbols); the reactions were stopped at the appropriate times (0-120 s)
by the addition of 60 pi ice cold 3 M TCA. The samples were allowed to
extract at 4°C for 30 min and were then partitioned with freon/octylamine
(1:1, v/v) as described in (2.7.2). The upper phases (150 pi) were neutralised
with 60 mM NaHCCh, and the Ins(l,4,5)P3 mass of the neutralised extracts
determined exactly as described (2.7.3). Results represent the mean±sem of 3
separate experiments each performed in duplicate.
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Figure 6.6
Figure 6.6 Effects of TNFa Priming on 1 nM fMLP-stimulated Ins(l,4,5)P3
Accumulation in Human Neutrophils.
Neutrophils (7.2xl06 in 225 pi PBS with calcium and magnesium) were
incubated with (circles) or without (squares) TNFa 200 U/ml for 30 min at
37°C/ prior to stimulation with fMLP 1 nM (closed symbols) or vehicle (open
symbols); the reactions were stopped at the appropriate times (0-120 s) by
the addition of 60 pi ice cold 3 M TCA. The samples were allowed to extract
at 4°C for 30 min and were then partitioned with freon/octylamine (1:1, v/v)
as described in (2.7.2). The upper phases (150 pi) were neutralised with 60
mM NaHCOs, and the Ins(l,4,5)P3 mass of the neutralised extracts
determined exactly as described (2.7.3). Results represent the mean±sem of 3
separate experiments each performed in duplicate.
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Table 6.1













Table 6.1 Effects of TNFa Priming on fMLP-stimulated Ins(l,4,5)P3
Accumulation at 5 and 10 min
Neutrophils (7.2xl06 in 225 pi PBS with calcium and magnesium) were
incubated with or without TNFa 200 U/ml (added in 25 pi) for 30 min at
37°C/ prior to stimulation with 1 nM or 100 nM fMLP (50 pi) or vehicle; the
reaction was stopped at 5 or 10 min by the addition of 60 pi ice cold 3 M TCA
with vortexing. The samples were allowed to extract at 4°C for 30 min and
were then partitioned with freon octylamine as described in (2.7.2). The
upper phases (150pl) were neutralised (60 mM NaHCOa, 40 pi), and the
Ins(l,4/5)P3 mass of the neutralised lipid extracts was determined exactly as
described (2.7.3). Results (pmol/107 cells) represent the mean+sem of 2
separate experiments each performed in duplicate.
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Ins(l,4/5)P3 accumulation in response to 1 nM or 100 nM fMLP were seen
between 0-120 s following fMLP addition, although the response to 100 nM
fMLP was slightly prolonged; the marginal enhancement of the 10 s peak
response to 1 nM fMLP did not reach statistical significance in this series of
experiments. In separate experiments, Ins(l,4,5)P3 mass was determined 5
and 10 min following stimulation; again, no significant differences between
primed and unprimed cells were seen with either concentration of fMLP
(Table 6.1).
6.5 Effects of PAF on the Time-course of fMLP-stimulated Ins(l,4,5)P3
Accumulation
From Figure 6.7 it can be seen that the time-courses of Ins(l,4,5)P3
accumulation in unprimed and PAF-primed cells were superimposable
when 100 nM fMLP was applied. The data for 1 nM fMLP confirm the
previously detected enhancement of Ins(l,4,5)P3 accumulation in PAF-
primed cells at 10 s, and values at 5 and 30 s are also slightly elevated (Figure
6.8); however, a higher baseline (unstimulated) level of Ins(l,4,5)P3 was also
detected in primed neutrophils compared to the unprimed controls. The
increase in basal Ins(l,4,5)P3 in PAF-primed cells is similar in magnitude to
the augmentation of fMLP-stimulated Ins(l,4,5)P3 detection, and is probably




Figure 6.7 Effects of PAF Priming on 100 nM fMLP-stimulated Ins(l,4,5)P3
Accumulation in Human Neutrophils.
Neutrophils (7.2xl06 in 225 pi PBS with calcium and magnesium) were
incubated with (circles) or without (squares) PAF 100 nM for 10 min at 37°C,
prior to stimulation with fMLP 100 nM (closed symbols) or vehicle (open
symbols); the reactions were stopped at the appropriate times (0-120 s) by
the addition of 60 pi ice cold 3 M TCA. The samples were allowed to extract
at 4°C for 30 min and were then partitioned with freon/octylamine (l:l,v/v)
as described in (2.7.2). The upper phases (150 pi) were neutralised with 60
mM NaHCOs, and the Ins(l,4,5)P3 mass of the neutralised extracts




Figure 6.8 Effects of PAF Priming on 1 nM fMLP-stimulated Ins(l,4,5)P3
Accumulation in Human Neutrophils.
Neutrophils (7.2xl06 in 225 pi PBS with calcium and magnesium) were
incubated with (circles) or without (squares) PAF 100 nM for 10 min at 37°C/
prior to stimulation with fMLP 1 nM (closed symbols) or vehicle (open
symbols); the reactions were stopped at the appropriate times (0-120 s) by
the addition of 60 pi ice cold 3 M TCA. The samples were allowed to extract
at 4°C for 30 min and were then partitioned with freon/octylamine (1:1, v/v)
as described in (2.7.2). The upper phases (150 pi) were neutralised with 60
mM NaHCOa, and the Ins(l,4,5)P3 mass of the neutralised extracts




We have demonstrated that fMLP at a concentration of 100 nM induced
maximal Ins(l,4,5)P3 accumulation that could not be augmented by
preincubation under optimal priming conditions with LPS, TNFa or PAF;
under identical conditions fMLP alone caused minimal activation of the
NADPF1 oxidase, but 02" generation was enhanced 5-10 fold following
exposure to a priming agent. These data argue strongly against a role for
augmentation of Ins(l,4,5)P3-mediated Ca2+ release in neutrophil priming.
While a statistically significant increase in Ins(l,4,5)P3 mass at 10 s was
detected in PAF-primed versus unprimed neutrophils stimulated with 1 nM
fMLP, the results were no more than additive; indeed, the values obtained
did not differ significantly from those obtained for cells treated with PAF
alone (Fig 6.4). Neutrophils primed with PAF (100 nM, 10 min) exhibited
significantly higher unstimulated Ins(l,4,5)P3 mass than controls,
presumably reflecting persisting PAF-induced phosphoinositide hydrolysis.
Priming with TNFa also resulted in a slight elevation of resting Ins(l,4,5)P3
mass (not reaching statistical significance) and of the mass detected
following 10 s stimulation with 1 nM fMLP (p<0.05, Fig 6.3); these results are
surprising in view of the generally accepted dictum that TNFa does not
mobilise Ca2+ in human neutrophils. However, TNFa-induced [Ca2+]j
oscillations have been reported in adherent human neutrophils (Schumann
et al., 1993). Whilst the neutrophils in our experiments were kept in
suspension, the higher cell density (7.2xl06/ml) may have promoted cell-cell
interactions, thereby simulating some of the conditions pertaining to the
adherent state (although cells incubated at this density did not produce 02~
in response to TNFa alone (Figure 6.1), in contrast to the studies of Nathan et
al., 1987 and 1989a, using adherent neutrophils). A precedent for modified
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phosphoinositide metabolism in adherent cells exists; McNamee et al. (1993)
demonstrated that adhesion of a fibroblast cell line (CH3 10Y1/2) to
fibronectin increased the synthesis on PtdIns(4,5)P2 and enhanced PDGF-
stimulated inositol phosphate release.
The use of a mass assay to measure Ins(l,4,5)P3 obviates the need for a
prolonged (2 h or greater) incubation of neutrophils with [3H]inositol, with
possible adverse functional consequences; such labelling artefact may
underlie the discrepancies between the reports of MacPhee (1992) and of
Corey and Rosoff (1989), the former demonstrating enhanced, and the latter
unchanged accumulation of [3H]Ins(l,4,5)P3 in neutrophils primed with GM-
CSF and stimulated with fMLP. The use of plasma/Percoll-prepared cells in
combination with the mass assay technique allowed us to contrast the
intracellular signals of truly unprimed cells with deliberately primed cells;
the remarkably similar Ins(l,4,5)P3 profiles contrast sharply with the
previously demonstrated functional differences. In many experiments,
following stimulation with fMLP a fall of Ins(l,4,5)P3 to levels below baseline
was seen (e.g. Figure 6.6); this undershoot phenomenon has been previously
reported in bovine tracheal smooth muscle cells (Chilvers et al., 1989) and
has been attributed to agonist-stimulated Ins(l,4,5)P3 metabolism (Chilvers
et al., 1991).
How can the results presented in this chapter be reconciled with those of
Forehand et al. (1989), who demonstrated elevated baseline [Ca2+]i and an
enhanced and prolonged Ca2+ spike in LPS-primed cells? Ca2+ transients
were measured by Forehand utilising the Ca2+-sensitive indicator dye, fura-
2/AM. Although this dye is superior to pre-existing reagents (Grynkiewicz
et al., 1985), its use still presents problems (discussed by Marks et al., 1990,
and Schumann et al., 1993) including buffering of [Ca2+]; by the dye, and the
generation of cellular autofluorescence due to excitation of the dye at UV
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wavelengths. Different Ca2+ indicators may give rise to disparate data even
in the same cell type (Williamson and Monck, 1989). We have also found
that standard loading of neutrophils with 2 pM fura-2/AM for 30 min leads
to a slight degree of priming, mainly attributable to the DMSO in which the
dye is dissolved (nmol 02~ generated per 106 cells in response to 100 nM
fMLP: control (PBS) 3.4±1.2, fura-2/AM 5.9±1.6, and 0.1% DMSO (vehicle)
5.2±0.9). While these limitations of Ca2+-indicators are generally accepted,
they are unlikely to account for differences between unprimed/primed cells
loaded together or in parallel. Priming agents could theoretically alter the
uptake and cellular distribution of fura-2/AM or its cleavage to fura-2, or
induce changes that quench fura-2-generated fluorescence, but these issues
have not as yet been addressed experimentally.
Studies of [Ca2+]; at a single cell level indicate that priming probably results
in the recruitment of a proportion of cells into a more highly responsive
pool, with heterogeneous calcium responses observed following LPS
priming (Yee and Christou, 1993) and in response to fMLP, C5a and IL-8
(Eisner et al., 1992); additionally, Elbim et al. (1994) demonstrated
recruitment of cells into an fMLP-responsive H^C^-producing neutrophil
pool subsequent to priming with TNFa, GM-CSF, and, to a lesser extent, IL-
8. Heterogeneity may also exist at the level of the Ins(l,4,5)P3 receptor.
Although a family of at least three receptors has been characterised,
Sugiyama et al. (1994) found that rat neutrophils expressed predominantly
the type 2 receptor, which exhibited a significantly higher affinity for
Ins(l,4,5)P3 than the originally described cerebellar type 1 receptor despite
significant sequence homology. The density of Ins(l,4,5)P3-sensitive Ca2+
channels within intracellular Ca2+ stores was found to be non-uniform in
vascular smooth muscle cells by Hirose and lino (1994), although these data
have not yet been extended to other cell types. Additionally, the affinity of
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the Ins(l/4,5)P3 receptor for its ligand may be modulated, by the oxidative
state of critical receptor sulfhydryl groups (Kaplin et al., 1994) or by receptor
phosphorylation (discussed by Fisher, 1995). Small, localised changes in
Ins(l,4,5)P3 concentration (possibly at a subplasmalemmal location) in only a
proportion of cells could therefore be important in signalling the primed
state, with currently available assays being insufficiently sensitive to detect
such fluctuations.
A further complication is that Ca2+ flux may be regulated by mechanisms
distinct from PtdIns(4,5)P2 hydrolysis. Rigley et al. recently (1995)
demonstrated a role in Ca2+ signalling for the non-receptor tyrosine kinase
p59fyn(T) in Jurkat T cells; decreased expression of p59fyn(T) (produced by
transfection with anti-sense cDNA) led to a reduced Ca2+ influx in response
to cross-liking of the T-cell receptor, whilst Ins(l,4,5)P3 production was not
attenuated. Sphingosine (an endogenous sphingolipid) was found to elevate
human neutrophil [Ca2+]i with no effect on basal or fMLP-stimulated
Ins(l,4,5)P3 generation (Wong and Kwan-Yeung, 1993). Finally, Jurkat T
cells were reported to possess ryanodine receptors (Guse et al., 1993;
discussed in Murphy et al., 1995), raising the possibility of the involvement
of cyclic adenosine diphosphate-ribose (cADPR; Galione et al., 1993), the
presumptive physiological regulator of Ins(l,4,5)P3-insensitive Ca2+ release
via ryanodine receptor-like channels. Hence it is still possible that Ca2+
transients may have a role in neutrophil priming, but any differences would
appear to be independent of Ins(l,4,5)P3 accumulation.
In summary, priming did not augment or prolong Ins(l,4,5)P3 accumulation
stimulated by 100 nM fMLP, and the minor augmentation seen when 1 nM
fMLP was used as a stimulus was probably an additive effect. While this
makes a major role for Ins(l,4,5)P3 in neutrophil priming unlikely,
improving mass assays and Ca2+-imaging techniques may in future further
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clarify the role of these mediators, and the elucidation of other routes of
Ca2+-mobilisation may also be informative.
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Chapter 7: The Roles of Phosphatidylinositol 3,4/5-
trisphosphate and Ceramide in Neutrophil Priming by TNFa
7.1 Introduction
In recent years it has become established that a wide range of agonists can
stimulate a rapid and dramatic accumulation of the novel phospholipid
phosphatidylinositol 3,4,5-trisphosphate (Ptdlns(3/4,5)P3) in their target cells
(Traynor-Kaplan et al., 1988 and 1989, Auger et al., 1989, Stephens et al.,
1991, Cantley et al., 1991, Downes et al., 1991). This event is not driven by
activation of other known signalling pathways (Downes et al., 1991, Traynor-
Kaplan et al., 1989, Jackson et al., 1992); however, many of the agonists
which cause accumulation of PtdIns(3,4,5)P3 also drive the translocation of a
phosphoinositide 3-hydroxy kinase (PI3K) activity, which can synthesise
PtdIns(3,4,5)P3 from PtdIns(4,5)P? in vitro, into receptor-associated signalling
complexes (Schlessinger and Ullrich, 1992, Corey et al., 1993). These
observations led to the hypothesis that PtdIns(3,4,5)P3 could function as a
second messenger.
PI3K was initially characterised by means of its association with, and
tyrosine phosphorylation by, receptor or src-associated protein tyrosine
kinases (PTKs), and was found to comprise an 85 kDa regulatory subunit
(Escobedo et al., 1991, Otsu et al., 1991,) and a tightly associated 110 kDa
catalytic subunit (Carpenter et al., 1990). However, in human neutrophils,
rapid accumulation of PtdIns(3,4,5)P3 has been demonstrated in response to
fMLP (Traynor-Kaplan et al., 1989), PAF and ATP (Stephens et al., 1993a and
1993b), agents which transduce their signals via heterotrimeric G-proteins;
PtdIns(3,4,5)P3 accumulation seen following the application of these agonists
was sensitive to pertussis toxin. Furthermore, Vlahos and Matter (1992)
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demonstrated that, in contrast to growth factor signal transduction systems,
the activation of PI3K by fMLP in neutrophils does not require its tyrosine
phosphorylation. Stephens et al. (1994) have subsequently shown that, in the
U937 macrophage cell line, most, if not all ATP-stimulated PtdIns(3,4,5)P3
accumulation is driven by the activation of a distinct PI3K that is sensitive to
Gpysubunits but insensitive to PTK-dependent activation. More recently
still, Stoyanov et al. (1995) have cloned (from a human bone marrow cDNA
library) a unique enzyme with G-protein-activated PI3K activity, designated
pllOy, which does not bind p85 and has no sequence homology to
previously isolated PI3K subunits. This recently characterised enzyme may
be responsible for the majority of PtdIns(3,4,5)P3 accumulation in stimulated
human neutrophils.
Studies with cells expressing mutant growth factor receptors have
implicated PI3K in the regulation of mitogenesis (Fantl et al., 1992); however,
PI3K activity is also stimulated in a number of non-proliferating cells
including neutrophils (Traynor-Kaplan et al., 1989) PC12 cells (Kimura et al.,
1994) and platelets (Kucera and Rittenhouse, 1990), suggesting additional
roles for this enzyme. Further clarification of the importance of this
signalling pathway was achieved when the fungal metabolite wortmannin
was shown to be a potent non-competitive inhibitor of PI3K at low (nM)
concentrations (Arcaro and Wymann, 1993, Okada et al., 1994b and Thelen et
al., 1994). Wortmannin abolished the fMLP-triggered respiratory burst in
neutrophils (Baggiolini et al., 1987); indeed, two separate pathways, one
Ca2+-sensitive and the other wortmannin-sensitive, were found to be
obligatory in fMLP-stimulated 02~ generation (Dewald et al., 1988; see
Figure 7.1). Since PtdIns(3,4,5)P3 accumulation appears to be vital in
signalling the fMLP-stimulated respiratory burst, we decided to investigate































Figure 7.1 Inositol lipid signalling pathways involved in 02" generation
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and LPS (L. Stephens, personal communication) elevate neutrophil
PtdIns(3/4/5)P3 directly, we elected to study the effects of priming with TNFa
(which has no overt effect on neutrophil PI3K activity; L. Stephens, personal
communication) on fMLP-stimulated human neutrophil PtdIns(3,4,5)P3
accumulation.
During the course of these studies, ceramide (generated by the action of the
enzyme sphingomyelinase on the membrane lipid sphingomyelin) was also
identified as a key element in the TNFa-generated signal transduction
cascade (Kim et al., 1991, Dressier et al., 1992). It has been suggested that at
least in some cell types, ceramide mediates many of the effects of TNFa,
including cell growth and differentiation (Olivera et al, 1992), apoptosis in
HL60 cells (Obeid et al, 1993), and stimulation of a ceramide-activated
protein kinase (Dressier et al., 1992). We therefore investigated the role of
ceramide in neutrophil priming utilising the cell-permeable ceramide
analogue C6-ceramide, and also exogenous sphingomyelinase to generate
intracellular ceramide.
157
7.2 Effects of C6-ceramide and Sphingomyelinase on Human Neutrophil
O2" Generation
It can be seen from Figure 7.2 that addition of the cell-permeable ceramide
analogue C6~ceramide (30pM for 30 min at 37°C) produced no discernible
direct or priming effect on O2" release; neutrophils from the same donor
incubated in parallel with TNFa as a positive control exhibited a classic
augmentation of the O2" response to fMLP. In a separate series of
experiments C2- and C6-ceramide were shown to mimic the effects of TNFa
in inducing apoptosis in HL-60 cells, although again these agents did not
affect the rate of constitutive apoptosis in neutrophils (M. Lawson and J.
Murray, personal communication). The slight apparent effect of
sphingomyelinase on O2" generation (both direct and fMLP-stimulated) was
in fact attributable to its vehicle (50% glycerol/PBS, 50 mM Tris-HCl, pH
7.5). It was therefore concluded that ceramide does not mediate the effect of
TNFa in the priming of human neutrophils, in agreement with data obtained
by Yanaga and Watson (1995).
7.3 Effects of Wortmannin on Neutrophil O2" Generation and Shape-
Change
At low (nM) concentrations, the fungal metabolite wortmannin is thought to
be a specific and irreversible inhibitor of PI3K (Arcaro and Wymann, 1993).
Preincubation of neutrophils with 100 nM wortmannin for 30 min at 37°C
completely abolished fMLP-stimulated O2" generation by both unprimed
and TNFa-primed (200 U/ml, 30 min, 37°C) neutrophils (Figure 7.3.A). That
wortmannin is not acting as an oxidase inhibitor is confirmed by the finding
that the oxidative burst in response to PMA was unaffected or in fact slightly
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Figure 7.2 Effects of Sphingomyelinase, Cg-ceramide and TNFa on
Human Neutrophil Superoxide Generation
Human neutrophils (106 in 90 pi PBS with calcium and magnesium) were
incubated at 37°C with neutral sphingomyelinase (S'Mase) 200 U/ml, Cs~
ceramide 30 pM, TNFa 200 U/ml or the appropriate vehicles for 30 min
prior to the addition of pre-warmed cytochrome C (final concentration 1.2
mg/ml) and fMLP (final concentration 100 nM, hatched bars) or vehicle
(open bars) in a final volume of 1 ml. SOD 375 U was included in one of
each set of quadruplicate incubations. After 15 min cells were pelleted at 4°C
and the optical density of the supernatants determined at 550 nm by
scanning spectrophotometry; O2" generation was calculated as described in
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Figure 7.3 Effects ofWortmannin on 02" Generation and Shape Change
A. Neutrophils (107/ml) were incubated in the presence (hatched bars) or
absence (open bars) of 100 nM wortmannin for 30 min prior to addition of
TNFa (200 U/ml, 30 min) or PBS and stimulation (10 min) with 100 nM
fMLP, 10 ng/ml PMA or appropriate buffer (controls). Superoxide
generation was measured by the superoxide dismutase-inhibitable reduction
of cytochrome C as previously described (2.3), n=3.
B. Neutrophils (5xl06/ml) were incubated in the presence (closed symbols)
or absence (open symbols) of 100 nM wortmannin for 30 min prior to
treatment with fMLP 0-100 nM; reactions were terminated at 10 min by
fixation with an equal volume of 0.5% glutaraldehyde. Shape-change was
assessed under light microscopy as described (2.4). Data are mean+sem of
n=3 duplicate determinations; all error bars were <10% of the mean and lie
within the data points. * p<0.05 for presence versus absence of wortmannin.
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fMLP-induced shape-change, inhibiting this response only when 1 nM fMLP
was used as the stimulus (Figure 7.3.B). Wortmannin (100 nM) did not affect
cell viability as assessed by trypan blue exclusion (data not shown).
7.4 Priming of Neutrophils in Phosphate-free Buffer
To optimise labelling of neutrophil phospholipids with [32P]Pi, a prolonged
(70 min) incubation of cells with the isotope in phosphate-free medium was
utilised. To confirm that priming could occur under these conditions,
neutrophils underwent a 70 min incubation in sterile, phosphate-free
medium (110 mM NaCl, 10 mM KC1, 1 mM MgCl2, 10 mM glucose, 30 mM
HEPES, 1.5 mM CaCl2, pH 7.4, custom supplied by GIBCO) prior to priming
with TNFa (200 U/ml, 30 min) and measurement of fMLP-stimulated 02~
release. As illustrated (Figure 7.4), a competent priming response was still
observed in the phosphate-free medium even with the inclusion of an
additional 70 min incubation step, and cells not treated with TNFa produced
little 02" in response to 100 nM fMLP, thereby validating the labelling
procedure.
7.5 fMLP-stimulated PtdIns(3,4,5)P3 Accumulation in Unprimed and
TNFa-primed Human Neutrophils
PtdIns(3,4,5)P3 determinations were carried out in unprimed and TNFa-
primed neutrophils at 10 s and 1 min following stimulation with 100 nM
fMLP. Logistics (the cell numbers required, and the level of radioactivity
involved) dictated that a single time-point only was examined in each
experiment. At 10 s after the addition of fMLP (Figures 7.5 and 7.6.A) a 1.4-
fold enhancement of stimulated PtdIns(3,4,5)P3 accumulation in primed
versus unprimed cells was demonstrated. However at 1 min a 6.2-fold
increase in PtdIns(3,4,5)P3 was seen in primed cells stimulated with fMLP
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Figure 7.4
Figure 7.4 Priming of Human Neutrophils in Phosphate-free Medium
108 neutrophils suspended in 2.5 ml phosphate-free buffer were incubated in
a shaking water bath for 70 min at 37°C, washed twice and resuspended in
1.2 ml phosphate-free medium. 100 pi aliquots of cells were further
incubated with TNFa (200 U/ml, added in 40 pi) or buffer control for 30 min
and stimulated with 100 nM fMLP (40 pi). 02~ release was quantified by the





Figure 7.5 Effects of TNFa on fMLP-stimulated (10 s) PtdIns(3,4,5)P3
Accumulation in Human Neutrophils: Autoradiograph of TLC Plate
Human neutrophils (108 in 2.5 ml phosphate-free buffer) were labelled with
2 mCi/ml [32P]P; (70 min, 37°C), washed twice and resuspended in 1.2 ml
phosphate-free buffer. 100 pi aliquots of labelled cells were incubated in the
presence or absence of 200 U/ml TNFa (added in 40 pi) for 30 min prior to
stimulation with fMLP 100 nM (40 pi). Reactions were quenched at 10 s by
the addition of 675 pi methanol/chloroform (2:1, v/v) and lipids were
extracted and deacylated as described (2.8.2). The deacylated lipids extracts
were dried and redissolved in 2 pi 20 mM HC1, 1 mM K2PO4 and
chromatographed on PEI-cellulose plates; the plates were developed in 0.48
M HC1 and the radioactivity quantified by means of a phosphoimager.
Figure 7.5
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Figure Legend for Figure 7.6
Figure 7.6 fMLP-stimulated PtdIns(3,4,5)P3 Accumulation In Unprimed
and TNFa-primed Human Neutrophils
A and B. Human neutrophils (108 in 2.5 ml phosphate-free buffer) were
labelled with 2 mCi/ml [32P]Pi (70 min, 37°C), washed twice and
resuspended in 1.2 ml phosphate-free buffer. 100 |il aliquots of labelled cells
were incubated in the presence or absence of 200 U/ml TNFa (added in 40
pi) for 30 min prior to stimulation with fMLP 100 nM (40 pi). Reactions were
quenched at 10 s (A) or 60 s (B) by the addition of 675 pi
methanol/chloroform (2:1, v/v) and lipids were extracted and deacylated as
described (2.8.2). The deacylated lipids were dried and analysed by TLC or
HPLC as detailed in (2.8.2). Data (mean+sem of triplicate determinations for
n=3 (A) or n=2 (B)) are expressed as % maximum response.
C. For the n=5 experiments represented by (A) and (B), neutrophils
underwent the labelling, priming and stimulation procedures and were
subsequently analysed for superoxide release by the superoxide dismutase-
inhibitable reduction of cytochrome C (2.3). Data (mean+sem, n=5
experiments each performed in triplicate) are expressed as % maximum
response.
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above that seen in unprimed stimulated cells (Figure 7.6.B); the level of
accumulation in primed and stimulated cells was >100-fold that seen in
control cells. TNFa alone did not affect PtdIns(3,4,5)P3 detection.
Superoxide anion release was measured simultaneously to confirm adequacy
of priming (Figure 7.6.C).
7.6 Effects of TNFa and fMLP on [32P]Phosphoinositides.
Incubation of [32P]Pi-labelled neutrophils with 200 U/ml TNFa for 30 min
resulted in an increase in [32P]PtdIns4P (Tables 7.1 and 7.2); no consistent
effect on [32P]PtdIns(4,5)P2, the immediate precursor of PtdIns(3,4,5)P3, was
observed. Most strikingly, the changes in [32P]PtdIns(3,4,5)P3 were closely
paralleled by changes in its immediate metabolite, [32P]PtdIns(3,4)P2- Both
phospholipids were virtually undetectable in control and TNFa-treated cells;
following fMLP stimulation, at 10 sec near maximal elevation was observed
in unprimed cells whilst at 60 s the accumulation of both phosphoinositides
was much greater in primed cells (6.2-fold and 7.6-fold respectively);
accumulation in primed cells was far greater at 1 min than at 10 sec, whilst
levels in unprimed cells were similar at the 2 time-points. Accumulation of
PtdIns3P was also increased in primed versus unprimed cells 1 min after
stimulation, with only a slight effect at 10 s. At 1 min, depletion of
[32P]PtdIns(4,5)P2 was much greater in primed, stimulated cells, consistent
with sustained PI3K activity to form [32P]PtdIns(3,4,5)P3.
7.7 Effects of TNFa and fMLP on Neutrophil PI3K Activity in Anti-
phosphotyrosine Immunoprecipitates
To further characterise the enhanced accumulation of PtdIns(3,4,5)P3 seen in
TNFa-primed human neutrophils 1 min following stimulation with fMLP,
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Table 7.1
PtdIns4P PtdIns(4,5)P2 PtdIns(3,4)P2 PtdIns3P PtdIns(3,4,5)P3
Control 15897±1055 4102712232 2916 541143 96116
TNF 23626±520 490911926 5013 77517 118138
fMLP 15119+627 3266811775 397127 574151 1682197
TNF+fMLP 2218811013 4121012080 554143 824177 26611107
Table 7.1 Effects of TNFa on fMLP-stimulated (10 s) Changes in Human
Neutrophil Phosphoinositides.
[32P]p._labelled human neutrophils were washed twice and resuspended at
6xl07/ml in phosphate-free buffer. 100 pi aliquots of labelled cells were
incubated in the presence or absence of 200 U/ml TNFa (added in 40 pi) for
30 min prior to stimulation with fMLP 100 nM (40 pi). Reactions were
quenched at 10 s by the addition of 675 pi methanol/chloroform (2:1, v/v)
and lipids were extracted and deacylated as described (2.8.2). The
[32p]giycerophosphoesters were resolved by anion-exchange
chromatography on a Partisphere SAX column by Dr. L. Stephens
(Department of Signalling, Babraham Institute, Cambridge) as described




PtdIns4P PtdIns(4,5)P2 PtdIns(3,4)P2 PtdIns3P PtdIns(3,4,5)P3
Control 9567±813 24062+830 24±5 252±49 31+3
TNF 13298±689 22814±2081 38±4 381±28 28+3
fMLP 10803±242 21972±189 308±30 308+10 535+35
TNF+fMLP 11890±451 15702±353 2349±204 629+44 3316±354
Table 7.2 Effects of TNFa on fMLP-stimulated (60 s) Changes in Human
Neutrophil Phosphoinositides
[32p]p._iabelled human neutrophils were washed twice and resuspended at
6xl07/ml in phosphate-free buffer. 100 pi aliquots of labelled cells were
incubated in the presence or absence of 200 U/ml TNFa (added in 40 pi) for
30 min prior to stimulation with fMLP 100 nM (40 pi). Reactions were
quenched at 60 s by the addition of 675 pi methanol/chloroform (2:1, v/v)
and lipids were extracted and deacylated as described (2.8.2). The
[32p]giycerophosphoesters were resolved by anion-exchange
chromatography on a Partisphere SAX column by Dr. L. Stephens
(Department of Signalling, Babraham Institute, Cambridge) as described
(2.8.2). Data are d.p.m., mean+sem, n=2 triplicate values.
168
PI3K activity in PY20 antiphosphotyrosine immunoprecipitates was
determined by Dr L. Stephens, Department of Signalling, Babraham
Institute, Cambridge. Figure 7.9 illustrates that a 1.7-fold increase in primed
versus unprimed cells was detected; simultaneous measurement of fMLP-
stimulated O2" release revealed an amplification of greater than 13-fold in
primed versus unprimed cells. Interestingly, a slight decrease in PI3K
activity below control values was noted in response to TNFa alone, with




Figure 7.7 Effects of TNFa and fMLP on Neutrophil PI3K Activity in Anti-
phosphotyrosine Immunoprecipitates
A). Human neutrophils (3 x 107/ml) were incubated in the presence or
absence of TNFa (200 U/ml) for 30 min and stimulated with fMLP 100 nM
or vehicle for 60 s prior to pelleting and snap-freezing in liquid nitrogen.
The PI3K activity in antiphosphotyrosine immunoprecipitates was
quantified by Dr L. Stephens according to the method described in (2.8.3).
Data represent the amount of [32P] incorporated into PtdIns3P during the
assay and are the mean of n=2 determinations performed in triplicate.
B). Simultaneously, neutrophils from the same donors were primed with
TNFa 200 U/ml and stimulated with fMLP 100 nM; the release of O2" was
quantified by the superoxide dismutase-inhibitable reduction of cytochrome
C. Data are the mean of n=3 determinations performed in triplicate.
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7.8 Discussion
The key finding presented in this chapter is that priming with TNFa
augmented the accumulation of PtdIns(3,4,5)P3 generated in human
neutrophils in response to fMLP stimulation. This effect was relatively small
at an early time-point (10 s) following the addition of fMLP (fMLP alone
70%±5.6% of the PtdIns(3,4,5)P3 accumulation seen in primed and stimulated
cells) but by 1 min after fMLP stimulation PtdIns(3,4,5)P3 accumulation was
enhanced by 620% in primed cells, and the value for primed and stimulated
cells was approximately 100 times that seen in control unprimed,
unstimulated cells. The effect of fMLP alone in these experiments is
comparable to that reported by other investigators (e.g. Traynor-Kaplan et
al., 1989); no previous studies of the possible role of 3-phosphorylated
inositol phospholipids in neutrophil priming have been reported. The
finding that the magnitude and duration of the PtdIns(3,4,5)P3 were greatly
increased in TNFa-primed cells suggests a possible role in signalling for the
primed respiratory burst.
The fact that fMLP-stimulated PtdIns(3,4,5)P3 accumulation in neutrophils is
pertussis toxin-sensitive but resistant to tyrosine kinase inhibitors (Stephens
et al., 1993b, Corey et al., 1993) and associated with little (Stephens et al.,
1993b) or no (Vlahos and Matter, 1992) increase in PI3K activity detected in
anti-phosphotyrosine antibody immunoprecipitates, indicates that the
classical p85/pll0 enzyme activated by receptor or src-type tyrosine kinases
may not be the principal PI3K isoform associated with the fMLP-driven
PtdIns(3,4,5)P3 response in these cells. We have confirmed that neither fMLP
TNFa alone induced a significant increase in the PI3K activity associated
with antiphosphotyrosine immunoprecipiates; in fact, treatment with TNFa
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alone resulted in a slight fall in the baseline PI3K activity present in anti-
phosphotyrosine immunoprecipitates; a similar effect has been reported with
fMLP alone (in THP-1 cells: Okada et al., 1996) and with thrombin (in
1321N1 cells: Batty and Downes, 1996) but its significance is unclear. The
increase in the anti-phosphotyrosine immunoprecipitable PI3K activity seen
in TNFa-primed and stimulated cells versus unprimed stimulated cells (1.7-
fold) is slight in comparison to the corresponding increases in PtdIns(3,4,5)P3
detection (6.2-fold) and O2" generation (13.3-fold); comparison of control
(unprimed, unstimulated) cells with primed and stimulated cells reveals an
even greater gulf between increase in the PI3K activity present in
immunoprecipitates (1.7-fold increase) and elevation of PtdIns(3,4,5)P3
(approximately 100-fold increase) or augmentation of O2" generation (>1000-
fold increase). Thus, although a small contribution from the recruitment
and activation of a tyrosine kinase-regulatable p85/pll0 PI3K cannot be
excluded, it seems likely that the majority of the PtdIns(3,4,5)P3 generated in
stimulated neutrophils is the product of a different PI3K isoform.
Stephens et al. (1994) first described the activation by G-protein (3y-subunits
of a PI3K isoenzyme immunologically and chromatographically distinct
form the well-characterised p85/pll0 enzyme; the identification and cloning
of a novel catalytic subunit of PI3K (pllOy) that is activated by both a and (3y-
subunits of heterotrimeric G-proteins was subsequently reported (Stoyanov
et al., 1995). More recently, Okada et al. (1996) showed that insulin and
fMLP can exert a synergistic effect on PtdIns(3,4,5)P3 formation in THP1
cells, suggesting that there is cross-talk between the tyrosine
phosphorylation-dependent transduction pathway and the G-protein-
dependent pathway; this was confirmed in a cell-free system. The authors
also separated two PI3K activities, one responsive to (3y-subunits alone and
the other activated synergistically by (3y-subunits and by a tyrosine-
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phosphorylated peptide based on the insulin receptor-substrate-1. These
data may well be pertinent to neutrophils, since elevations of neutrophil
PtdIns(3,4,5)P3 have been documented in response to GM-CSF in a genistein-
sensitive but pertussis toxin-insensitive fashion (Corey et ah, 1993).
However, although TNFa can stimulate tyrosine phosphorylation of
neutrophil proteins (Berkow and Dodson, 1988, Lloyds et ah, 1995), our data
demonstrate that TNFa did not significantly affect PtdIns(3,4,5)P3
accumulation at 30 min or directly stimulate PI3K activity in PY20
immunoprecipitates; Corey et al. (1993) also reported that incubation of
neutrophils with TNFa 1000 U/ml for 3 min did not lead to significant
PtdIns(3,4,5)P3 elevation. Additionally, in the experiments described by
Okada et al. (1996), the two agonists (fMLP and insulin) were added
simultaneously. This suggests that the situation in TNFa-primed
neutrophils is not directly analogous to their system, in that TNFa is not
synergistically activating one or more isoforms of PI3K with fMLP. Since the
enhanced accumulation of PtdIns(3,4,5)P3 did not appear to reflect increased
PtdIns(4,5)P2 substrate availability or decreased PtdIns(3,4,5)P3-5
phosphatase activity (Tables 7.1 and 7.2), it is likely that TNFa acts directly
on PI3K itself, or at a proximal step in the signal transduction pathway.
The fungal metabolite wortmannin has been shown to inhibit PI3K (Arcaro
and Wymann, 1993, Okada et al., 1994b, Stoyanov et al., 1995) by binding
irreversibly to the enzyme (Thelen et al., 1994). This interaction has been
shown to inhibit respiratory burst activity and granule release induced by
fMLP, C5a, PAF and LTB4 (but not PMA) without influencing agonist-
induced Ca2+ transients or directly affecting protein kinase C, the NADPH-
oxidase or the process of granule exocytosis (Baggiolini et al., 1987, Dewald
et al., 1988). Unfortunately, as wortmannin abolished O2" generation in
response to fMLP in unprimed as well as primed cells (Figure 7.3), its
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usefulness in investigating any selective role for PI3K in neutrophil priming
is severely limited. Additionally, concerns have been raised regarding the
specificity of this inhibition, since wortmannin has been reported to inhibit
other enzymes such as myosin light chain kinase (Nakashini et al., 1992),
phospholipase C (Nakashini et al., 1994, Bonser et al., 1991), phospholipase D
(Bonser et al., 1991) and phospholipase A2 (Cross et al., 1995); however in all
but the last report the IC50 values for inhibition were considerably higher
than the IC50 reported for inhibition of PI3K by wortmannin (low
nanomolar). A second PI3K inhibitor, LY294002, has more recently been
characterised (Vlahos et al., 1995); its effects on neutrophils are similar to
those of wortmannin, but as yet data concerning its specificity are lacking.
Inhibition of PI3K activity has been shown to compromise many different
cellular activities, including cell growth and mitogenesis (Auger et al., 1989,
Cantley et al., 1991), membrane ruffling (Wennstrom et al., 1994), insulin-
induced glucose transport (Okada et al., 1994a), early endosome fusion
(Jones and Clague, 1995) and the neutrophil respiratory burst (Dewald et al.,
1988). The downstream targets of PtdIns(3,4,5)P3 responsible for exerting
these varying functions are only just beginning to be elucidated. Studies in a
variety of cell lines, utilising receptor mutations and PI3K inhibitors, have
suggested that PI3K may lie upstream of several protein kinase cascades,
including p70 S6 kinase (Chung et al., 1994, Baxter et al., 1995), the MAPK
pathway activated by PDGF, insulin and IL-2 (Baxter et al., 1995, Welsh et
al., 1994, Cross et al., 1995, Karnitz et al., 1995) and the serine-threonine
kinase Akt-1 (Franke et al., 1995, Kohn et al., 1995); however, the relevance of
these observations to O2" generation in neutrophils is at present unclear.
Activation of Ca2+-independent PKC isoforms by PtdIns(3,4,5)P3 has also
been demonstrated (Nakanishi et al., 1992, Toker et al., 1994); as
phosphorylation of P47Phox by PKC is involved in activation of the
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respiratory burst, this is a potential mechanism by which PI3K could
influence the neutrophil respiratory burst. However, activation of PKC by
alternative routes (Ca2+ and DAG) also occurs during fMLP stimulation,
hence PKC is unlikely to be the only effector of PtdIns(3,4,5)P3 involved. A
further downstream target of PtdIns(3,4,5)P3 which is more likely to be
physiologically relevant is the small G-protein p21rac, whose translocation to
the neutrophil membrane is essential for activation of the respiratory burst
(Quinn et al., 1993, Abo et al., 1994). Hawkins et al. (1995) have
demonstrated that p21rac activation lies downstream of PI3K activation in the
mediation of PDGF-induced membrane ruffling. In resting human
neutrophils, all the p21rac present in the cytosol exists in an inactive state
complexed to GDI, but this interaction was shown to be disrupted by various
lipid mediators including arachidonic acid and phosphatidylinositols
(Chuang et al., 1993). Furthermore, in bcr-null mutant mice (bcr limits p21rac
activation by enhancing the intrinsic rate of GTP hydrolysis), a threefold
increase in p21rac translocation to the neutrophil membrane was observed,
and neutrophils from these mice generated more O2" in response to agonists
than did those from wild-type mice (Voncken et al., 1995). Thus it is possible
that the exaggerated PtdIns(3,4,5)P3 response seen on stimulation of TNFoc-
primed human neutrophils is translated into enhanced p21rac dissociation
from GDI and subsequent membrane translocation, with concomitant
activation of the NADPH oxidase.
The cell-permeable ceramide analogue C6-ceramide and exogenous
sphingomyelinase failed to prime or stimulate the neutrophil NADPH
oxidase (Figure 7.2), suggesting that elevation of ceramide alone is not
sufficient to elicit either of these response. However, these data do not
exclude a permissive role for ceramide in priming; in a recent paper, Higuchi
et al. (1996) demonstrated that ceramide analogues and exogenous
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sphingomyelinase did not influence apoptosis in human myeloid leukaemia
Ml-la cells, but that inhibition of acid sphingomyelinase blocked the pro-
apoptotic effect of TNFa; furthermore, this block could be overcome by the
inclusion of ceramide analogues in the incubation. The role of ceramide as a
second messenger for other agonists such as LPS and PAF is completely
unknown, and detailed studies await the general availability of a specific
sphingomyelinase inhibitor.
In summary, priming of human neutrophils with TNFa leads to an
augmented and prolonged fMLP-stimulated PtdIns(3,4,5)P3 response; the
accompanying increase of anti-phosphotyrosine immunoprecipitable PI3K
activity is of much smaller magnitude, suggesting that activation of the (3y-




This thesis has focused on the signal transduction mechanisms involved in
neutrophil priming, the process by which resting neutrophils achieve a state
of preactivation associated with greatly augmented responsiveness on
subsequent stimulation.
The in vivo relevance of priming has been established by the detection of
priming agents in the circulation of many patients with sepsis (Parsons et al.,
1989, Sun et al., 1990), by the detection of primed neutrophil subpopulations
in patients with inflammatory disease states (Chollet-Martin et al., 1992, Bass
et al., 1986) and by the enhanced release of ROI from neutrophils observed
following infusion of priming agents into healthy volunteers (Wewers et al.,
1990, Van der Poll al., 1992) or laboratory animals (e.g. Mayer and Spitzer,
1991). However, some procedures used to isolate pure populations of
neutrophils from whole blood have been shown to effect a degree of priming
(Haslett et al., 1985), perhaps by the exposure of cells to trace concentrations
of LPS contaminating laboratory reagents. The in vitro study of priming
mechanisms necessitates the isolation of purified but unprimed neutrophils;
we have found that this ideal situation is most closely approached using
neutrophils separated on plasma/Percoll gradients (Haslett et al, 1985);
when this preparative method was used, neutrophils produced only
minimal quantities of O2" unless they were first incubated with a priming
agent (e.g. Figures 3.3-3.5).
The wide range of priming agents so far identified encompasses bacterial
products, inflammatory cytokines, pharmacological agents and the cross-
linking of adhesion molecules (see Table 1.1). In this thesis, physiologically
relevant inflammatory mediators - LPS, TNFa and PAF - have been selected
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to further study priming mechanisms. LPS, the first neutrophil priming
agent identified (Guthrie et al., 1984) is released from Gram-negative
bacteria; in vitro, low concentrations of LPS have been shown to accentuate
chemotactic factor-induced endothelial injury (Smedley et al., 1986), and in
vivo low doses of LPS infused into rabbits greatly accentuate the tissue
damage caused by subsequent injection of formylated peptide or
complement fragments (Worthen et al., 1987). TNFa is produced in response
to LPS, principally by cells of the monocyte-macrophage lineage, and serum
levels of this cytokine correlate with a poor outcome in septic shock (Pinsky
et al., 1993). Endothelial monolayers treated with thrombin prime
neutrophils layered on top of them by the production of the biologically
active lipid PAF (Vercellotti et al., 1989); in an in vivo study of endotoxic
shock, elevated plasma levels of both TNFa and PAF were required to
produce severe hypotension, and many of the detrimental effects of
endotoxin infusion were prevented by PAF antagonists (Sun et al., 1990),
further emphasising the in vivo significance of PAF as a biological mediator.
PAF is expressed by stimulated endothelial cells (Vercellotti et al., 1988,
Lorant et al., 1991) and may therefore modulate the function of adherent
neutrophils in vivo (Lorant et al., 1993). With reference to their physiological
importance and efficacy as neutrophil priming agents (Figures 3.2-3.5) these
three agonists utilise widely differing transduction machinery (PAF acts via
a G-protein-linked receptor and primes very rapidly, TNF interacts with a
receptor trimer and induces priming in 10-30 min, and LPS complexes with
LBP to activate transduction processes via CD14 but requires 60-120 min to
establish the primed state).
Agonist concentrations and incubation conditions were selected to produce
equivalent priming of fMLP-stimulated CV release (LPS 100 ng/ml for 60
-120 min, TNFa 200 U/ml for 30 min and PAF 100 ng/ml for 10 min).
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Unfortunately, different batches of LPS (from the same supplier) were found
to vary in their priming efficacy (see, for example, Figure 3.3 versus Figure
3.6); additionally, although washing procedures were standardised, it is
possible that exposure of neutrophils to serum proteins during
centrifugation through plasma/Percoll gradients may have affected their
responses (Figure 3.2). For this reason, in some experiments 1% heat-
inactivated serum was included with LPS in the incubation medium. The
activity of TNFa in U/ml, rather than the concentration, was kept constant
since wide variations in the activity per mg were quoted for different batches
of the reagent (again from a constant supplier). When experimental
protocols necessitated further manipulation of neutrophils or extra
incubation steps, simultaneous determinations of fMLP-stimulated O2"
release were performed to ensure that the cells were not primed by the new
experimental conditions (see, for example, Figure 7.4).
Cell-cell and cell-matrix interactions provide communication between cells
and their environment, and are essential to the development and
maintenance of inflammatory responses. Recruitment of leukocytes to sites
of inflammation and infection is dependent on the carbohydrate-binding
selectin glycoproteins, the integrins and the immunoglobulin superfamily
members. Priming agents have been shown to regulate neutrophil adhesion
molecule expression in an agonist-specific fashion. LPS, TNFa and PAF all
upregulated integrin expression and decreased neutrophil CD62-L
expression (Figures 4.2-4.4); however, the effects of PAF on CDllb were seen
at lower concentrations than those required to influence CD62-L (EC50 38±12
nM versus 102±23 nM respectively) whilst for LPS, the opposite was true
(EC50 for CDllb upregulation >204±49 ng/ml, and for CD62-L loss 53±6
ng/ml). TNFa affected CDllb and CD62L expression with fairly similar
potency (EC50 138+35 U/ml versus 71±24 U/ml). For each agonist, the time-
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course for modulation of adhesion molecule expression correlated closely
with the time-course for augmentation of the stimulated respiratory burst
(Figures 4.6 and 4.7 versus Figure 3.6). Priming agents also caused a
profound upregulation of integrin function, as judged by the binding of
ACLB; this event is probably as critical to neutrophil adhesion as the
upregulation of integrin expression (Vedder and Harlan., 1988). Modulation
of neutrophil adhesion molecule expression may represent a mechanism
whereby priming agents alter subsequent responsiveness to activating
stimuli, since engagement of integrins also initiates multiple signalling
cascades (Clarke and Brugge, 1995), and upregulation of integrin expression
may promote such signals. While this may be of limited relevance to cells
maintained in suspension (as examined throughout this thesis), integrin
engagement is essential for the conversion of TNFa and GM-CSF from
priming agents to powerful secretagogues (Nathan et al., 1989a).
In HL-60 cells differentiated towards neutrophil maturation, the fMLP
receptor is coupled to PIC via Gia2 and Gia3( (Uhing et al., 1987, Gierschik et
al., 1989). In neutrophils, the major isoenzyme of PI3K responsible for
phosphorylating PtdIns(4,5)P2 to PtdIns(3,4,5)P3 is coupled to G-proteins
and not regulated by tyrosine kinases as is the conventional p85/pll0
isoenzyme (Stephens et al., 1994 , Stoyanov et al., 1995 and Figure 7.7).
Furthermore, upregulation of membrane-associated Gia2 has been
demonstrated to occur on incubation of neutrophils with LPS (Yasui et al.,
1992), GM-CSF (Durstin et al., 1993) and TNFa (Klein et al., 1995). In view of
these findings, a detailed study to examine the relationship between Gja2
translocation and priming by LPS, TNFa and PAF was undertaken. All
three priming agents increased the detection of Gitt2 in neutrophil
membranes, the time-course of this upregulation correlating closely with the
time-course for augmentation of the fMLP-stimulated respiratory burst
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(Figures 5.1-5.3 compared to Figure 3.6). However, the degree of
upregulation of Gia2 expression and function was far less than the
corresponding upregulation of stimulated O2" production. Since little or no
augmentation of the Ins(l,4,5)P3 response to submaximal concentrations of
fMLP was seen in primed cells (Chapter 6), it is unlikely that the modest
degree of G-protein upregulation is relevant in this signalling pathway,
although it could make a minor contribution to the augmented
PtdIns(3,4,5)P3 effect (see Chapter 7 and below).
Few previous studies have addressed the role of Ins(l,4,5)P3 (the signalling
molecule responsible for release of Ca2+ from intracellular stores) in
neutrophil priming, although modulation of basal and peak Ca2+ levels has
been implicated as a mechanism underlying the effects of priming agents
and the Ca2+ transient itself is essential for secretagogue-induced activation
of the respiratory burst (Forehand et al., 1989, Finkel et al., 1987, Dewald et
al., 1988). A detailed investigation of the effects of priming agents on basal
and fMLP-stimulated Ins(l,4,5)P3 accumulation was therefore undertaken,
using a mass assay to minimise the need for additional manipulation of the
cells under study. fMLP (100 nM) alone induced maximal Ins(l,4,5)P3
accumulation that was not augmented by preincubation under optimal
priming conditions with any of the priming agents studied (Figures 6.2-6.4,
6.5 and 6.7); under identical conditions, the respiratory burst was minimal in
response to fMLP alone but was enhanced 5-10 fold by priming (Figure 6.1).
A small (but statistically significant) increase in Ins(l,4,5)P3 accumulation in
response to 1 nM fMLP was seen in PAF- and TNFa-primed cells at 10 s
(Figures 6.3 and 6.4); however, neither agent significantly affected the time-
course (0-10 min) of Ins(l,4,5)P3 accumulation induced by either 1 or 100 nM
fMLP (Figures 6.5-6.8 and Table 6.1). These data render an important role
for Ins(l,4,5)P3 in neutrophil priming unlikely. All these studies, however,
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relate to neutrophil populations; when analysed on an individual basis,
neutrophils demonstrate heterogeneity on multiple levels (Gallin, 1984)
including Ca2+ signalling (Yee and Christou, 1993, Eisner et al., 1992) and
respiratory burst activity in unprimed (Fritzsche and de Week, 1988) and
primed neutrophils (Elbim et al., 1994). It is therefore possible (though
unlikely) that enhanced responses in a subpopulation of cells were masked
by unaffected cells.
In company with Ins(l,4,5)P3 signalling, the recently elucidated
PtdIns(3,4,5)P3 signal transduction pathway is critical to the generation of
the neutrophil respiratory burst (Dewald et al., 1988). Additionally,
activation of the small GTP-binding protein p21rac, which is an essential
component of the NADPH oxidase, has been shown to lie downstream from
PtdIns(3,4,5)P3 in PDGF-stimulated membrane ruffling in an endothelial cell
line (Hawkins et al., 1995). Since TNFa does not elicit PtdIns(3,4,5)P3
accumulation in human neutrophils (L. Stephens, personal communication),
we elected to study the effect of preincubation with TNFa on the fMLP-
stimulated PtdIns(3,4,5)P3 signal. It was clearly demonstrated that TNFa
augmented the accumulation of PtdIns(3,4,5)P3 generated in response to
fMLP stimulation. This effect was small but significant 10 s following the
addition of fMLP (an enhancement of 144±11% in primed versus unprimed
cells, Figure 7.6.A) but by 1 min after fMLP stimulation, a time
corresponding to peak O2" generation (Christiansen, 1988 and L. Kitchen,
personal communication) this enhancement was 620+74% (Figure 7.6.B). The
enhancement of O2" generation from the pooled experiments was 393±15%,
suggesting a potentially important role for the prolonged and augmented
accumulation of PtdIns(3,4,5)P3 in the TNFa-primed, fMLP-stimulated
respiratory burst. In the same experiments, changes in the detection of
PtdIns(3,4,5)P3 were closely paralleled by changes in its immediate
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metabolite, PtdIns(3,4)P2, suggesting that the augmented PtdIns(3,4,5)P3
accumulation is not secondary to decreased metabolism.
In view of the wide spectrum of priming agents, it is possible that their
influence on the final common pathway of NADPH oxidase activation may
occur via differing routes. For example, it has been speculated that
PtdIns(3,4,5)P3 may promote dissociation of p21rac from its inhibitor,
rhoGDI, thereby enhancing p21rac translocation to the neutrophil membrane;
other biologically active lipids, including arachidonic acid, also disrupt the
complexation of rac with GDI (Chuang et al., 1993), thus activators of PLA2
could also potentially regulate NADPH oxidase activity via this route.
Phosphorylation of the oxidase component p47Phox is an important step in
respiratory burst activation which is potentially regulated by a number of
tyrosine kinases, including MAPK; the extensive literature on this subject has
been summarised by Hallett and Lloyds (1995), and has not been further
addressed in this thesis.
In conclusion, the work presented in this thesis has demonstrated that
priming agents regulate neutrophil membrane adhesion molecule and Gia2
expression, but do not influence Ins(l,4,5)P3 signalling; the priming agent
TNFa markedly enhanced fMLP-stimulated PtdIns(3,4,5)P3 accumulation, an
effect which may be relevant to the membrane translocation of p21rac, an
obligatory component of the NADPH oxidase.
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